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ABSTRACT 
ABSTRACT 
Photoplethysmography, a technique to measure by optical means volume changes, 
has been known and applied for many years. One of its most popular applications is 
pulse oximetry, a non-invasive method to measure oxygen content in arterial blood. 
It is based on the principle of arterial blood volume changes' due to heart 
contractions, known as systoles. Systolic pulsations appear on the arterial vascular 
system, while blood flow in veins does not normally present pulsations, especially 
at remote parts of the peripheral vascular system, such as the fingers. Therefore, 
pulse oximetry is only applicable to arteries as their pulsations allow for separation 
of the pulsatile components from the rest of the absorbing components. A novel 
non-invasive technique permits the measurement of venous oxygen saturation by 
introducing a series of pulsations in the veins thus allowing the separation of venous 
signal components for calculation of venous oxygen saturation. 
This thesis presents a theoretical model describing the mechanical coupling of 
arteries and veins and its effects in the accuracy of oxygen saturation measurement. 
Hardware and software design of the prototypes used both in the lab and in the 
clinical setting is also presented in detail. A clinical feasibility study was carried 
out, where peripheral venous oxygen measured by Venox was compared to central 
venous oxygen saturation during cardio-pulmonary bypass. A comparative 
calibration of Venox versus a commercial pulse oximeter was performed by using a 
set of light absorbers, a finger phantom and commercially available pulse oximetry 
probes, in order to investigate the accuracy of the prototype. A laboratory trial using 
healthy volunteers was performed, in order to investigate venous de-saturation 
effects and how accurately they can be detected by the venous oximetry method. 
Other laboratory experiments evaluated and validated the theoretical model 
describing the arterio-venous coupling. 
It is concluded that the venous oximetry method and technology are worthy of 
further research. 
ACKNOWLEDGEMENTS 
ACKNOWLEDGEMENTS 
It is a pleasure to acknowledge the major contribution from my supervisors 
Professor Peter R. Smith and Dr Sijung Hu. I am grateful for their guidance and 
support throughout the duration of my research. I would also like to express my 
deep appreciation to my co-supervisor Dr Vassilios Chouliaras for his invaluable 
guidance and support right through the course of my work. I would also like to 
thank all the other members of the Optical Engineering Group for their 
companionship and numerous scientific discussions. I am very thankful to the 
collaborating team led by Prof Tomasz Spy!, Cardiothoracic Clinic, Glenfield 
Hospital, Leicester for their precious efforts, advice and support throughout this 
project. 
I am very thankful to the technicians and other staff from Loughborough University 
for their advice and assistance in realisation of this project. I would also like to 
acknowledge the Department of Electronic and Electrical Engineering for the full 
support of my studentship and BTG plc who have provided financial backing for 
this proj ect. 
Finally, I wish to express my deep appreciation to my wife Niki and to my parents 
for their continuous support and patience throughout the duration of my research. 
11 
CONTENTS 
CONTENTS 
ABSTRACT ............................................................................................................ i 
ACKNOWLEDGEMENTS .......................................................................... .ii 
CONTENTS .......................................................................................................... iii 
1. Chapter 1 - INTRODUCTION ..................................................................... I 
1.1. Background context ...................................................................................... 2 
1.2. Aims and objectives ....................................................................................... 4 
1.3. Plan of thesis .................................................................................................... 7 
2. Chapter 2 - PHYSIOLOGY AND OXIMETRY ................................. .10 
2.1. Oxygen supply in the human body ......................................................... .! 1 
2.1.1. The human cardiovascular system ......................................................... I 1 
'2.1.2. The oxygen transportation mechanism ................................................. .12 
2.1.3. The role of physiological parameters in oxygen supply.and demand .... 13 
2.2. Invasive oximetry methods ........................................................................ 16 
2.2.1. Continuous mixed venous oxygen saturation monitoring ..................... .16 
2.2.2. Continuous central venous oxygen saturation monitoring .................... .18 
2.2.3. Non-continuous peripheral venous oxygen saturation (Spv02) ............. 19 
2.2.4. Limitations and drawbacks of invasive techniques ................................ I9 
2.3. Non-invasive oximetry methods ............................................................. 22 
2.3.1. Blood oxygen measurement using near infrared spectroscopy .............. 22 
2.3.2. Blood oxygen saturation measurement using PPG ................................ 25 
2.3.2.8. Application of photo plethysmography in human tissues ......................... 26 
2.3.2.b. Photoplethysmographic components in human tissues ........................... 27 
2.3.2.c. Photoplethysmographic waveform ...................................................... 28 
2.3.2.d. Principle of pulse oximetry operation .................................................. 29 
2.3.3. The importance of venous oxygen saturation measurement... ............... 30 
2.4. Overview ....................................................................................................... .32 
3. Chapter 3 - MODELLING ........................................................................... 33 
3.1. Venous oxygen saturation measurement.. ............................................ .34 
3.1.1. Artificial venous pulsatile signaL ....................................................... .34 
111 
CONTENTS 
3.1.2. Beer-Lambert model for pulse oximetry ............................................... 36 
3.2. Extension of Beer-Lambert model for venous oximetry .................. .39 
3.2.1. Model hypotheses ................................................................................. .39 
3.2.2. Arterio-venous cross-coupling modelling ............................................ ,42 
3.2.3. Path length elimination from the mode1... ............................................ ,45 
3.2,4. Introduction oftime in the model.. ....................................................... ,47 
3.3. Calibration model.. ....................................................................................... 55 
3.4. Overview ......................................................................................................... 58 
4. Chapter 4 - ENGINEERING DEVELOPMENT.. ................................ 59 
4.1. First generation - prior techno1ogy .......................................................... 60 
4.1.1. PPG system ............................................................................................ 60 
4.1.2. Pressure modulation control.. ................................................................. 61 
4.1.3. Data acquisition system and software .................................................... 61 
4.2. Second generation prototype ..................................................................... 62 
4.2.1. DISC04 PPG system ............................................................................. 64 
4.2.2. Digital pressure modulation control... .................................................... 65 
4.2.2.a. Pressure system configuration ........................................................... 66 
4.2.2.b. Control board communication protocol.. ............................................. 69 
4.2.2.c. Control board system architecture ...................................................... 73 
4.2.3. Data acquisition system and software .................................................... 79 
4.3. Third generation prototype - current version ...................................... 88 
4.3.1. Miniature PPG system ............................................................................ 88 
4.3.2. Automatic digital pressure modulation control.. .................................... 89 
4.3.3. Embedded acquisition system ................................................................ 91 
4.4. Overview ........................................................................................................ 94 
5. Chapter 5 - EXPERIMENTAL INVESTlGATION ........................... 96 
5.1. ·In-vitro comparative ca1ibration ............................................................... 97 
5.1.1. Experimental purpose, protocol and setup ............................................. 97 
5.1.2. Experimental results ............................................................................... 99 
5.1.3. Discussion and analysis ........................................................................ 1 00 
5.2. Experimental investigation of the theoretical model... ...................... l04 
IV 
CONTENTS 
5.2.1. Experimental purpose, protocol and setup .......................................... .104 
5.2.1.a. Arterial-to-venous coupling ............................................................ 1 04 
5.2.1.b. Venous-to-arterial coupling ............................................................. 1 07 
5.2.2. Experimental results ...................................................................... ; ....... 109 
5.2.2.a. Arterial-to-venous coupling results .................................................. 11 0 
5.2.2 .b. Venous-to-arterial coupling results ................................................... 113 
5.2.3. Discussion and analysis ........................................................................ 116 
5.2.3.a. Arterial-to-venous coupling ............................................................... 117 
5.2.3.b. Venous-to-arterial coupling ............................................................... 118 
5.3. Venous oxygen de-saturation investigation ....................................... .120 
5.3.1. Experimental purpose, protocol and setup .......................................... .120 
5.3 .2. Experimental results ............................................................................. 121 
5.3.3. Discussion and analysis ........................ : ............................................... 129 
5.4. Feasibility study in heart surgery patients ............................................ 135 
5.4.1. Experimental purpose, protocol and setup .......................................... .135 
5.4.2. Experimental results ............................................................................. 137 
5.4.2.a. Venous oxygen saturation and blood temperature as a function of oxygen 
consumption ....................................................................•............ 13 8 
5.4.2.b. Venous oxygen saturation as a function of blood temperature ............... 139 
5.4.2.c. Venous oxygen saturation as a function of cardiac index ...................... .141 
5.4.3. Discussion and analysis ........................................................................ 142 
5.5. Overview ...................................................................................................... 146 
6. Chapter 6 - CONCLUSIONS / FUTURE WORK ............................ .148 
6.1. Conclusions ................................................................................................. 149 
6.2. Suggestions for future work. ................................................................... 151 
6.2.1. Design ofa disposable venous oximetry probe .................................... 151 
6.2.2. Design of a reflection-mode probe ....................................................... 153 
6.2.3. Application of venous oximetry to other areas ................................... .154 
6.2.4. Assessment of arterial calcification ...................................................... 155 
6.2.5. Calibration at a more central area ....................................................... .155 
6.2.6. In-vitro circulatory calibration system ................................................ .156 
REFERENCES ..................................................................................................... 159 
v 
CONTENTS 
Appendix I. Clinical feasibility study plots ........................................... .171 
Appendix 11. Electronic circuitry ................................................................ 192 
Appendix Ill. Ethical approvals ................................................................... 200 
vi 
INTRODUCTION 
1 INTRODUCTION 
Non-invasive measurement of oxygen saturation can be performed on arterial 
blood only with the current technology. The principal factor limiting the non-
invasive measurement of venous oxygen saturation is the lack of pulsations 
in the peripheral venous flow, although it has been reported that venous 
pulsations can appear at peripheral sites[I,2]. Pulse oximetry employs the 
principle of photoplethysmography (PPG) to distinguish the light absorption 
due to arterial blood by measuring the change of light intensity whenever an 
arterial pulse is detected in the measured area. The arterial pulsatility helps 
distinguish the light absorption due to arterial blood by measuring the 
minimum and maximum light intensity between pulses. Given that other 
biological structures do not change their light absorption characteristics over 
this short period of time, the light intensity changes are attributed purely to 
arterial blood volume changes. 
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1.1 BACKGROUND CONTEXT 
The non-invasive measurement of arterial oxygen saturation is very important and is 
currently standard procedure in a variety of clinical and ambulatory environments, 
with the most important application being in anaesthesia, as it provides information 
about the adequacy of oxygen supply to the tissues. Although the value of arterial 
oxygen saturation must be interpreted with great attention and in conjunction with 
other physiological parameters, it is a widely used, rapid assessment tool of oxygen 
supply to the tissues. 
The use of pulse oximeters for the monitoring of arterial oxygen saturation provides 
information on the oxygen supply but it does not offer information on the demand 
for oxygen which is consumed in the human body. The poor supply and demand 
balance is only evident in a pulse oximeter once the cardiovascular system presents 
serious deterioration because of low cardiac output or in severe pathophysiological 
conditions which may affect the carriage or binding of oxygen. A more complete 
image of the oxygen supply and demand would be provided if both arterial and 
venous oxygen saturations were known, in which case clinicians would have a more 
powerful tool to assess the oxygen supply and utilisation. For example, high arterial 
oxygen saturation indicates that there is adequate oxygen in arterial blood to be 
delivered to tissues and organs, but what is really important is how much oxygen 
returns to the lungs, that is the venous oxygen saturation. When the venous oxygen 
saturation drops below certain values which depends on the duration and intensity 
of physical activities, then oxygen reserve mechanisms are activated. This oxygen 
reserve may provide compensation for short periods of time, after which the value 
of venous oxygen saturation can drop to critical levels, often followed by lactic 
acidosis in the absence of oxygen in the metabolic process. 
A novel oxygen assessment technique, capable of measuring arterial and venous 
oxygen saturation non-invasively, is presented in this thesis. The method allows for 
the detection and correction of arterial and venous mechanical coupling which may 
affect the accuracy of pulse oximetry readings under certain conditions. The method 
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allows not only the real-time 'monitoring of oxygen consumption in tissues but it 
also provides a valuable tool for the correction of errors in conventional pulse 
oximetry, caused by arterio-venous mechanical coupling. 
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1.2 AIMS AND OBJECTIVES 
The aims of this thesis are: 
1) To provide an understanding of oxygen supply in the human body, focusing 
on the cardiovascular system, the oxygen transportation system, and the role 
of human physiology in the oxygen supply and demand. 
2) To introduce the fundamental principles of the Beer-Lambert law as applied 
to tissue spectroscopy and to further expand it into a novel opto-
physiological model. 
3) To present the various stages of design and development of the venous 
oximeter with a particular focus on the acquisition systems, the venous pulse 
modulation control system and the importance of modulation depth and 
frequency. 
4) To investigate and validate the performance and accuracy of the venous 
oximeter in a combination of clinical and laboratory environments and to 
explore the clinical significance of venous oxygen saturation in a variety of 
pathophysiological conditions. 
5) To identify and discuss the potential of venous oximetry in other 
applications as well as to suggest further work which can be carried out to 
extend the applicability of the venous oximeter to other sites of the human 
body. 
From these aims, the following objectives become apparent: 
1) To describe the current invasive and non-invasive oximetry techniques, what 
are . their advantages and disadvantages, and what is the importance of 
venous oxygen saturation as a physiological parameter (aim 1). 
2) To describe the role of oxygen in the human body and how it is transported 
from the heart to the tissues and vice-versa, to provide an insight into the 
human cardiovascular system and to elucidate the role of human physiology 
in oxygen utilisation and the importance of venous oxygen saturation 
measurement (aim 1). 
3) To provide an overview of the invasive venous oxygen saturation 
measurement methods in terms of their limitations and underlying risks for 
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the patient and to introduce the application the Beer-Lambert law, in 
conjunction with spectroscopy and photoplethysmography, in the non-
invasive measurement of arterial and venous oxygen saturation (aim 1). 
4) Starting from first principles in fundamentals of light propagation, to 
develop a theoretical model in order to describe the arterial and venous PPG 
signals under certain physiological and anatomical conditions. The model 
will provide the means of defining the optimal operating conditions of the 
artificial venous modulation system as well as the possibility to introduce a 
method of correcting arterial oxygen saturation obtained from pulse 
oximeters (aim 2). 
5) The development of three different generations of prototypes will outline the 
course of functionality improvement, by introducing a digitally controlled 
pulse modulation board and two generations of photoplethysmographic 
systems, in order to facilitate the automatic and continuous operation of the 
venous oximeter, shifting from a manually controlled to an automatic pulse . 
modulation system (aim 3). 
6) To validate the arterio-venous coupling model through experimental 
protocols specifically targeting the variation of the mechanical coupling 
between arteries and veins (aim 4). 
7) A system calibration will be carried out in order to define the performance in 
terms of measuring the absorbance of haemoglobin and how closely it 
compares with a commercial pulse oximeter. A finger phantom will be 
employed in the investigation of the technique's accuracy, in conjunction 
with a series ofIight absorbers simulating the light absorbance of blood (aim 
4). 
8) A venous oxygen de-saturation study will be performed in order to confirm 
that the device is able to detect the gradual decrease of venous oxygen 
saturation. The venous oximeter will be compared to a blood gas analyser, 
after obtaining blood samples from the participants (aim 4). 
9) A feasibility study in the clinical setting will investigate the performance 
and functionality of the device in real-life conditions and from different 
perspectives. The environmental perspective will test the utility of the device 
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in its operational surroundings (Le. the operating theatre); the feasibility 
perspective will investigate the use of the device with a variety of patients 
who have a range of physiological conditions; the performance perspective 
will cross-validate the results taken from the device with the accepted gold 
standard physiological measurement (aim 4). 
10) The mathematical model describing the effects of arterio-venous mechanical 
coupling will be validated through two different experimental protocols. The 
first experiment will target the investigation of arterial oxygen saturation 
variation follo~ng venous pressure augmentation, thus providing a way to 
detect and correct the error· when the arterial-to-venous coupling is 
significant. The second experiment will demonstrate that the effects of 
mechanical artefact originating from the artificial venous modulation can 
lead to erroneous values of venous oxygen saturation - although these errors 
can be corrected (aim 4). 
11) Design ideas for new disposable and re-usable probes will briefly be 
presented, extending the application of venous oximetry to other sites of the 
body which require the use of a surface-mount probe. In addition, future 
application ideas are presented, including the potential for arterial 
calcification assessment by employing the arterio-venous coupling model in 
a suitable protocol (aim 5). 
12) Suggestions for future work will show the path to the next stage of 
evaluation and optimisation of the venous oximetry system (aim 5). 
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1.3 PLAN OF THESIS 
Chapter 2 starts by introducing the basic principles of oxygen supply to human 
tissues and organs, presenting briefly the cardiovascular system, the mechanisms of 
oxygen delivery, as well as the oxygen supply and demand relationship and the role 
of physiological parameters. Current invasive and non-invasive techniques are also 
discussed including basic operating principles and limitations of the current 
technology. Photoplethysmography and pulse oximetry are presented including the 
operating principles and the techniques used for the calculation of arterial oxygen 
saturation. 
In chapter 3 a novel model is developed to describe the mechanical coupling of 
arteries and veins and how it can affect the measurement of arterial and venous 
oxygen saturation using the novel non-invasive venous oxygen saturation method. 
Whilst physical interpretation of the origin of the arterio-venous coupling is 
explored theoretically, the effects caused to the measured oxygen saturation values 
are investigated experimentally. Through the experimental analysis it is confirmed 
that the mechanical coupling does affect the both arterial and venous oxygen 
saturation values, hence it is concluded that arterial PPG signals can have venous 
components that contribute to the calculation of arterial oxygen saturation. 
Chapter 4 discusses the engineering design and implementation of a next generation 
oximeter that measures both arterial and venous oxygen saturations. Starting from a 
manually-operated prototype device, the latest version of the prototype was 
developed under a different philosophy than conventionally designed experimental 
equipment, taking into account the possibility of delivering prototype devices to 
multiple locations for a fast, large-scale trial to further evaluate the method and if 
necessary, advance the technology even further. The relatively low-cost, easy to 
operate portable embedded prototype device does not require any external 
connections making it a self-contained continuous arterial and venous oxygen 
saturation monitor. 
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An experimental investigation into the validity of hypotheses upon which the model 
was built is presented in chapter 5. The arterial-to-venous effects are investigated 
separately from the venous-to-arterial effects since they required different 
experimental protocols. Also presented in this chapter is the comparative calibration 
of the device against a commercial pulse oximeter when using a finger phantom 
with a series of light-absorbing solutions. Furthermore, the method was tested on 13 
healthy subjects in a venous de-saturation study in order to establish whether the 
device could detect the gradual decrease of venous oxygen saturation when the 
arterial blood supply to the arm was stopped. Finally, the results from a clinical 
feasibility and evaluation study are presented in the last section of the chapter, 
where the device was employed in 23 patients undergoing a heart operation. Results 
from this study have previously been published. 
A S Echiadis, V P Crabtree, J Bence, L Hadjinikolaou, C Alexiou, T J Spyt and S 
Hu, 'Non-invasive measurement of peripheral venous oxygen saturation using a 
new venous oximetry method: evaluation during bypass in heart surgery', in loP 
Physiological Measurement, (2007) Vol 28(8), pp.897 -911. 
V P Crabtree, A S Echiadis, P R Smith, M Boehm, M Qc, J Bence, D Machin, J 
Swanavelder, C Alexiou, G Doukas, W Pidgeon, L Hadjinikolaou and T J Spyt, 
'Prospective Venox Feasibility Study', In: Proceedings of the 27th Annual 
International Conference of the IEEE Engineering in Medicine and Biology Society, 
(Shanghai, 2005), pp.1968-1971, ISBN 0-7803-8741-4. 
Chapter 6 briefly reiterates the major achievements of the work and provides 
concluding remarks. Recommendations are also made for further studies in this 
area. 
The references are collected in a common section following the main body of the 
report. Appendices are included that give technical details about the prototype 
device, analytical results from the clinical evaluation and copies of the ethics 
approvals obtained for the studies. 
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Other publications relating to work carried out in photoplethysmography, pulse 
oximetry and the development of the prototype device are listed below: 
S Xin, S Hu, V P Crabtree, J Zheng, V Azorin-Peris, A Echiadis, P R Smith, 
'Investigation of blood pulse PPG signal regulation on toe effect of body posture 
and lower limb height', in Journal of Zhejiang University - Science A, (2007) Vol 
8(6), pp.916-920. 
A S Echiadis, V P Crabtree, P R Smith, 'VENOX - a non-invasive method for 
venous pulse oximetry from the upper limb', Proceedings of the 4th IEEE EMBSS 
UKRI (Reading, 2005), pp.39-40, ISBN 0-9543-1573-1. 
AS Echiadis, V P Crabtree, P R Smith, 'VENOX Technology Implementation', 1st 
ESC Division Conference (Loughborough, 2005), pp.31-34. 
P Y S Cheang, A S Echiadis, P Gibbon, P R Smith, 'Methodology for evaluation of 
an oximetry foot probe', In: Proceedings of the 3rd IEEE EMBSS UKRI 
(Southampton, 2004), pp.19-20. 
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2 PHYSIOLOGY AND OXIMETRY 
Oxygen is a vital element for the survival of living organisms and its 
monitoring is one of the most valuable tools in the hands of clinicians. 
Monitoring the levels of oxygenation can have a number of different 
meanings, such as arterial oxygen saturation and venous oxygen saturation or 
total oxygen supply and demand, all related to each other but each with a 
particular clinical meaning. In order to make an overall assessment of the 
oxygenation, a combination of measurements must be perfonned before a 
clinician can produce an overall clinical image of a patient. Two of the major 
parameters in the assessment of oxygenation are arterial and venous oxygen 
saturations. Arterial saturation can be measured either invasively or non-
invasively but current venous saturation measurement techniques are 
invasive. The introduction of a non-invasive method for the measurement of 
venous oxygen saturation will constitute an important addition to the existing 
clinical tools for the continuous assessment of oxygenation. 
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2.1 OXYGEN SUPPLY IN THE HUMAN BODY 
Hwnan living tissues and organs require oxygen (02) which is delivered via a 
transportation system, the cardiovascular circulatory system. The circulatory system 
serves to transport and distribute essential substances to the tissues and to remove 
metabolic by-products. The circulatory system also serves in homeostatic 
mechanisms such as regulation of body temperature and adjustments of oxygen and 
nutrient supply in different physiologic states. Oxygen delivery to the tissues is 
achieved with the aid of haemoglobin molecules, contained in the red blood cells, or 
erythrocytes. In the lungs, oxygen from the inhaled air attaches to haemoglobin 
molecules and is transported to the cells for aerobic respiration. Carbon dioxide 
(C02) produced by cell respiration is carried by the blood to the lungs for 
elimination in the exhaled air. The oxygen supply and utilisation depends on a 
number of parameters which are briefly presented within this section. 
2.1.1 The Human Cardiovascular System 
The cardiovascular system consists of a pwnp, a series of distributing and collecting 
tubes and an extensive system of thin vessels that permit rapid exchanges between 
the tissues and the vascular channels. The pwnp of the system is the heart. which 
consists of two pwnps in series: the right ventricle to propel de-oxygenated blood 
through the lungs for exchange of C02 and 02, and the left ventricle to propel 
oxygenated blood to the hwnan body. Unidirectional flow through the heart is 
achieved through flap valves which open and close accordingly. Although the blood 
supply from the heart (cardiac output) is intermittent, continuous flow is achieved 
by expansion of the aorta and its branches during ventricular contraction (systole) 
and subsequent elastic recoil of the walls of large arteries that move the blood 
forward during ventricular relaxation (systole). Blood moves through the aorta and 
its arterial branches, which become narrower and their walls become thinner and 
change histologically toward the periphery. The predominantly elastic structure of 
large arteries such as the aorta becomes more muscular until the muscular layer 
predominates at the arterioles. 
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In the large arteries, frictional resistance is relatively small and blood pressure 
values are relatively close to the aortic blood pressure. However, the resistance 
increases in smaller arteries and becomes maximal in the arterioles; hence the 
pressure drop is significant and is greatest in the small arteries and in the arterioles. 
Tissue blood flow is regulated by the adjustment in the degree of contraction of the 
circular muscle and aid in the control of arterial blood flow. In addition to a sharp 
reduction in blood pressure across the arterioles, there is also a change from 
pulsatile to steady flow as pressure continues to decline from the arterial to the 
venous ends of the capillaries, where the oxygen extraction happens. Therefore the 
arterial pulsatile flow caused by the cardiac ejection, is damped at the capillaries by 
the combination of distensibility of the large arteries and frictional resistance in the 
arterioles. 
From each arteriole, many capillaries arise so that the total cross-sectional area of 
the capillary bed is very large, despite the fact that the cross-sectional area of each 
capillary is less than that of each arteriole. As a result blood flow becomes very 
slow and the ideal conditions in the capillaries permit the effective exchange of 
diffusible substances between tissues and blood. On its return to the heart from the 
capillaries, blood passes through venules and then through veins of increasing size 
with a progressive decrease in pressure until it reaches the right atriurn(3J. 
2.1.2 The Oxygen Transportation Mechanism 
Blood consists of red blood cells, white blood cells and platelets suspended in a 
complex solution (plasma) of various salts, proteins, carbohydrates, Iipids and 
gases. Haemoglobin is the main protein in the erythrocytes and consists of haem, an 
iron-containing tetrapyrrole. Haem is linked to globin, a protein composed of four 
polypeptide chains. The iron moiety of haemoglobin binds loosely and reversibly to 
02 to form oxyhaemoglobin. 
In the centre of each haem is one atom of iron, which can combine with one 
molecule of 02. Thus each haemoglobin molecule can combine with four molecules 
of 02. The loading reaction occurs as deoxy-haemoglobin (Hb) and 02 combine to 
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form oxy-haemoglobin (Hb02), which takes place in the lungs. The unloading 
reaction occurs as oxy-haemoglobin dissociates to yield deoxy-haemoglobin and 
free 02, which happens in the systemic capillaries. The reversible reaction of 
haemoglobin and O2 is shown in equation 2.1: 
lungs) 
<. Hb02 
tissues 
[2.1] 
The extent that the reaction will go in each direction depends on the partial pressure 
of O2 in the environment (POz) and the affinity between haemoglobin and O2. High 
P02 in the pulmonary capillaries drives the equation 2.1 to the right in order to 
combine 02 with Hb, while low P02 drives equation 2.1 to the left to promote 
unloading of 02 in the tissue capillaries. The affinity between haemoglobin and O2 
also influences the reaction and depends on pH, temperature aild 2,3-DPG 
(diphosphoglycerate). The affinity is decreased when the pH is lowered and 
increased when the pH is raised, called the Bohr Effect. The net effect is that the 
tissues receive more O2 when the pH is lowered, which can happen when C02 
increases (through the formation carbonic acid). Therefore the Bohr Effect helps to 
provide more O2 to the tissues when their CO2 output (due to high metabolism) is 
increased. The temperature also affects the affinity by decreasing it when the 
temperature is elevated. Therefore, the net effect at high temperatures (for example 
in warmed muscles during exercise) is more 02 being unloaded to the tissues[4J. 
2.1.3 The Role of Physiological Parameters in Oxygen Supply and 
Demand 
The regulation of blood flow throughout the body is an extremely complex system 
which requires substantial clinical knowledge and its complete analysis is not in the 
scope of this thesis. The clinical investigation which was carried out in this work 
included the study of the effects of temperature, blood flow and oxygen 
consumption, parameters which are being controlled either directly or indirectly 
during cardiopulmonary bypass (CPB) in heart surgery. In a typical CPB operation, 
the blood temperature is reduced in order to reduce the rate of metabolism in 
tissues, hence protect them from damage[SJ. The blood flow is directly proportional 
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to the oxygen delivery hence a high cardiac output will result in an elevated venous 
oxygen saturation value. The difference between Sa02 and SV02 (L'l.02) is attributed 
to tissue oxygen consumption, which is a function of cardiac output (CO) (the 
volume of blood pumped by the heart per minute), blood haemoglobin (Hb) 
concentration and oxygen consumption (V02). 
The total oxygen consumption depends on a number of physiological and 
pathological factors. Namely, a physiological factor is the intensity level of 
exercising muscles and their ability to utilise supplied oxygen, while pathological 
factors may include dysfunctional haemoglobin, hypothermia and hyperthermia, 
sepsis and other 'complications in sick patients, where there is impaired functionality 
of the metabolic system. The relation between oxygen saturation and oxygen supply 
and demand is shown in the following modified Fick equation[6]: 
1.306xCOx Hb 
[2.2] 
where SV02 is the mixed venous oxygen saturation, Sa02 is the arterial oxygen 
saturation, V02 is the total oxygen consumption, Hb is the haemoglobin 
concentration and 1.306 is the oxygen combining power of haemoglobin [7]. V02 is 
particularly important in the clinical diagnosis of certain conditions, such as tissue 
hypoxia which may occur when the cardiac output is Iow, hence oxygen supply is 
lower than oxygen demand. The normal cardiovascular response to increasing 
oxygen consumption is the augmentation of CO which may, or may not fully 
compensate for the increased metabolic rate. A Iow value of SV02 does not 
necessarily indicate tissue hypoxia while a normal or high value of SV02 may be 
hiding underlying pathological conditions such as sepsis, where the misdistribution 
of blood flow and the disturbance of mitochondrial oxygen utilisation may cause 
anaerobic metabolism even in the presence of normal or high SV02. Therefore it is 
important that V02 values are interpreted carefully in the context of a wider clinical 
and biochemical picture. 
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The clinical investigation of the method was particularly focussed on the effects of 
temperature, blood flow and oxygen consumption and results are presented in 
chapter 5. 
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2.2 INVASIVE OXIMETRY METHODS 
Oximetry is the tenn used for a range of techniques which are employed for the 
measurement of oxygen saturation in blood. Oximetry can be divided in two main 
categories: arterial and venous oximetry. Arterial oximetry measurement is 
employed in the monitoring of oxygen supply through the arteries while venous 
oximetry investigates the body's demands for oxygen by measuring the oxygen 
transported back to the lungs through the venous vascular system. 
Venous oxygen measurement can be separated in two major categories: invasive 
and non-invasive methods which can be continuous or non-continuous. Continuous 
measurement of oxygen saturation is usually perfonned with electro-optical 
catheters while non-continuous monitoring requires blood samples which can be 
obtained from catheters or by directly drawing a blood sample from the tissue 
region which needs investigation. Continuous monitoring is much preferred because 
it constantly measures the oxygen saturation without requiring further tests, such as 
blood gas analysis. Blood sampling is however used for the calibration of non-
invasive oxygen saturation monitors, such as the heart-lung bypass machine used iJ;l 
heart surgery and the electro-optical monitors which use fibre-optic catheters[81, 
often used during cardiac surgery and post-operatively in the Intensive Care Unit 
(ICV). Continuous and non-continuous venous oxygen saturation can be separated 
in three further categories: continuous mixed venous (SV02), continuous central 
venous (SCV02) and non-continuous peripheral venous oxygen saturation (SpV02)' 
2.2.1 Continuous Mixed Venous Oxygen Saturation Monitoring (SV02) 
Mixed venous oxygen saturation is obtained by inserting an oximetric pulmonary 
artery catheter (PAC) and indicates the balance between oxygen supply and demand 
and therefore provides an way to assess the overall tissue oxygenation, since the 
pulmonary artery carries all venous blood from the right ventricle to the lungs[9,lOl. 
SV02 can be directly measured by using a PAC or it can be calculated from other 
parameters such as the oxygen delivery 002, which is a function of cardiac output 
(CO), haemoglobin (Hb) and arterial oxygen saturation (Sa02). 
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Direct measurement of SV02 is most often carried out by using a pulmonary artery 
catheter which was first introduced by Swan and Ganz in the 1960s and became a 
standard by the 19708. The current monitoring technique is a variation of the Swan-
Ganz catheter and became a standard in the ICU for the post-operative evaluation of 
. heart surgery patients, to monitor the fluid balance in patients with serious burns or 
for the monitoring of patients with kidney disease. The catheter is a long, thin 
plastic tube which contains multiple channels within it. 
The use of P AC involves high risk for the patient and severe complications, since 
accessing the pulmonary artery is a highly invasive procedure. Additionally, the 
requirement for a specially trained clinician to perform the procedure and the 
elevated cost of the catheter increase the health care cost[Il,I2,13,14]. Moreover, in a 
recent overview of the P AC in anaesthesia practice the usefulness of its application 
was questioned[lS]. It was found that among other reasons for the PAC's inability to 
improve outcome, the blood filling pressures measured from the catheter and 
particularly the pulmonary artery 'wedge' pressure, have no physiologic value. The 
wedge pressure has been shown not to correlate with other accepted methods of 
determining left ventricular filling of intravascular volume while it does not help to 
generate cardiac function curves. Therefore, knowledge of it may actually lead to 
incorrect management more frequently than not. 
A typical PAC installation procedure[16] is described as shown in figure 2.1: after 
administration of local anaesthetic, the catheter is fist inserted into a vein usually 
under the collar bone, in the neck, in the arm or in the leg. The P AC in then 
advanced through the vein and through the right ventricle and right atrium it reaches 
the pulmonary artery. It is usually left in place for 24 to 72 hours depending on each 
individual patient. Its primary use is the monitoring of haemodynamic 
parameters[l7], such as the pumping ability and the chambers' pressures of the heart 
which are important indicators for the outcome of surgery. 
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Figure 2.1 - Pulmonary artery catheter installation 
A further variation of the PAC was introduced in the late 1980s where two fibre-
optic bundles were added to the catheter for the transmission and reception of light 
at the tip of the catheter[181. The receiving fibres were then connected to a 
photodetector which converted the light absorption into venous oxygen saturation, 
based on the principles of spectrophotometry and on the fact that blood becomes 
darker as it releases oxygen. Therefore, the darker the colour of blood becomes, the 
less oxygen it contains. This modified PAC is expensive to use and its potential 
complications widely limit its use therefore it is still not being used in all 
haemodynamic monitoring. 
2.2.2 Contiuuous Central Venous Oxygen Saturation (ScvOz) 
Central venous oximetry is performed by inserting a catheter in the superior vena 
cava which carries venous blood from the upper body and it is considered less ri sky 
and less painful, easier to insert and less expensive than the PAC(19,20I. Additionally, 
central venous catheters are routinely used in [CU patients for central venous 
pressure monitoring, vasoactive and others drugs, parenteral nutrit ion and fluid 
resuscitation, therefore measurement of central venous oxygen satw'ation (SCV02) 
can be performed without the need for additional catheteri sation. Hence central 
venous ox imetry is a simple and attractive alternati ve measurement method of SvOz 
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for the initial evaluation of critically ill patients, since it is less risky and less costly 
than PAC[21 1. 
Regarding the similarity of the two parameters (SV02 and SCV02), there is a 
discordance in literature; some studies suggest that SV02 and SCV02 are 
interchangeable[22,23,24,251 but other investigators[26,27,28,29,301 reported that there is 
poor correlation between the two parameters and questioned the usefulness of 
SCV02 measurement. However, in the same studies it was found that there is 
significant correlation between the two parameters only under certain conditions, 
such as heart failure or when the patient is not in shock. 
2.2.3 Non-Continuous Peripheral Venous Oxygen Saturation (SpV02) 
Peripheral venous oxygen saturation (SpV02) is useful in the assessment of more 
confined areas of the human body such as in the adult human forearm[311. Oxygen 
supply to the peripheral tissues of animals under shock and critically ill patients 
have been studied by measuring the partial pressure of oxygen (P02), where it was 
found that the measurement of peripheral oxygenation is a sensitive method of 
studying the progress of shock and resuscitation. Additionally, it was found that the 
measurement of SpV02 in conjunction with exercise protocols can help in the 
diagnosis of peripheral vascular disease (PVDi321. Other applications of SpV02 
include measurement of regional blood flow and muscle oxygenation during intense 
exercise and under physiopathological conditions which present impaired 
oxygenation, such as cardiovascular disease and septic shock[331. 
2.2.4 Limitations and Drawbacks ofInvasive Techniques 
Although continuous and real-time monitoring offered by these techniques is 
extremely advantageous, there are certain aspects which limit their use. For 
example, one of the limitations is the fact that only two wavelengths are used and 
therefore the accuracy of these monitors is affected by the presence of certain 
elements in the blood, such as excess lipids or dyes which can adversely affect the 
perceived redness of blood and therefore obtain false SV02 readings[341. There were 
however further improvements of the two wavelength system, when Baxter 
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addressed the problem by modifYing the processing methods and further studies 
support its accuracy[25,35,36,371, 
Another limitation is the time and skills required to install a catheter. Many patients 
require urgent admission to the operating room therefore an immediate assessment 
of venous oxygen saturation is needed and there might not be sufficient time to 
carry out catheterisation on these patients. Lack of precision during the insertion 
procedure could cause severe complications such as perforation of vessels and may 
prove fatal for the patient. A non-invasive device such as a pulse oximeter to 
measure venous blood would be extremely useful, especially in cases where there is 
not very much time to spare or in the ambulatory setting, where during the 
transportation time paramedics could measure the venous oxygen saturation without 
delay. 
A major drawback of catheterisation is the invasive nature of the measuring probe 
with severe underlying risks for the patient. Resistant bacteria or superbugs, such as 
the methicillin-resistant staphylococcus aureus (MRSA), could enter the body 
through the catheterisation point and cause severe complications which can also be 
fatal, especially for patients with impaired immune system after surgery or 
following a prolonged sickness. Therefore a non-invasive monitor would be 
extremely advantageous in this aspect. 
The high cost of the SV02 catheters is also a problem for clinical management, as 
their multi-channel configuration and the addition of optical fibres for the 
spectrophotometric monitors involve high manufacturing cost, given the fact that 
they require precision engineering and sterilised environment to produce and deliver 
safely to hospitals. There are however studies suggesting that early goal directed 
therapy for patients with severe sepsis, which includes treatment goals for SV02, 
was able to increase survival rate in these patients[381. Therefore, monitoring the 
oxygen saturation of venous blood is extremely important and therefore a non-
invasive venous oxygen. saturation monitor would provide all the advantages of 
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SV02 monitoring without side-effects, risks and cost associated with invasive 
techniques. 
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2.3 NON-INVASIVE OXIMETRY METHODS 
The aforementioned limitations of invasive oximetry methods have driven the 
technology towards alternative solutions, minimising the risk factor for the patient. 
The use of light for diagnostic and therapeutic purposes in the transillumination 
tissue spectrum window extending from about 600 to 1200 nm has become very 
attractive because of the light's ability to penetrate tissues in this range. Penetration 
depth is dependent upon wavelength and ranges from several micrometers to several 
millimetres also depending on the underlying biological structure[391. The Iight-
tissue interaction is of great importance in the development of non-invasive 
monitoring methods since biological tissues are extremely complex with absorption 
and multiple scattering effects dominating the on-going research. 
Over the last few decades there have been several attempts to describe biological 
tissue and light interaction with mathematical models often leading to complicated 
and impracticable solutions. Two of the major competitors in the field of non-
invasively oximetry are Near Infrared Spectroscopy (NIRS) and Pulse Oximetry. 
They can be described as neighbouring technologies since they both utilise the near-
infrared light spectrum, there is however a fundamental difference between the two: 
NIRS requires the knowledge of the light path among other parameters, while pulse 
oximetry is based upon several assumptions which render it more practicable. 
2.3.1 Blood Oxygen Measurement Using Near Infrared Spectroscopy 
The history of near-infrared radiation dates back in 1800 with Herschel concluding 
that there was light radiation beyond what we now know as visible spectrum, 
through his experiments to filter heat from a telescope. After a long period of 
neglect, near-infrared spectroscopy (NIRS) was applied for the first time in the 
1950's by Wilbur Kaye with Beckman Instruments and published two papers which 
established NIR spectroscopy[401• More than 20 years later in 1977, J6bsis published 
the first paper to investigate the use of NIRS for the purposes of the monitoring 
cerebral and myocardial oxygen sufficiency and other circulatory parameters[411. 
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Other studies have followed which investigated cerebral haemodynamics in 
newborn babies, children and adults[42.43.44]. 
In NIRS, the light emitted by light sources which are typically laser diodes in the 
wavelength range between 650 and 900nm, is transmitted into the skin of the 
subj ect. . During propagation through the biological tissues, the light is attenuated 
through both absorption and scattering effects[451. The optical absorption occurs due 
to a number of structures which constitute tissue, and due to other substances such 
as water, cytochrome Cl and Cl3, myoglobin, melanin, bilirubin, lipids and 
haemoglobin which absorb most of the light in the NIR range. Scattering of light 
occurs primarily in the membranes and organelles, where the refractive index 
presents discontinuities. A dominant light absorber in the range between 700nm and 
850nm is haemoglobin in both oxygenated (oxy-haemoblogin, Hb02) and reduced 
format (deoxy-haemoglobin, Hb), with a single isobestic point at approximately 
790nm. After propagating through the tissues, a small part of the light will reach the 
skin through diffusion and scattering effects, where it can be detected at a distance 
from the light source. The spacing between light emitter and detector is very 
important for the sensitivity; when the distance from the emitter is large, the 
detected light will have travelled through a long optical path thus carrying more 
information about the underlying tissue. There is however a trade-off between 
sensitivity and signal-to-noise ratio (SNR), since sensitivity also depends on the 
signal quality but at the same time, in order to achieve a sufficiently high SNR it is 
necessary to limit the distance between emitter and detector[46]. 
The mathematical models and algorithms describing NIRS vary with respect to the 
applied field, for example, a model describing exclusively the concentration 
changes of the three major absorbing species of blood, otherwise known as 
chromophores (Hb02, Hb and cytochrome (X3) is briefly presented. 
An algorithm of NIRS based on a modified version of Beer-Lambert Law using 
three wavelengths[47] is briefly presented, which mathematically relates the 
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absorbance of a substance with the concentration and effective path length of the 
light incident through a linear model. The gel)eralised form of the Beer-Lambert 
Law is expressed as: 
[2.3] 
where /1l. is the specific absorption coefficient (I morl cm-I) which is wavelength 
dependent, L is the effective light path length (cm), C is the concentration of the 
substance (mol rl) and A is the total light absorbance. Therefore, concentration 
changes of chromophores result in a change of absorbance. A further modification 
of the Beer-Lambert Law includes a further parameter G known as the length 
modifier. 
A=/1).xCxLxG [2.4] 
The addition of G compensates for tissue properties and geometrical characteristics 
of the measurement probe, called the optode. If we assume that L, /1l. and G remain 
constant, then the only parameter which can affect the total absorbance is the 
concentration C. 
M = /1). x !:1CxLx G [2.5] 
The three chromophores which are taken into consideration are Hb02, Hb and a3 
and if we consider the absorption of each chromophore separately, the total 
absorption due to all chromophores will be given by: 
A 
--).- = "HbO, xC + "Rb xC + ,,"3 xC L x G ,..). HbO,'" ). Rb"'). "3 [2.6] 
In order to calculate the concentration change of the chromophores, three light 
sources of different wavelengths are required in order to form a system with three 
simultaneous equations. Further discussion of this path length-dependent method is 
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out of the scope of this thesis, which focuses on a path length-independent 
photoplethysmographic approach. 
There are limitations in the application of the modified Beer-Lambert Law in 
biological tissues. Their complex structure which not only absorbs but also scatters 
light is the primary reason for inaccuracies when carrying out measurements in 
living tissue. As a result of the scattering and the inhomogeneity of tissues, it is not 
possible to know the exact path of the light incident or the G factor in the modified 
Beer-Lambert equation, since they both vary with different skin types and body 
characteristics of the subject, such as skin thickness and body fat percentage. 
The problem is currently being investigated with light time-of-flight and phase 
modulation techniques which might turn NIRS into a clinical tool for venous 
oxygen assessment rather than its present use a research tool. The current main 
application of NIRS on physiological measurements is the use of spectrometric 
techniques to measure cerebral oxygenation and perfusion changes. 
2.3.2 Blood Oxygen Saturation Measurement Using PPG 
PPG stands for photoplethysmography (literal translation "registration of population 
through light"), originating from the Greek words "phos" and "plethysmos" which 
translate to light and population, respectively. It was first discovered by Hertzman 
in 1938[48J and it is known for its ability to non-invasively measure volume changes 
and more specifically blood volume changes. It is based upon the simple principle 
of light absorption changes when blood volume changes at the measurement site. 
The cardio-vascular pulse wave which is caused by the heart's contractions can be 
detected throughout the human body since it propagates through arteries. There are 
many different clinical applications of PPG, such as the monitoring of blood volume 
changes, pressure and heart rate[49J, pulse transit time (PTT), with the most 
important application being pulse oximetry[50J. 
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2.3.2a Application of Photo plethysmography in Human Tissues 
The simplicity and the non-invasive nature of this method have resulted in the 
dominance of optical radiation in biomedical applications. Photoplethysmography 
was originally described as a photoelectric method for the blood supply 
measurement in fingers and toes[Sll and in various skin areas. PPG signals can be 
detected by illuminating a tissue region and by placing a photodetector at a nearby 
position or at the opposite side of the measurement site. Blood volume changes 
resulting from the arterial pulsations affect the quantity of light reaching the 
photodetector and result in the formation of a PPG waveform. 
Depending on the relative position between light source and detector, PPG probes 
can be separated in two categories: transmission and reflection mode. Transmission 
mode probes are in the form of a clip that has the light source and the detector 
positioned opposite to each other so that when the probe is applied to the 
measurement site (e.g. the finger), the light source is touching the front side of the 
tissue while 'the detector is placed on the back side of it. Therefore, as the arterial 
blood volume changes through the cardiac cycle, the amount of light reaching the 
photodetector also varies, hence the light is modulated by the vascular bed. In 
reflection mode, both the light source and the detector are positioned on the same 
side of the tissue (similarly to the NIRS optode configuration) and usually a few 
millimetres apart, in order to achieve the desired SNR with the highest possible path 
length and without direct light coupling between source and detector. Reflection 
mode probes allow monitoring on peripheral sites, such as the forehead, limbs and 
chest[S21. 
One of the major applications of PPG is pulse oximetry[S31, a technique capable of 
measuring the oxygen content of haemoglobin in arterial blood. It relies on the 
principle that when two compounds with different absorption spectra are mixed 
together, the ratio of the two concentrations can be derived by measuring the light 
absorbance at two different wavelengths. 
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2.3.2b Photoplethysmographic Components ill Human Tissues 
Light absorption in human ti ssue can be due to many di fferent str uctures such as 
skin, ti ssue (fat or muscle) and bone, as well as due to liquids fo und in the human 
body such as water and blood. All ti ssue structures present a static absorption of 
light, provided that they remain motionless, while light absorption of blood is 
changing because the heart wave changes the blood vo lume. There are two principa l 
components in a PPG wavefonn[54L the dynamicall y changing component (ca lled 
the AC signal) which is due to blood volume changes, and the static component 
(called the DC signal) which represents the constant absorption of all other ti ssue 
components, including blood and other fluids, as shown in fi gure 2.2. The amplitude 
of the AC is usuall y around 1_5%[55J of the amplitude of the DC which however can 
be accurately measured by filtering and amplification of the PPG signal. T he 
amplitude of the AC signal due to arterial pulsations has been described as a 
measure of skin blood perfusion[561, while the value of DC is indicati ve of the 
venous blood volume when employed in comparison methodsL57,581. Therefore, both 
AC and DC components of photoplethysmography are employed in di fferent ways 
which depend on the application, and are of extreme importance. 
Total 
Absorption 
Skin , Tissue, Bone 
DC 
Time 
Absorption due to 
Pulsatile Arterial Blood 
AC 
Static Absorption 
Due to Non-Pulsatile 
Components 
DC 
Figure 2.2 - Photoplcthysmographic components 
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2.3.2c Photo plethysmographic Waveform 
A typical PPG waveform, as mentioned above, can be obtained by amplifying the 
received signal from the photodiode. In well-perfused areas it is often possible to 
observe the changing light intensity just by looking at the DC signal, where small 
amplitude changes occur upon a heart induced wave. However, it is necessary to 
remove the DC offset and amplify the dynamic component (AC) in order to achieve 
high resolution when digitising the AC signal. If the AC component would be 
digitised without amplification, there would be large errors in the calculation of 
parameters derived from the plethysmograph. Although it is an implicit assumption 
that the AC PPG signal is due to blood volume changes, the over simplistic Beer-
Lambert law of optical transmission does not allow for quantitative formulation 
between the observed pulsations and the underlying physiological dynamics. Whilst 
the received light intensity is dependent on numerous factors (anatomical and 
physiological), appropriate sensor designs coupled with smart techniques to adjust 
the transmitted light intensity[59) and the received intensity gain can result in a 
quasi-static DC component and an amplified AC component suitable for digitisation 
and further signal processing. The separation of the two signal components is of 
dual purpose: to isolate the absorption of dynamically-changed blood (arterial) from 
the absorption of static components, and also to provide a measurement baseline 
(total absorption in absence of arterial pulsation) and to compensate for different 
physiological and anatomical conditions. To achieve this, the AC values are divided 
by the DC val ues in order to normalise the dynamic component. 
The PPG waveform can be used to infer physiological information. For example, it 
can be used to assess the mechanical properties of the arteries by looking at the 
amplitude of the AC signal during posture changes or before and after exercise, for 
example, on diabetics[60). By comparing the measured response before and after, it is 
possible to carry out simple screening tests for neuropathy or atherosclerosis before 
carrying out more complex examinations. Another example is the measurement of 
Pulse Transit Time (PTT) by placing two PPG probes at locations of known 
distance; the measurement of transit time between two set points can provide 
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extremely valuable infonnation about the elasticity of the arteries[61]. A more 
obvious feature of the PPG wavefonn is the dichrotic notch which is a small pulse 
observed immediately after the heart pulse and it is attributed to the pressure wave 
reflection from the lower body at the bifurcations of the arterial tree[62]. Studies have 
shown that this feature slowly disappears with age[63] due to reduced wave 
reflection. 
2.3.2d Principle of pulse oximetry operation 
The degree to which oxygen is chemically combined with haemoglobin is called 
functional arterial oxygen saturation (Sa02i64]. This quantity is defined as the ratio 
of concentration of oxy-haemoglobin (oxygenated haemoglobin, or Hb02) to the 
sum of deoxy-haemoglobin (de-oxygenated haemoglobin, or Hb) and oxy-
haemoglobin Hb + Hb02, shown in equation 2.7. 
SaO = Hb02 xIOO% 
2 Hb+Hb02 
[2.7) 
Sa02 is closely related to the fractional arterial oxygen saturation which is the ratio 
of oxy-haemoglobin to the sum of haemoglobin of all species, including those found 
in small quantities in blood such as carboxyhaemoglobin and methaemoglobin. 
However, the do have an effect in the accuracy of pulse oximeter readings[65.66] so 
they cannot be ignored as part ofthe calibration process. 
The spectroscopic method for measuring the concentration of each species of 
haemoglobin relies on the fact that oxy-haemoglobin has different absorption 
characteristics than deoxy-haemoglobin, as shown in figure 2.3. 
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Figure 2.3 - Absorption spectra of haemoglobin species (lib and HbOz) 
By illuminating the measured area at two wavelengths ),/ and ),2, the intensity of 
light transmitted or reflected (depending on the type of probe used) at the two 
wavelengths is used to calculate the light absorption for each wavelength and hence, 
calculate the oxygen saturation. The method is presented more in detail in chapter 3. 
2.3.3 The Importance of Venous Oxygen Saturation Measurement 
Conventional pulse oximetry provides information about the uptake of oxygen in 
the lungs and the delivery to the tissues, but it does not provide any indication of 
how oxygen is utilised or if it. is enough to fulfil the oxygen needs. Moreover, if 
oxygen consumption is to be measured in a particular region, for example to 
monitor a skin graft or burn, a more localised measurement technique must be 
employed. A non-invasive venous oximeter can provide extremely valuable 
information about the oxygen supply and demand balance not only in the clinical 
setting to monitor patients but also in the ambulatory setting where fast and robust 
decisions must be made in order to preserve the vital functions of the patient. The 
importance of continuous venous oxygen saturation monitoring centrally was 
discussed in section 2.3, but the risks involved clearly show the advantages of a 
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non-invasive venous oxygen saturation monitor which could be employed in a 
variety of applications. Apart from the obvious application in critically ill patients, 
for example during surgery or post-operatively in the intensive care unit, another 
application could be the long-term monitoring of patients who suffer from heart 
insufficiency. In this case their long-term venous oxygen saturation could indicate 
how well the prescription medicines perform by looking at the venous oxygen 
saturation before and after drug administration, where low values of venous oxygen 
saturation for example, would indicate insufficiency of oxygen supply to the tissues. 
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2.4 OVERVIEW 
The basic principles of the oxygen supply via the cardiovascular system were 
presented, in order to provide an overall understanding of the mechanism. A more 
profound analysis of the parameters involved, would certainly provide a lot more 
information and grounds for further analysis but with the main focus of this thesis 
being engineering, the study was confined to the effects of temperature, blood flow 
and oxygen consumption. These parameters, in fact, provide extremely useful 
information about the oxygen supply and demand balance, a very important 
parameter in the clinical management of patients. 
The principles of arterial and venous oxygen saturation were introduced stressing 
the importance of venous oxygen saturation monitoring, especially in critically ill 
patients. Monitoring techniques were introduced and the advantages/disadvantages, 
as well as the limitations of each method were discussed. The use of a catheter for 
the continuous monitoring of venous oxygen saturation was discussed from 
different perspectives, such as clinical usefulness, risks involved and. cost 
efficiency, stressing the importance for a non-invasive venous oxygen saturation 
monitor. 
Non-invasive methods based on simplified Beer-Lambert models were also 
introduced with a particular interest in near-infrared spectroscopy, for which the 
principles of operation were briefly presented, introducing the light absorption in 
tissues and how chromophores affect the overall absorption of the travelling light. 
The principles and applications of photoplethysmography were introduced and 
further discussed in the context of pulse oximetry. The photoplethysmographic 
waveform and the method of extracting particular components for pulse oximetry 
were presented briefly, followed by a more detailed discussion in the following 
chapters. The importance of non-invasive venous oxygen saturation measurement 
concludes this section by highlighting in brief the potential applications of non 
invasive venous oximetry. 
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3 MODELLING 
There are numerous photoplethysmographic models for pulse oximetry 
which were approached from a number of different theoretical perspectives 
to include motion artefact compensation, scattering effects, probe geometry 
etc. The development of a photoplethysmographic model for venous 
oximetry was approached from a physiological and anatomical point of view, 
in order to investigate the mechanical interaction between arteries and veins. 
Previous modelsl67] consider the venous flow to be quasi-static and free from 
any pulsations and this assumption, in fact, works well in pulse oximetry. 
However, the non-invasive venous oximetry method requires the introduction 
of artificial pulsations in the veins by inflating and deflating a cuff which was 
previously assumed to affect only venous flow. The introduction of arterio-
venous mechanical coupling coefficients aims at the more accurate 
description of the venous photoplethysmographic model which is presented 
here, investigating both the arterial-to-venous and venous-to-arterial 
mechanical effects. The experimental protocols are also presented for both 
the photoplethysmographic model validation and the calibration of the 
prototype device. 
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3.1 VENOUS OXYGEN SATURATION MEASUREMENT 
Presently available techniques require either the installation of a catheter in a vein or 
alternatively, collection of a blood sample for gas analysis. Current techniques are 
invasive, require certain skills and they impose risks to the patient. The method of 
venous oxygen saturation measurement is considered to be virtually risk-free, as it 
is non-invasive, and it requires no particular skills to perform a measurement, like 
with pulse oximetry. The similarity with pulse oximetry does not only lie on the 
simplicity of application, but also from a theoretical point of view, the method is in 
a way, an extension of pulse oximetry. The major difference between the two 
methods is the shape of the captured photoplethysmographic signal; traditionally, a 
pulse oximetry waveform is similar to figure 3.1 and is attributed to the changing 
arterial blood volume, which results in changing light intensity captured by the 
photodiode. 
EJECTION 
TIME 
.75aPERIOO 
RATE80IMIN 
DICROTIC 
NOTCH 
Figure 3.1 - A typical PPG waveform 
3.1.1 Artificial Venous Pulsatile Signal 
To separate the venous from the arterial signal, the new method introduces an 
artificial pulsatile signal in the range of 6.5-8Hz into the venous system[65,681, the 
aim of which is to perturb the venous flow. The modulation frequency was chosen 
to be distant from the heart's frequencies. The pulsatile signal is created by inflating 
and deflating a small digit cuff tied around the base of the I sI finger as shown in 
figure 3.2, at a peak pressure below 40mmHg to avoid interfering with the arterial 
system, which carries blood at a higher pressure, 
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Figure 3.2 - Principle of operation of the method 
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A miniature air pump provides the air and a pinch valve dri ven with square pulses 
controls the inflation and defl ation of the cuff (O-40mmHg). Figure 3.3 shows the 
vari ation of cuff pressure and the effect it has on the PPG signal. The shape of the 
pressure sensor signal is similar to a capacitor charging-discharging cycle, which 
means that the cuff is acting as a capac itor. The characteri sti cs of the pressure 
variation are lost however, as it can be seen in the PPG signal. 
PRESSURE SENSOR PPG SIGNAL 
Time 
Figure 3.3 - The effect of miniature cuff pressure on the PPG signal 
The high-frequency component in the PPG signal is slightly di ffe rent in shape, 
because the biological tissues have a certain frequency response and some of the 
cuff pressure frequency components are essentially being fi ltered out. 
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3.1.2 Beer-Lambert Model for Pulse Oximetry 
The commonly employed Beer-Lambert model in pulse oximetry, describes the 
effective optical absorbance of a medium when light travels through a given path 
length. In pulse oximetry, the Beer-Lambert law describes the relation between 
incident and transmitted light which has travelled through the medium, in this case, 
the finger. The transmission of light is a logarithmic function of the density or 
concentration of the absorbing solution, and is also dependent on the path length of 
the absorbing medium. The law can be expressed with the following equation: 
I(A) = MA) exp[-,u(..1.) l] [3.1] 
Where ,u(..1.) is the absorption coefficient and I is the path length, in other words the 
distance between the light emitter and the collector. Io(..1.) is the light intensity of the 
light source and I(..1.) is the received intensity, which is dependent on the wavelength 
of the illuminated light, since the absorption coefficient varies with wavelength. The 
Beer-Lambert law is valid in pure absorbing mediums which have a certain range of 
concentration (molarity) and its accuracy gets reduced when either the concentration 
is very high or if there is a significant scattering component in the medium. 
Additionally, for the law to be valid the path length must be known exactly and no 
other absorbers must exist in the measured solution. It has been shown however, 
that certain assumptions and approximations in pulse oximetry can give a 
reasonable first order solution[691. 
Since living biological tissues and structures are too complex to directly describe, it 
is impossible to know the exact path length of the measured site; there is however 
an important feature which helps take the law one step further and that is the arterial 
blood pulsation. Upon every heart contraction, the arterial blood volume varies and 
therefore the light absorption is different between the systoIic and diastolic phases 
of the cardiac cycle. This allows for the dynamic component of the arterial blood to 
be expressed separately from the rest of the absorbers, such as baseline arterial 
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blood, venous blood, tissue, bone etc. The absorption coefficient can therefore be 
expressed as: 
!-l(A) I = !-ldyn(A) r(t) + !-l,tatic(A) d [3.2) 
where !-ldyn()J is the absorption coefficient of the changing arterial blood volume and 
!-lstatic(A) is the absorption coefficient of the 'static components such as baseline 
arterial and venous blood, tissue, bone etc. r(t) is the time changing path length of 
the dynamic component which is the arterial blood variation, and d is the path 
length of the static components. 
The absorption coefficient of the dynamic component can be further analysed in the 
sense that oxygenated blood has a different absorption curve than reduced-oxygen 
blood. Therefore for a given wavelength of illuminating light, the path length of the 
dynamic component can be expressed as: 
[3.3) 
where 8 is the proportion of haemoglobin that is oxygenated, in other terms, the 
arterial saturation 8a02, !-lHb02 and !-lHb are the extinction coefficients of oxy-
haemoglobin and deoxy-haemoglobin respectively. This equation allows expressing 
the received light intensity at a wavelength A, as a function of oxygen saturation and 
time: 
I(t,A) = Io(A) exp{ -[(8 !-lHbO,(A) + (1-8) !-lHb(A) r(t) + !-lstatic(A) d)} [3.4) 
Therefore it is possible to create instances of the above equations at different 
wavelengths to form a system of equations which can be solved to calculate the 
oxygen saturation 8a02. There are different approaches regarding the calculation of 
8a02 utilizing light intensities, namely the linear peak and valley method and the 
differential method. The new method employs the latter and is described in detail in 
the following sections. 
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Applying the linear differential method, the derivative of the received light intensity 
is given by: 
d[I(t,..1,)] 
-ID (..1,)exp{-[(S,uHbo2 (A) + (1- S),uHb (..1,»r(t) + ,u"ati' (..1,)d]) 
dt 
d[r(t)] 
x [S,uHb02 (A) + (1- S),uHb (..1,)]---,-~ 
dt 
[3.5] 
Assuming that the time variant optical path length change r(t) is not wavelength-
dependent, the ratio of two instances of equation 3.5 eliminates the path length 
dependence. 
In discrete time, 
d[I(t,A,)]/dl = I(t2,A,)-I(t",~,) 
I(t,A,) 1(/3 ,A,) 
AC(A,) 
DC(A,) 
[3.6] 
[3.7] 
where t1 and t2 are the maximum and the minimum of the waveform (AC value) and 
t1<t3<t2. t3 is some point in time between t1 and t2 (DC value)[70J• Therefore the ratio-
of-ratios R is given by: 
R = AC(A,)/ DC(A,) 
AC(..1,2)/ DC(..1,2) 
The calculation of oxygen saturation from R is presented in chapter 5, where 
calibration methods are presented in detail. 
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3.2 EXTENSION OF BEER-LAMBERT MODEL FOR VENOUS 
OXIMETRY 
In section 3.1.1 the artificial pulsation of the venous system was described, which 
penuits the further break down of the absorbing components. The artificial venous 
pulsation helps distinguishing the venous blood from the rest of the absorbing 
components, thus enabling the possibility of calculating venous oxygen saturation 
by employing an algorithm similar to conventional pulse oximetry. The Beer-
Lambert law will be discussed in detail, with particular attention to effects arising 
from the natural arterial pulsations and the artificial venous pulsations. 
Recalling equation 3.1, the Beer-Lambert law combines the physical path length 
and the medium's absorbance into a single definition of optical density, which is 
employed in conventional pulse oximetry. The new model is an extension of the 
Beer-Lambert law, and will consider separately the path length of pulsatile arterial 
blood and artificially pulsatile venous blood, as well as the mechanical interaction 
between the modulating cuff, the arterial and the venous compartments. The model 
has more than one dynamic component: the natural arterial pulsatile blood and the 
artificially generated pulsatile venous blood, as well as three more dynamic tenus 
which arise from the cross-coupling of the two blood compartments and the 
modulating cuff. 
3.2.1 Model Hypotheses 
The model is based upon a sequence of initial hypotheses. Figure 3.4 shows a 
simplified structure of the measured site, which is the 1 sI digit. Human anatomy 
defines two pairs of main blood vessels which run along the sides of the finger, with 
the veins being close to arteries, primarily for heat exchange[7l], as this is one of the 
thenuoregulatory mechanisms of the human body. 
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Figure 3.4 - Simplified representation of blood flow in the finger 
The first hypothesis of the model is regarding the mechanical coupling o f arteri es 
and veins. More specifica ll y, the arteri al expansion during systole introduces 
mechanical stress to the adjacent vein. With the venous vascular system running at 
very low pressure «20mmHg) the hi ghly-pressuri sed arteri al system (between 
80mmHg and 120mmHg in a healthy adul t) affects surrounding ti ssues upon 
expansion, and therefore introduce a change in venous blood flow by momentarily 
di storting the walls of the adjacent vein, therefore the arterial pulse transfers to a 
neighbouring veinl72 l. This arterio-venous coupling is, in fact, one of the venous 
return mechanisms. The coupling will have an effect in the dynamic components' 
path length and the received light intensity will have a dynamic component which 
will not be purely due to arterial blood volume change, but part of it will be due to 
venous blood volume change. As a result, the pulse oximeter will be measuring a 
mixture of arterial and venous blood oxygen saturation and to be more precise, the 
calculated saturation will be lower than the actual va lue, since the venous oxygen 
saturation is lower that the arteri al saturation. 
The second hypothesis is concerning the breakthrough of the artificial pulsation in 
the venous system either by direct induction of the cuffs pressure pulse or by 
coupling of the venous pulses to the arterial compartment. Although there is no 
literature for venous-to-arteri al coupling, the arteriovenous couplingf701 implies that 
there is mechanical coupling arteries and veins, and the artificially generated venous 
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pulsation could in principle transfer to neighbouring ve ins. Hence, when the cuff is 
inflated to a maximum pressure that is higher than the diasto lic pressure, the 
artificial pulses will not only cause change in venous blood Ilow, but will also affect 
arterial blood flow; on the other hand, when the cuff pressure is smaller than the 
arterial pressure, the cuff pulsations will break through to the veins wi th possible 
coupling of the pulse from the venous to the arteri al compartment. As a result of the 
appearance of artifi cial pulsations in the arteri al fl ow, the measured venous oxygen 
saturation will be higher than the rea l value, since the venous dynamic signal 
component will in reali ty be due to a mixture of venous and arterial blood being 
modulated by the cuff. Figure 3.5 illustrates the hypothesis, where the fin ger is 
divided in three sections A, B and C. Section B is where the cuff is positioned and 
light is illuminated and co llected in section C. 
A B c 
Figure 3.5 - Simplified representation of blood flow in the finger 
There are two scenarios during the inflation phase: 
i) The cuff pressure is small and unable to cause any direct disturbance to 
the arteri al system: in thi s case, there is a change in venous blood flow 
and more specificall y, the blood vo lume increases in section C, while it 
decreases in section A. This is because the venous flow is from the 
periphery towards the heart, therefo re referring to fi gure 3.5, from ri ght 
to left . The part ial occlusion of the vein (the degree of which depends on 
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the cuff pressure) causes venous blood pooling in section C resulting in a 
variation of received light intensity, since the additional venous blood 
volume changes the optical path length. On the other hand, venous blood 
volume in section A decreases, as blood continues to flow towards the 
left, through the non-return venous valves. Additionally, there is the 
possibility of venous pulsation transfer to neighbouring arteries based on 
the arterio-venous coupling[70], although is it assumed that the venous-to-
arterial effect is small or insignificant because of the large pressure 
difference between arterial and venous systems, with the latter being 
lower. 
ii) The cuff pressure exceeds the arterial pressure: in this case, there is a 
change in venous and arterial blood flow and more specifically, arterial 
blood volume will decrease and venous blood volume will increase in 
section C upon cuff inflation. This is because the arterial flow is from the 
heart towards the periphery (left to right in figure 3.5) and venous flow is 
from right to left, as described previously. During inflation there is 
probably total occlusion of the vein, since the cuff pressure is a lot 
higher than the venous pressure, but the level of arterial occlusion 
depends on the cuff pressure. On the other hand, venous blood volume 
decreases and arterial blood volume increases in section A. At the 
measured site (section C), the light intensity will change because both 
arterial and venous path lengths change either because of direct break 
through of the cuff pressure to the artery, or indirectly by coupling of the 
venous pulsation into the arterial compartment. 
3.2.2 Arterio-Venous Cross-coupling Modelling 
Starting from first principles, the arterial-to-venous coupling model considers the 
natural arterial pulsations and the mechanical coupling to the venous vasculature. 
Figure 3.6 shows the variation of path length during diastole and systole. 
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Figure 3.6 - Path length changes due to arterial pulsations 
Za is the varying arterial optical path length, Zao is the baseline arterial path length 
(during diastole) and t1Za is the variation of the path length due to the arteria l 
pulsation. Similarly, Zv is the varying venous optical path length, ZVo is the baseline 
venous path length (when the cuff is de flated) and t1Zva is the variation of the path 
length due to the arteri al pulsation. 
The initial hypothesis is the ex istence of mechanical coupling which ori ginates from 
the natural arterial pulsations and breaks through to neighbouring veins[ 7oJ. There 
are connecti ve ti ssues between arteries and veins therefore part of the mechanical 
force ori ginating from the artery is absorbed by the connective tissues, as they 
undergo a degree of compression before mechanical energy is transferred to the 
vein. At thi s point a coeffi cient to describe the degree of arteri al-to-venous coupling 
is introduced, call ed the coupling coeffi cient B. 
The arteri al and venous path lengths considering the artery-to-vein effect can be 
expressed as fo llowing (with reference to fi gure 3.6): 
Za = Zao + t1Za 
and 
Zv = ZVo - t1Zva 
13.91 
13.101 
The opposite signs in equations 3.9 and 3.10 are due to the opposite variations of 
path lengths. In the artery, the natural pulsation is causing expansion of the artery, 
therefore an increase in path length (positive sign), while in the vein , the arteria l 
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expansion causes compressIOn of the vein and therefore the venous path length 
decreases (negative sign). While I:1Za only depends on the arterial pulsation a , I:1Zva 
depends on the following three parameters: the coupl ing coefficient G, the baseline 
venous perfusion leve l having path length ZVo, and the arterial pulsation a. 
Therefore the venous path length may be expressed as foll ows: 
[3.111 
Considering the second part of the model where the venous-to-arteri a l effects are 
described, figure 3.7 shows the variation of the path lengths during the inflated and 
deflated states of the cuff. 
DEFLATED fNFLATED DEFLATED fNFLATED 
ARTERIAL PATH LENGTH VENOUS PATH LENGTH 
Figure 3.7 Path length variations due to artificial venous pulsations 
The path lengths in equations 3.9 and 3. 1 I can now be expressed as: 
Za = Zao + I:1Zo. - I:1Za v 
and 
Zv = ZVo -Ii ZVo 0. + I:1Zv 
13.12[ 
13.131 
Again, the opposite signs 111 equations 3.12 and 3.13 are due to the opposite 
variations of path lengths upon inflation/deflation. Upon inflation, the arteri al flow 
wi ll be decreased due the cuffs mechanical stress app lied to the arterial wall s, 
causing a drop of arterial blood vo lume in section C (referring to fi gure 3.5) and 
therefore the arterial optical path length wi ll decrease. On the other hand, as a result 
of the occlusion of the vein, the venous path length will increase in section C (fi gure 
3.5), since there will be venous blood pooling. I:1Zav will depend on three 
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parameters: the coupling coefficient 0, the baseline arterial perfusion level having 
path length Zao, and the artificial venous pul sation v introd uced through the 
inflation and deflation of the cuff. The refore the arteria l path length may be 
expressed as follows: 
Za = Zao + /,;Za - 0 Zaov [3.141 
Coupling coefficients c and 0 essentiall y describe the same coupling effect but with 
different nature and origin. Since the structure between arteri es and veins is the 
sanle when considering the mode l, then the two coupling coeffic ients wou ld be 
numerically equal if the mechanical effects ori ginating from the artery to the vein 
and vice versa. However, due to the differences of the mechanica l effects, both in 
nature and origin, the arterio-venous coupling coefficient was separated to arterial -
to-venous (c) and venous-to-arterial (b) , since they are independent of each other. 
3.2.3 Path Length Elimination from the Mode1168] 
Calling 10 the light ource intens ity, I the received light intensity and T the 
transmittance of the light absorbing medium (the finger), 1 can be expressed as : 
1= T x 10 [3.151 
For the case of n identical absorbing mediwns, equation 3. 15 may be rewritten as: 
1 = 1" x 10 [3.161 
STATIC ARTERIAL VENOUS 
10 A, 
Figure 3.8 - Block diagram illustrating the transmittance of light through 
different components of the finger 
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Figure 3.8 illustrates the light path as it travels through different components inside 
the finger. The static components have absorbance Al and they include tissue, bone, 
skin, and arterial (during diastole) as well as venous blood, in baseline conditions. 
The dynamic components having absorbances A2 and A3 and path lengths d2 and d3 
are the arterial and venous pulsatile blood, respectively. The received light intensity 
lJ emerging from the static components can be written as a function of the incident 
light 10 based on equation 3.1 : 
[3.17] 
Likewise, the intensity of light h emerging from the pulsatile arterial component is 
a function of its incident light intensity 1/ and can be expressed as follows: 
[3.18] 
Similarly, the light intensity emerging from the pulsatile venous component is a 
function of its incident light h and can be written as follows after substitution of h 
from equation 3.18: 
[3.19] 
Substituting the expression of 1/ (equation 3.17) in the expression for h the light 
emerging from the finger as a function of the incident light intensity 10 is as follows: 
[3.20] 
The effect of light variation produced by the arterial and venous blood volume 
changes is given by the relationship between h and h Defining the change in 
transmittance produced by the arterial and venous components as t1T, we have: 
[3.21] 
CHAPTER 3 46 
Substituting equations 3.17 and 3.20 into 3.21, yields: 
10 exp[-(AA +A2d2 +A3d3)] 
10 exp[-(A1d1)] 
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[3.22) 
The tenn 10 in the numerator and the denominator, as well as the tenn Aldl can be 
eliminated, therefore !:;'T will be independent of the light source intensity and the 
static components. As a result, the change of arterial and venous transmittance can 
be expressed as: 
[3.23) 
Hence, this principle renders the method self-calibrating, since it does not depend 
on the incident light intensity or the particular structure of the finger, since change 
in transmittance is independent of the static components. 
3.2.4 Introduction of Time in the Model 
The next step is to introduce the 'real life' representation of the absorbance and path 
length in the fonn of blood absorbance and arterial and venous path lengths. 
Recalling equations 3.14 and 3.13, the arterial and venous path lengths are given by 
Arterial path length: Za = Zao + !:;.Za - J Zao v 
Venous path length: Zv = ZVo + !:;'Zv - e ZVo a 
Zao and ZVo are the baseline path lengths of the arterial and the venous blood, 
respectively. !:;.Za and !:;'Zv are the changes in the path length, due to the natural 
arterial pulsations and the artificial venous pulsations respectively. J and e are the 
arterial-venous and venous-arterial coupling coefficients respectively. The path 
lengths will now be expressed as functions of time, since they are time variant. aCt) 
is the time variant natural arterial pulsations and v(t) are the time variant external 
venous pulsations. At this point it is assumed that arterial pulsations have a 
frequency range of 0.7Hz to 3Hz (42 to 180 beats/min as a guide), however the 
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minimum and maximum heart rate varies significantly between persons, depending 
on age, level of fitness, and generally by the autonomic nervous system[31. The 
external venous modulation frequency is set higher at 8Hz, in order to make 
possible the separation of the arterial from the venous signal through signal 
processing techniques[661. The arterial and venous optical path length changes can 
now be expressed in the time domain: 
I!.Za = art) Zao 
I!.Zv = v(t) ZVo 
[3.24) 
[3.25) 
The time variant arterial and venous path length changes due to arterial and venous 
cross-coupling can also be expressed in the time domain: 
- 15 Zao v = 15 Zao v(t) 
- e ZVo a = e ZVo art) 
[3.26) 
[3.27) 
The time variant arterial and venous path lengths can be expressed in the time 
domain by substituting 3.24, 3.25, 3.26 and 3.27 into 3.14 and 3.13: 
Za(t) = Zao[1 + art) - 15 v(t)) 
Zv(t) = ZVo[1 + v(t) - e art)] 
[3.28) 
[3.29) 
At this stage equation 3.20 is recalled from the development of the generalized 
model. The intensity h of light emerging from the finger was given by: 
[3.20) 
Introducing comprehensive notations for the absorption coefficients and the path 
lengths, table 3.1 can be constructed. . 
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Table 3.1a - Extinction coefficients of measured biological structures 
Static Components Dynamic Components 
AI Arterial Az VenousAJ 
Tissue, bone, skin and Arterial blood. Venous blood. 
other finger structures. 
/lstatic /la /lv 
Table 3.1b - Effective path lengths of measured biological structures 
Static Components Dynamic Components 
dl Arterial dz VenousdJ 
-Tissue, bone, skin and Pulsating arterial blood. Pulsating venous blood. 
other finger structures. Za(t) Zv(t) 
Zstatic 
-Baseline arterial blood. 
Zao 
-Baseline venous blood. 
ZVo 
Equation 3.20 can now be expressed similarly to equation 3.4 in terms of time, 
introducing also the wavelength A. as a parameter. . 
l(t,A.) = 10 exp[-(,ua Zao + /-Iv Zvo+ J.!static Zstatic) - (,ua Zao art) - O/-la ZU.O V(t)) 
- (,uv ZVO V(t) - e /-Iv ZVO art)~] 
Rearranging 3.30 yields: 
STATIC TERM ARTERIAL TERM 
r------------------------,I '1------------------, 
l(t,A.) = 10 exp[-(J.!a Zao + J.lv Zvo + J.!stalic Zstat/c)] x exp[-(,ua Zao - e flv Zvo) a(t)] 
[3.30) 
x exp[-(,uv Zvo - 0 fla Zao) v(t)] [3.31) 
VENOUS TERM 
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The static term is essentially the light intensity in baseline conditions, in other 
words, the DC component of the PPG signal. At this point, the origin of the cross-
coupling can be seen by expanding equation 3.31 to second order. The Taylor 
expansion of e" is: 
x
2 
e" = l-x+--
2 
[3.32) 
Therefore by approximating the dynamic term (arterial + venous) to second order, 
equation 3.31 becomes: 
l(t,A) '" 10 (A) exp[-,uaZao - ,u,Zvo - ,u"alicZ"atlcl x 
[
1- (,uaZao -c,u,Zvo)a(t) - (,u,Zvo - o,uaZao)v(t) +~(,uazao - c,u,ZVO)2 a2(t)] 
1 2 2 " +-(,u,Zvo -o,uaZaO) v (t)+(,uaZao -c,u,Zvo)(,u,Zvo -v,uaZC/o)a(t)v(t) 2 
[3.33) 
In the absence of pulsations, art) = v(t) = O. Hence the static term (DC) is given by: 
l(t,A} = 10 exp[-(lta Zao + Itv ZVo + It,t.tic Zstatic)] [3.34) 
The dynamic terms (AC) normalised by the static term (DC) can be expressed as: 
ARTERIAL VENOUS ARTERIAL 
[3.35) 
Equation 3.35 shows the origin of light intensity components in the signal, including 
the previously described multiplicative term[65], which is: 
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[3.36) 
It is worth noting that even if there is no mechanical coupling between arteries and 
veins (t: = !5 = 0), the cross coupling term is always finite. This makes physical sense 
as the 'multiplication' of the arterial and venous light intensities can either be 
optical or mechanical (or both) in origin. For example, some of the light will only 
be modulated by arterial blood (ARTERIAL in equation 3.31), by venous blood 
(VENOUS in equation 3.31) and part of it will be modulated by both arterial and 
venous blood, as shown in equation 3.36. ' 
Equation 3.35 can be further simplified, in order to investigate how the cross 
coupling between arteries and veins can be mitigated. By approximating e'x to (I-x), 
considering x (the dynamic term) to be a very small value (1-5% of the overall 
intensity signal[S31) the normalised dynamic term in equation 3.35 is further 
simplified to first order, yielding: 
[3.37) 
According to the model, the arterial and venous path length variations are a function 
of the arterial and venous pulsations. art) is the function which describes the arterial 
pulsations and v(t) describes the venous pulsations. Equation 3.37 can be expressed 
in terms of path length variation, since functions art) and v(t) are unknown. 
[3.38) 
Equation 3.38 is still dependent on the path length. A common technique in pulse 
oximetry is the use of two wavelengths to obtain a ratio of signals, and with the 
assumption that the path length is the same at both wavelengths, oxygen saturation 
calculation becomes independent of the path length. A method of deriving the ratio-
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of-ratios using the separated AC and DC parts of the PPG waveform is presented 
here(731. 
In this method the ratio-of-ratios is determined using derivatives, the instantaneous 
change in path length due to arterial pulsation must also be the same for both 
wavelengths. Recalling equation 3.1 : 
I(A) = 1o(A) exp[ -p(A) l] 
Then the derivative will be: 
dJ(t,A) 
dt 
Jo(A)eXP[-p(A)I( - p(A) :) 
Dividing by I(t,A) yields: 
dJ(t,A)/dt = (_ p(A) dl) 
J(t,A) dt 
Using two wavelengths Al and A2 and taking the ratio of the two equations: 
( d[J~;A,)])/J(t,A,) _ p(A,) dl _ -7-:::-::-:---:-~'-;--- = dt ~ Ratio = p(A,) ( d[I(t'~)])/I(t~) _ p(~) dl - p(~) dt ' dt 
[3.1) 
[3.39) 
[3.40) 
[3.41) 
Equation 3.40 can be expressed in discrete time between two instances t1 and t2. If t1 
and t2 are the minimum and the maximum of the waveform respectively (AC PPG 
component), and a point in time t3 between t1 and t2 (DC PPG componenti681, then 
equation 3.40 yields: 
dJ(t,A)/dt M(A) =_ (A)~l~ J,I(A)-J'2(A) = AC(A) =_ (A)M [3.42) 
J(t,A) J(A) P J,3(A) DC(A) P 
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Applying equation 3.42 to two wavelengths Al and A2 and taking the ratio, yields: 
( d[I~;A,)])/I(t,A,) M(A,)/I(A,) 
(d[I~~)])/I(t,~) = M(~)/l(~) 
=> ACCA,)/DCCA,) - peA,) R 
ACC~)/ DCC~) - p(~). 
- peA,) M 
- p(~) M [3.43] 
From equation 3.42, M(A) is essentially equal to- p.(A)M, which is equal to the 
leA) 
ratio ACCA). Therefore equation 3.38 can be written as: 
DCCII.) 
M(t,A) - -[A(A) - &V(A)]- [V(A) - <£4(11.)] 
l(t,A) 
[3.44] 
where A(A)= ~~~~~ A" is the normalised arterial peak-to-peak signal and 
V(A)= ~~~~~ v,. is the normalized venous peak-to-peak signal. Since the artificial 
venous pulsation is applied at a different frequency (8Hz) than the arterial 
frequency, arterial and venous signals can easily be separated by applying band-pass 
filtering. Equation 3.44 may be applied to two different wavelengths, after arterial 
and venous signals have been separated: 
/ M(t,A,)/I(/,A,») = A(II.,)-&V(A,) Ro 
\M(t,A,)/I(/,A,) o",,'a' A(A,)-&V(A,) 
[3.45] 
[3.46] 
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At this stage e, <5 are unknown and therefore Ra and Rv cannot be evaluated. 
Nevertheless, equations 3.45 and 3.46 may be used to write the explicit relations: 
0= V(A2 )R, -V(.-1,) 
A(A2 )R, - A(.-1,) 
[3.47) 
[3.48) 
In conventional pulse oximetry it is assumed that there the PPG signal is purely 
arterial, therefore e=O. Hence equation 3.45 describing the arterial ratio-ofratios R 
becomes consistent with equation 3.8: 
[3.49) 
whereA().) 
The model is validated experimentally in chapter 5, where the interpretation and 
experimental protocol are described in detail. 
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3.3 CALIBRATION MODEL 
Since the venous oximetry method employs pulse oximetry principles, it was 
anticipated that pulse oximetry calibration curves for arterial blood would extend to 
venous blood. Calibration curves are derived empirically and are usually different 
between manufacturers of pulse oximeters due to particular signal processing 
teclmiques, different probes, different light source wavelengths and other 
parameters which affect signals. The empirical calibration of a pulse oximeter is 
carried out by the manufacturer in a controlled environment where oxygen content 
in air 'is reduced slowly, in order to introduce mild de-saturation of the arterial 
blood. More specifically, the way this works is by 'starving' the lungs in terms of 
oxygen, rendering difficult for the lungs to completely re-saturate venous blood. 
Hence, the smaller the inspired oxygen volume is, the smaller the percentage of 
haemoglobin that carries oxygen in arterial blood will be. During the gradual 
reduction of the oxygen volume, arterial blood samples are taken from the 
calibration volunteers while PPG signals are being recorded with the pulse oximeter 
which undergoes calibration, and the result is an X-Y plot which relates the 
measured oxygen saturation of the blood sample with the signals recorded during 
the sampling period[74]. This plot is the calibration curve which is stored in the 
pulse oximeter memory and serves as a lookup table when PPG signals are captured 
from a measured subject. 
The calibration procedure described involves a certain risk and ethics approval 
which must be obtained prior to testing. Furthermore, due to health risks involved it 
is not permitted to carry out the de-saturation below 60%[68] of measured arterial 
saturation, as oxygen insufficiency might result in tissue damage or organ failure. 
An alternative approach was decided to be followed, which was an in-vitro 
calibration using a finger phantom and light absorbing solutions with different 
absorption characteristics at certain wavelengths. A comparative calibration against 
a commercial pulse oximeter (Nonin 8600) was performed by employing a simple 
finger phantom, similar to a commercially available calibration phantom (Nonin 
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Phantom, Nonin Medical IncFJ). Part of a Nonin Finger Phantom shown in figure 
3.9 was used as a scanering medium, and a set of light absorbers inside the phantom 
shown in figure 3. I 0 simulated the changing absorbance of blood against di ffering 
oxygen saturation values. The simulation of blood absorption was done by 
preparing absorption solutions of Methylene Blue (otherwise known as India ink) 
and Cupric Sul phate Pentahydrate (CUS04·SI-I20). Methylene blue is a strong 
absorber in the red region (peak absorption around 660nm) and cupric sulphate 
absorbs strongly in the near-inf rared region. By mixing the two solutions at 
different proportions, speci fi c absorption ratios can be achieved at the desired 
wavelengths)75) . 
Figure 3.9 - Nonin Finger Phantom light diffuser 
The finger model shown in figure 3. 10 was constructed from a pair of I mm thick 
glass slides cut 1611lm x 76mm x 3mm (width x height x depth). A chamber was 
formed between the two slides using double-sided high density sponge tape of 1 mm 
thjckness, following the contour of the glass to form a watertight container of 1 mm 
thjckness. 
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Figure 3.1 0 - Finger phantom constructed from microscope glass slides (left) 
The entry to the container was kept open to administer the light absorbing so lutions 
and the glass container was then inserted in the Nonin light di ffuser to fo rm the 
optical phantom. The experimental results a re presented in chapter 5. 
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3.4 OVERVIEW 
The new developed model for non-invasive venous oximetry has facilitated a way to 
detect and correct erroneous values of arterial and venous oxygen saturation when 
mechanical coupling occurs between arterial and venous compartments. The first 
section of the model, where the arterial-to-venous mechanical effects are 
introduced, is useful in the case the arterial expansion causes mechanical effects to 
, veins, which would result in lower values of arterial oxygen saturation. The second 
section of the model, where the venous-to-arterial mechanical effects are 
introduced, is useful when a large cuff pressure is required in order to obtain a 
venous signal. Especially in poor peripheral perfusion conditions, the model can 
indicate whether the cuff pressure is large enough to create arterial volume changes 
and therefore cause a higher venous oxygen saturation value which could lead to 
false diagnosis. The finger phantom model has been developed as close as possible 
to the commercially available version and has been successfully used to perform a 
sequence of comparative calibration measurements which are discussed in chapter 
5. 
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4 ENGINEERING DEVELOPMENT 
Over the past few years the prototype device of the venous oximetry method 
has been under continuous improvements in terms of functionality, safety, 
robustness and portability. Functionality was improved to make the device 
operable by non-technical persons, such as nurses and doctors when the 
device would undergo clinical testing. The second generation system was 
designed with a higher functionality, since the method required a clinical 
evaluation in order to identifY the response and sensitivity to different 
physiological parameters. Five second-generation prototypes were built 
(2004-2005) and used successfully in a pilot study, where the feasibility of 
the method was examined in the clinical setting. In this version a 
photoplethysmographic board was used (DISC04, Dialog Devices Ltd) and a 
control board was designed and built. The control board along with the 
photoplethysmographic board were both connected to a laptop computer via 
a single USB connection, making the system more versatile and convenient 
to use. The real-time processing and control software was written on the 
Labview platform and its functionality is described in detail later in this 
chapter. The system was subsequently updated again (2006) to form the third 
generation prototype which is a fully embedded device without the need for 
an external computer. The added value to the third generation prototype was 
the high portability and the simplicity of the system, capable to be operated 
by non-experts. This chapter presents in detail the development stages of the 
hardware and software used for the experimental and clinical evaluation of 
venous oximetry. Appendix II includes the schematic diagrams of the control 
board, as well as the software written for the J.1-controllers. 
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4.1 FIRST GENERATION - PRIOR TECHNOLOGY 
The first generation system which was split in two enclosures required an 
experienced operator, since all controls were manually set, such as the LED 
intensity, the amplifier gain, the cuff pressure level imd other parameters. 
Additionally, an external connection to the parallel port of a computer was required 
therefore overall, it was difficult to transfer the system from one location to another; 
for example, from the operating theatre to the intensive care unit if the device were 
to be used in a clinical study. It was built around a Programmable Logic Device 
(PLD) which was controlled in software via a computer's parallel port. An 
important feature which was missing at this stage was real-time control and display 
of raw data, and signal processing was .performed in Matlab (Mathworks Inc) after 
the end of the recording. Additionally, the setup of the system was performed via a 
script written in Matlab, without any means of control while recording data. The 
lack of this feature was one of the major tasks for the newer prototypes developed, 
since the real-time display of signals (raw and processed) and the ability to control 
certain parameters are important to ensure the correct setup of the acquisition and 
pressure control systems. 
4.1.1 PPG System 
The first generation system is shown in figure 4.1, where the 
photoplethysmographic system was in a separate box from the artificial pulse 
generator. The PPG system was built in-house and it was designed to operate with 
commercially available pulse oximetry probes, as shown in figure 4.1. LED 
intensity and amplifier gain were controllable via the PC through the execution of a 
script in Matlab. 
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Figure 4.1 - First Generation System 
4.1.2 Pressure Modulation Control 
The pressure modulation control system was enclosed in a separate container as 
shown in figure 4.1 and it was controllable via a PLD by execution of a script in 
Matlab, similarly to the PPG system. The pressure modulation was created with an 
air pump and a pinch valve, which was driven with a series of square pulses, at a 
fixed frequency of 6.5Hz. 
4.1.3 Data Acquisition System and Software 
The data acquisition system of the first generation system only allows recording of 
data but not real-time display of the raw signals. Therefore, recorded raw data are 
processed in Matlab after the device has finished recording; the lack of real-time 
processing and display posed a problem should the device be used in a clinical trial. 
Signal quality can degrade over the course of a measurement due to hypoperfusion 
or other physiological responses of the cardiovascular system. The software was 
written in C progranuning language and LED, gain and pressure parameters were 
controlled from Matlab through Dynamic Data Exchange (DDE). 
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4.2 SECOND GENERATION PROTOTYPE - LABORATORY 
TESTS AND CLINICAL STUDIES 
In order to address the lack of functionalities in the first generation prototype, a new 
system was designed around three main axes: functionality, safety and portability. A 
new PPG board (DISC04) supplied by Dialog Devices Ltd was employed in the 
new prototype allowing the real-time control of parameters, while raw signals were 
amplified and filtered before fed into an external data acquisition board (DAQ) for 
analogue-to-digital conversion. Additionally, a pressure control board was designed 
which allowed an air pump and a pinch valve to be connected and controlled via a 
USB connection from the computer. Another important feature was the addition of 
means of modulation frequency selection from software, while the previous 
prototype required the removal and re-programming of the modulation· frequency 
control IC. The second generation prototype also featured an LCD display on the 
front panel of the enclosure, which displayed messages sent from the control 
software. The purpose of the screen was to display status information and for 
debugging purposes, should the communication between the system and the 
computer be lost. The analogue-to-digital conversion of raw data was performed in 
a 14-bit DAQ (USB-6009, National Instruments), which sampled and streamed data 
in real-time to the computer with a 128Hz sampling rate. The software was also re-
designed from scratch and it was built in LabView (National Instruments Inc) with a 
friendly graphics user interface in order to provide easy operation of the device by 
non-experts. Data logging included both raw and processed data, with time stamp in 
both data sets in order to have a point of reference when analysing simultaneous 
recordings from other devices. Additionally, two temperature sensor inputs were 
added to provide a means of comparison between central with peripheral skin 
temperatures which can provide information about blood perfusion[761. Furthermore, 
signal quality indices were added for both arterial and venous signals, in order to 
provide a fast and easy way of assessing whether the current PPG and pressure 
configurations are satisfactorily set. Regarding safety, the second generation 
prototype had a medically approved power supply which was initially installed 
inside the enclosure, but at a later version, an external type was used in order to 
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comply with the latest medical device safety regulations. The overall size and 
weight of the device was reduced vastly, with the fi nal device weighing 
approx imately 2kg (d imensions: W27cm x D27cm x HI Ocm). T he second 
generation prototype was designed in three phases which are shown in figu re 4.2. 
(a) (b) 
(c) 
Figure 4.2 - Second generation prototypes: (a) was employed in a clinical study, 
(b) was designed for the second pbase study and (c) was used for 
laboratory tests 
The system comprises of the following components: 
• An air pump and a pinch valve which are controllable from the computer. 
• A data acquisition board (DAQ USB-6009, National Instruments Inc) 
converts all the PPG board signals to digital data at 14-bit reso lution. 
• A serial-to-USB converter along with the USB hub provide a 
communication channel to the PPG board, the control board and the DAQ 
connect via a single cable to the computer. 
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• A switch mode power supply provides +/- 15V to the PPG board and +15V 
to the linear power supply (PCM50UT05, XP Power Ltd). 
• A custom designed linear power supply provides +5V to the control board 
and + 12V to the pump, the valve and the opto-isolators. Additionally, it 
features two MOSFETs which help to drive the air pump and the valve from 
the PlC. 
A dual-J.lcontroller control board communicating with the computer, drives the LCD 
screen, the air pump and the valve and digitises the output signal of the pressure 
sensor. Furthermore, there is a level translator on-board to convert TTL to RS232 
levels and vice-versa. Figure 4.3 illustrates the block diagram of the prototype. 
Figure 4.3 - Second generation prototype system block diagram 
4.2.1 DISC04 PPG System 
The DISC04 PPG board is a four-wavelength photoplethysmographic system that 
provides all the necessary analogue signal-processing to perform multi-channel 
photoplethysmography or pulse oximetry. Whilst the primary outputs of this board 
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are analogue signals, the majority of system functions are configurable digitally, 
using an RS232 serial communications interface. The board requires a dual power 
supply of ± ISV and it can operate with standard pulse oximetry probes. The LED 
intensities are controllable digitally (8 bit resolution, 30mA or IOOmA selectable 
current), as well as the photodiode amplifier ga in (5 bit resolution wi th linear dB 
scale, 15dB :S Gain :s 77dB, 2dB step). The board provides two output channels for 
each wavelength which contain the raw and the processed output signals. The raw 
signal is essentia ll y the DC signal, if a low frequency low-pass filter is applied to it, 
while the processed signal is the AC signal. The LEDs are pulse-driven by the board 
and signals are de-multiplexed, in order to provide a clean signal, free from ambient 
light artefacts. This system works by switching LEDs sequentially on and off, so the 
ambient light registered during the LED-off period can be subtracted from the 
signal. The switching speed can be set to either I kHz or 2 kHz, depending on the 
probe, and attention must be paid to the photodiode's frequency response since a 
large photodiode will have a certain amount of capacitance which will slow down 
its response. The DISC04 PPG board is shown in figure 4.4. 
Figure 4.4 - DISC04 PPG system board 
4.2.2 Digital Pressure Modulation Control 
The pressure modulation depth and frequency are important for the proper use of the 
art ificial venous pulsation in two ways: 
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1) The pressure modulation depth (pressure of the cuff) must be below the 
arterial systemic pressure otherwise the modulation will also appear in 
arteries, resulting in higher venous oxygen saturation values, as described by 
the model in chapter 3. At the same time, the modulation depth should be 
large enough to introduce artificial pulsations in the venous flow. 
2) The pressure modulation frequency must be away from the heart frequency 
in order to make the artificial venous pulsations distinguishable via 
conventional filtering techniques. Furthermore, according to signal theory, 
the arterial signal will present harmonic components at multiples of the 
heart's frequency, e.g. if the heart beats at 60 beats per minute, that means 
that there will be one beat per second. In arterial signal terms, there will be a 
change of light intensity at the PPG probe every one second, therefore in the 
frequency domain there will be a signal component at 1Hz. The harmonics 
of the arterial signal will therefore appear at 2Hz, 3Hz, 4Hz and so on. 
Although harmonics become smaller and smaller as they become more 
distant from the fundamental frequency of the heart, they can be significant 
in terms of amplitude and possibly comparable to the amplitude of the 
pressure modulated venous signal. The amplitude of the harmonics depends 
on the morphology of the PPG signal, and more specifically most of the 
harmonics are due to the dichrotic notch[771. Therefore, the modulation 
frequency should lie between harmonics, in order to avoid overlapping of 
the venous signal with harmonics of the arterial signal, which would lead to 
false readings. . 
4.2.2a Pressure System Configuration 
The method of creating the pressure modulation was designed in a similar way to 
the first generation system by employing a miniature air pump and a pinch valve. 
The air pump provides the air which inflates the cuff and a two-way pinch valve 
controls the flow of air in and out ofthe finger cuff, in order to create pulsations of 
the cuff which in turn, are transmitted mechanically to veins and other biological 
structures. The arrangement of the pressure modulation system is shown in figure 
4.5. The diaphragm air pump (NMP50KNDC-12V, KFN Neuberger GmbH) is 
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driven from a pulsed voltage source, which is controlled in a microcontroller. The 
air pump can provide up to 4 lImin and can reach a maximum pressure of O.5bar (or 
375mmHg). The output air flow of the air pump is proportional to the rotation speed 
of the air pump motor hence the cuff s pressure is partially controlled by the air 
pump's air flow. The other parameter that affects the cuff pressure is the length of 
the pinch valve pulse which is driven from a pulsed voltage source, controlled by a 
dedicated microcontroller. 
There are infinite combinations of air pump speed and pinch valve pulse length in 
order to achieve the desired cuff pressure during a full cycle. However, not all 
combinations are practicable as one must also consider the length of the tubing 
between the device and the cuff which will need some certain time before pressure 
can be built up. After extended experimentation in order to find the right pinch 
valve pulse width, it was concluded that a square pulse waveform with a 50% duty 
cycle was the most appropriate for the given application and for the range of tubing 
length used with the device, which can be up to approximately 4m long. 
The pressure modulation is created through the switching of a two-way pinch valve 
(075P3MPI2-02B, Bio-Chem Valve !nc) as shown in figure 4.5. The valve has two 
ports which open and close in anti-phase. When port one is open, port two is closed 
and vice-versa, allowing air in and out of the modulation cuff. 
Starting from the top left corner of figure 4.5, air is supplied by the miniature air 
pump and fed to an expandable reservoir which has dual purpose: a) to dampen any 
air pulsations originating from the membranes of the air pump, and b) to build up 
pressure during the deflation phase of the cuff. 
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Figure 4.5 - Pressure modulation system 
The following sequence describes the principle of operation: 
Air 
Escape 
I 
1) This phase is applicable when the modulation is first switched on. The air 
pump is operating and supplying air. Port 1 of the pinch valve is closed 
therefore air supplied by the pump is stored in the reservoir. Port 2 of the 
pinch valve is open therefore the digit cuff is deflated. 
2) The air pump continues to supply air, port 1 opens allowing air into the cuff 
and at the same time port 2 closes restricting outflow from the cuff. The 
digit cuff builds up pressure and exercises force around the finger, altering 
the venous flow, thus creating an artificial pulse in the venous system. 
3) The air pump still supplies air, port 1 closes allowing the reservoir to build 
up pressure, and port 2 opens allowing air out of the digit cuff. The cuff has 
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now completed a full inflate-deflate cycle which caused a full cycle of the 
venous signal. 
Phases 2 and 3 occur continuously one after the other providing a continuously 
changing venous waveform, similar to the natural pulsatile waveform found in the 
arteries but different in frequency. For example when the venous modulation is set 
at 8Hz, then a full inflation-deflation cycle would last 1/8 s, hence at 50% duty 
cycle of the valve driving pulses, each phase would last 1116 s. 
4.2.2b Control Board Communication Protocol 
In contrast to the first generation prototype, the second generation prototype has 
real-time control of the modulation system allowing the setting of the cuff pressure 
and the modulation frequency to the desired values. The heart of the system is the 
electronic control board which provides serial communication (RS232 protocol) 
with a computer and controls the air pump and the pinch valve digitally. The core 
components are two PlC ~controllers (16F876A and 16F628A, MicroChip) both 
driven via a 20 MHz crystal oscillator. The 16F876A provides the serial 
communication, digitises the pressure sensor signal, and controls the LCD message 
screen and the air pump via PWM (Pulse Width Modulation) and drives the second 
~controller (16F628A) which in tum, controls the pinch valve. 
The control board is connected through the PPG DISC04 board to the computer via 
a single USB connection and communicates bi-directionally via the RS232 protocol. 
The control board communication protocol was designed in the same way as the 
PPG board protocol in the sense that the computer can send commands to either 
change or read a value, such as air pump speed or pinch valve operating frequency. 
Furthermore, the command syntaX is the same allowing for easy software 
implementation and modification. In order to distinguish whether a command is 
destined to the PPG or the control board, each one was assigned an ID, with the 
PPG board being IDl and the control board ID2. Therefore, each time there is a 
valid packet with ID=2, the control board reads and executes the command; 
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otherwise the command is ignored. The communication protocol is described in 
Table 4.1. 
Table 4.1 - Control board communication protocol 
Command Command Reply Value 
description PC to Board Board to PC Range 
Set air 
=2AXX<CR> 2A:OXXOK<CR> OO:.sxx::::FF pump speed 
Read air ?2A<CR> 2A:XX<CR> OO:.sxx::::FF pump speed 
Set valve 
=2BXX<CR> 2B:OXXOK<CR> 00:.sxx::::07 frequency 
Read valve ?2B<CR> 2B:XX<CR> 00::::XX::;07 frequency 
Read pressure ?2C<CR> 2C:XX<CR> 00::::XX::;03 
value (HN) 
Read pressure ?2D<CR> 2D:XX<CR> OO:.sxx::;FF 
value (LN) 
SendLCD 
=2EXX<CR> 2E:OXXOK<CR> OO:.sxx::::FF Control command 
ReadLCD ?2E<CR> 2E:XX<CR> OO:.sxx::;FF Control command 
SendLCD 
=2FXX<CR> 2F:OXXOK <CR> OO:.sxx::;FF Data command 
ReadLCD ?2F<CR> 2F:XX<CR> OO::::XX::;FF Data command 
The packet handling is briefly outlined with a flow chart in figure 4.6. 
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Figure 4.6 - Flowchart of the control board packet handling 
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Referring to figure 4.6, as soon as the Jlcontroller receives the first character, it 
checks ifit is the "start of packet" which is either character '=' (set command) or '?' 
(read command). If the received character is neither of the two, it goes back to the 
beginning and waits for the next "start of packet", otherwise it proceeds to the next 
step which is to check if the next character is equal to the control board ID, which is 
set to '2'. If the character is not equal to '2' it exits and returns to the beginning, 
else it continues to the next step which is to check which register is to be set or 
enquired. Register 'A' is for air pump speed, 'B' for valve frequency, 'e' and'D' 
for pressure sensor value (read-only), 'E' for LeD screen control and 'F' for LeD 
screen data. After the Jlcontroller has read which register needs reading or writing it 
proceeds to the next step which is either to retrieve the current value from the 
corresponding register (if it is a 'read' command), or to update the value of the 
corresponding register (if it is a 'set' command). In either case, the Jlcontroller will 
reply back to the computer to acknowledge that the command has been read and 
executed properly, by sending back a similar packet with the ID number, the register 
which has been set or read and the new value of the register. If the packet values are 
out of range or if characters are missing from the packet, the board replies back with 
the word 2:ERR. 
Through this simple procedure the computer can check whether the new register 
value was properly updated. This method of data packet hand-shaking makes the 
use of hardware hand-shaking redundant, since the computer can detect problems in 
the communication channel or in the control board by checking if the sent and the 
received values are matching. Therefore the serial connection channel only requires 
three wires: RX (receive), TX (transmit) and ground reference. Since the embedded 
RS232 hand-shaking facilities are not being used the transmission speed has been 
set to 9,600bps in order to maintain data integrity, although it has been successfully 
tested up to 115,200bps without errors, given that the cable length is very short. 
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4.2.2c Control Board System Architecture 
The control board was built to provide means of digital control of the air pump and 
the pinch valve, as well as to be able to record the cuff pressure waveform. The 
board has two !!controllers which provide serial communication, analogue-to-digital 
conversion (ADC), and digital control of the air pump and pinch valve, as well as 
general function input/output (I/O) ports which are provided for future use. The 
heart of the board is the PIC16F876A which belongs to the 8-bit PlC !!controller 
family of MicroChip. It can be considered the master !!controller of the board, as it 
performs the following tasks: 
• Serial communication with the computer 
• Encoding and decoding of data packets 
• Analogue-to-digital conversion of the pressure sensor signal 
• Air pump speed control 
• LCD screen driver 
• Communication with PIC16F628A 
The second !!controller (16F628A) can be considered as the slave !!controller and 
drives the pinch valve at an adjustable operation frequency set by the master 
!!controller. Referring to Table 4.1, the valve frequency set command may take 
values between hex'OO' and hex'OT and this is because the frequency can be set at 
seven different levels. The method in which the frequency value is sent from the 
master to the slave !!controller is shown in figure 4.7. The master !!controller sets 
port outputs RC3, RC4 and RCS (which are connected to RBS, RB6 and RB7 of the 
slave !!controller respectively) according to the desired frequency and subsequently, 
the slave !!controller reads inputs RBS, RB6 and RB7 and sets the valve frequency 
to the corresponding value. 
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Figure 4.7 - Communication between master and slave !,controllers 
Table 4.2 outlines the range of frequencies and the relevant commands. The 
maximum frequency is set to 8Hz because beyond this point the frequency response 
of the tissues is poor, acting as a low-pass filter, hence the artificial pulsations 
cannot reach efficiently the actual blood vessels. The minimum frequency of 6.45Hz 
was set to be as far away as possible from the harmonics of the heart, in order to 
avoid overlapping with significant arterial frequency components. 
Table 4.2 - List of valve frequencies and corresponding serial commands 
Frequency Serial Set Configuration On-Off Cycle 
Selection (Hz) Command Bits Time (s) 
OFF =2BOO<CR> 000 0 
6.45 =2B07<CR> 111 0.155 
6.67 =2B06<CR> 110 0.150 
6.90 =2B05<CR> 101 0.145 
7.14 =2B04<CR> 100 0.140 
7.41 =2B03<CR> 011 0.135 
7.69 =2B02<CR> 010 0.130 
8.00 =2BOl<CR> 001 0.125 
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The importance of frequency configurability lies in the fact that when hannonics of 
the heart overlap with the fundamental artificial venous components, the result is 
false venous oxygen saturation readings. Figure 4.8 illustrates a case where the heart 
rate is 60 beats/min (1Hz) with the artificial venous modulation being set at 7Hz. If 
the PPG signal is analysed to its frequency components it can be made clear that the 
6th hannonic of the arterial signal will overlap with the artificial venous modulation 
signal. This will cause implications in the accuracy of the venous oxygen saturation 
value, since part of the signal at 7Hz will be originated from the arterial signal. 
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Figure 4.8 - Arterial harmonic overlapping with the fundamental venous 
By constantly measuring the heart rate, the system can adjust the frequency of the 
artificial venous modulation in order to avoid this unwanted effect. Figure 4.9 
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shows how the overlapping can be avoided by shifting the modulation frequency to 
the right by O.5Hz. Hence, by applying a narrow band-pass filter to the PPG signal, 
the venous signal component can be safely recovered. 
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Venous I Cut-offPomts 
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Figure 4.9 - Avoiding overlapping effects by shifting the modulation frequency 
Although the modulation frequency is extremely important to the accuracy of 
venous oxygen saturation values, attention must also be paid to the strength of the 
modulating pulse. The previously explained effects of inflating the modulating cuff 
at high pressures can be overcame by controlling the air pump speed. Although 
there is a large difference between arterial and venous blood pressure in normal 
physiological conditions, it is sufficient to keep the cuff pressure close to the venous 
pressure. However, in non-clinical environments it can be difficult or time-
consuming to obtain venous and arterial blood pressures therefore it is not entirely 
safe to assume that arterial modulation does not occur at a low cuff pressure, since 
arterial pressure in critically ill patients can drop dramatically. On the other hand, a 
higher modulation pressure will be needed should the venous pressure raises above 
normal levels. Given the fact that the complex human cardio-vascular systemic 
governed by the sympathetic and parasympathetic nervous system is extremely 
dynamic, certain parameters such as venous blood pressure could diverge from 
normal values and hence require particular attention when performing 
measurements. 
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The level of cuff pressure (modulation depth) is configurable digitally via the serial 
communication of the control board with the computer, in 255 steps. The master 
Ilcontroller drives the mosfet which powers the air pump with PWM, which is a 
continuous train of square pulses with a fixed frequency of 2.46kHz but with 
different duty cycles. Examples of PWM are shown in figure 4.10. 
1cycle~ 40% duty cycle 
5 
~ 
Q) 
C) 
~ 
~ 
0 40.65 81.30 x 10-3 
Time (5) 
~1cycle~ 20% duty cycle 
5 - - ,....-~ 
~ 
Q) 
C) 
~ 
~ 
0 40.65 
Time (5) 81.30 
x 10-3 
Figure 4.10 - Examples ofPWM provided to the air pump driver 
The air pump response is linear therefore in the first example shown in figure 4.10, 
the air pump provides double the volume of air in comparison with the second 
example. Altering the length of the pulses essentially changes the average voltage 
applied to the air pump. The master Ilcontroller's PWM signal drives a mosfet 
(IRF520) via an opto-coupler (TPL250) in order to avoid back-EMF induced by the 
air pump's motor, as shown in figure 4.11. The opto-coupler's LED is driven 
through a current limiting resistor from the master Ilcontroller's PWM output. The 
signal is optically coupled to the receiver end and then fed into the MOSFET's 
Gate. Diode 01 is forward biased in order to suppress back-EMF coming from the 
air pump's inductive load and capacitor Cl reduces dV/dt in order to reduce the 
magnitude of the air pump's back-EMF. The pinch valve, operated through an 
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identical driver, is a solenoid operated valve and applies an inductive load to the 
MOSFET, therefore a similar design to the air pump was implemented. 
,------ Opto-coupler --------, r- MOSFET driver ----, 
+5V +12V 
2 
G 
3 S 
or 
Pinch Valve 
Figure 4.11 - Air pump and pinch valve opto-coupled MOSFET driver 
When the control board is first switched on, the master flcontroller runs through the 
initialisation routine, part of which is the default setting 'OFF' of the pinch valve by 
setting RC3, RC4 AND RC5 outputs to logic '0'. The PWM generator is also 
switched off initially, which means both the pressure modulation system is switched 
off. In order to set the air pump speed to the desired level, a serial command must 
be sent from the computer, as in Table 4.2. For example, to set the air pump to 
maximum speed (therefore maximum cuff pressure) the following command must 
be sent: 
=2AFF<CR> 
which results in a PWM of 100% duty cycle, or in other tenns, it provides a DC 
voltage. If the desired duty cycle were 50%, then the nearest hexadecimal value 
required would be: 
50% x decimal'255' '" decimal'128' = hex'80' 
Therefore, the serial command would be: 
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=2A80<CR> 
The control board provides 8-bit resolution for the cuff pressure setting. The current 
configuration of the pressure system can provide up to 130-IS0mmHg of pressure 
depending on the size of tubing, hence a pressure resolution of approximately 
O.SmmHg is achieved with the current system. 
The most important functions of the control board were described in this section, 
with a particular interest in the management of the air pump and the pinch valve to 
drive the digit cuff with proper pressure at the right frequency. Other tasks 
performed by the board are the control of the LCD message screen and monitoring 
of the cuff pressure by digitising the pressure sensor output signal. The master 
!!controller performs IO-bit analogue-to-digital conversion and stores the pressure 
value in a memory register, which is continuously compared to a software 
configurable threshold value stored in the !!controller, in order to provide a fail-safe 
mechanism in the case something should go wrong in the system; i.e. the air pump 
will be immediately switched off, if the cuff pressure supersedes the threshold 
value. 
In terms of the configurability, the control board was designed in such a way to 
provide expansion ports for future experiments, such as generic digital I/O ports, 
analogue comparators and analogue I/O ports. Moreover, the master !!controller 
firmware incorporates a boot-loader (Tiny Bootloader), providing an easy way to 
quickly update the function of the control board via USB, without having to remove 
the chip from the circuit board for programming. Hence the second generation 
prototype, a fully configurable system via a single USB connection, provides 
versatility and expandability. 
4.2.3 Data Acquisition System and Software 
The control software is based on the LabView (National Instruments Inc) software 
platform, which provides a fast way to interface a computer with external systems 
as well as to design virtual instruments. The control application has been designed 
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with a simple user interface to allow operation of the system by non-experts. 
Additionally, the touch-screen provides easy operation without the need for a mouse 
or keyboard adding more versatility to the system. The control software can control 
the artificial venous modulation in real time and raw signals along with processed 
values are, displayed on the screen. Additionally, processed values are logged and 
displayed on a history window which can display all the processed parameters by 
selecting the corresponding button on the user interface. 
Raw data are acquired by a data acquisition board (DAQ) which provides 14-bit 
resolution. Logged data include: 
• Red and Infrared AC and DC PPG signals 
• Pressure sensor signal 
• 2x Temperature probe signals 
• Control board supply voltage 
The PPG signals are separated into AC and DC signals. The DC signals represent 
the static components of the finger and the A C signals represent dynamic light 
absorbing components such as arterial blood, and venous blood when the pressure 
modulation operates. Figure 4.12 shows a typical set of PPG signals and the 
pressure sensor signal, when the pressure modulation operates. The correlation 
between the pressure sensor signal and the A C signals is noticeable, while the 
presence of small amplitude changes in the DC signals as highlighted is attributed to 
the arterial pulsations. The A C signals are essentially extracted from the DC signals, 
after removal ofthe offset and subsequent amplification. The raw signals are filtered 
in software and subsequently stored in the computer's hard disk, while they are also 
used in real-time to calculate arterial and venous oxygen saturation values, heart rate 
and signal quality indices. 
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Time 
Figure 4.12 - Typical raw signals 
The DAQ perfonns analogue-to-digital conversion of the PPG signals, the pressure 
sensor signal output and the two temperature probe signals. The analogue PPG 
signals have a range of values between -IOV and + IOV, therefore the DAQ 's 14-bit 
resolution can provide 
Voltage Range 10- (- 10) 20 
resolution = = = ~ 1.22m V 
Conversion Levels 214 - I 16384 - I 
In a typical configuration of the system, ACpk_pk and DCa,g values are ideally set 
between 4V and 6V therefore the resolution ofthe digitised signals is approximately 
SmV. The pressure sensor signal is also cOlmected to an analogue input of the DAQ, 
as well as the two temperature probes, the purpose of which is to monitor the 
temperature at two different sites of the body, for example centrally in the armpit 
and peripherall y on the measured finger. The change of temperature peripherall y 
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will most likely indicate change in blood perfusion[741. Figure 4. 13 illustrates the 
basic processing path of the signals. 
DAQ USB 
PRESSURE TEMPERATURE 
SENSOR PROBES 
Raw and Processed Signals Display 
ARTERIAL 
SIGNALS 
BPF LPF 
0.3 O.IHz 
" 
Ss Buffer 
TI 2 
Real-Time 
Display 
Figure 4.13 - Block diagram of signal processing path. Both arterial and 
venous signal filters are IO'h order HR Buttenvorth. 
The graphic user interface design was based on conm1ercial clinical monitors in an 
attempt to provide a comparable simplicity. The interface provides real-time display 
and history of calculated parameters (updated every Ss) as well as continuously 
plotted raw PPG signals. Additionally, the FFT of the raw signals is also available 
to provide detection of modulation sidebands, which indicate the modulation of 
arteri al blood besides venous blood. Figure 4. 14 shows the graphic user interface 
and the following parameters are shown on the right hand side of the screen: 
• Sa02 - Arterial oxygen saturation %. 
• SV02 - Venous oxygen saturation %. 
• HR - Heart rate in beats/min. 
• P - Average cuff pressure in mmHg. 
• Tm, Tp - Central and peripheral temperature in °c, respectively. 
• aSQ and vSQ - Arterial and venous signal quality index, respectively. 
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Figure 4.14 - Control software graphic user interface 
Sa02 and SV02 are calculated from an empirical calibration formula, after the ratio-
of-ratios R has been obtained from the AC and DC signals at two wavelengths. The 
relation between Sa02, SV02 and R is given by equation 4 .1 [78L 
Sa(v)O = 1000 -550R % 
2 900 - 350R 
[4.1 J 
HR is calculated by detecting the peaks and troughs of the AC signals and 
subsequently measuring the time I between two successive pulsations. The heart 
ratel791 is given by equation 4.2 : 
HR = 60 
I 
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Pressure is calculated from the pressure sensor signal and is an average value. The 
sensor's output is fully conditioned and temperature compensated, providing a 
calibrated value with a maximum error of ±2%. The output signal has a O.SV offset 
and it provides 0.8V {PSI (pounds of force per square inch, I PSI = S1.7149mmHg), 
therefore in order to obtai n a reading in mmHg the fo llowing formula must be 
applied: 
p = VDU1 - VOffie1 
mmll8 0.8 
= V.ut -0.5 x S1.7149 
0.8 
[4.31 
The temperatures are calculated from the calibration curve of the temperature 
probe' s datasheet (adult temperature skin probe 37904, Viamed Ltd). The resistance 
of the probe is converted to voltage in a voltage divider configuration. Figure 4.1 5 
shows the connection method of a temperature probe: 
Vcc 
< RI > 4k7 
< 
.
J T liP 
Temperature Cl =~O.22JlF V1T DAQ Probe RT LT------+--------~'GND 
+ 
-'--
Figure 4.15 - Temperature probe configuration 
From Ohm' s Law1801, the voltage across the temperature probe is given by: 
RI' Vr = x Vcc 
RI' + R, 
[4.41 
The temperature probe's resistance response (from the data sheet) to temperature is 
shown in figure 4.16, whi le a calibration curve relating VI' and temperature can be 
produced frol11 equation 4.4, as shown in figure 4.17 . 
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Figure 4.16 - Temperature probe res istance response to temperature 
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Figure 4.17 - Temperature probe calibration curve 
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Furthermore, the voltage-temperature curve in the range of interest ( 15°C-40°C) can 
fair ly accurately (R2=0.9994) be fitted to logaritlunic equation 4.5, which can be 
used to convert the probe's voltage to temperature (0C) : 
T = - 33.28 1 x InCVr ) + 40.852 °C [4.S[ 
The arterial and venous signal quality indices are correlation coefficients; in the 
case of arteria l signal, the signal quality index is the correlation coefficient between 
the band-pass filtered (0.3Hz-4Hz) red and infrared AC signals, while the signal 
quality index for the venous signal is calculated from the correlation between the 
band-pass filtered (6.0Hz-8.5Hz) infrared signal and the pressure sensor output 
signal, processed through the same filter. 
The top waveform chart displays the raw PPG signals providing visual indication of 
the signal quality, while the bottom window displays the history of each parameter. 
For example, to see the hi story graph of SV02, a touch on the SV02 value would 
show the graph and highlight the SV02 box in grey colour. The same window is 
used to display the FFT plot of the infrared AC signal upon activation from a hidden 
button, for a more technical representation of the signals. The history chart has 
control buttons to zoom into speci fi c parts of the history chart or to move the chart 
forwards or backwards in time. 
The control of the pressure modulation is made via three buttons; one button 
activates/deactivates the modulation and sets the pressure to a default value 
( IOmmHg), and two buttons are used to increase or to decrease the modulation 
depth, which is the digit cuff pressure. The maximum pressure permitted can be 
configu red in software in order to avoid excessive pressure levels, which would lead 
to erroneous venous oxygen saturation values. 
Data logging can be initiated by pressing a button on the screen, after entering 
identification data for the recording, which are subsequently logged as a header in 
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the data fil es. Data are stored in real-time instead to keeping them in the memory 
and purging them in a fi le at the end of the recording, hence providing virtually 
unlimited logging capacity. Logged data are stored in two separate fil es; one fi le 
contains all the raw data sampled at 128Hz for further processing if required, and 
the second file contains all the processed data as shown in figures 3. 18 and 3.1 9. 
Patient's Name: test-2-1 
This is the Raw Data Logger 
Acqu isition Started at: 14:51 :28 on: 21 /05/2007 
Ended at: 14:55:31 on: 21 /05/2007 
Sample rate in samples/second: 128 
IR DC IRAC R DC RAC Press 
2.319 1.273 2.341 0.916 0.982 
2.329 0.902 2.346 0.714 1.008 
2.337 0.567 2.366 0.469 0.852 
2.26 0.199 2.341 0.153 0.638 
2.334 -0.159 2.364 -0.181 0.581 
2.332 -0.428 2.351 -0.419 0.538 
2.4 -0.492 2.308 -0.439 0.52 
2.321 -0.272 2.397 -0.227 0.507 
2.372 0.229 2.343 0.112 0.495 
Figure 4.1 8 - Raw data file layout 
Patient's Name: test-2-1 
This is the Processed Data Logger 
Acquisition Started at: 14:5 1 :28 on: 21105/2007 
Ended at: 14:55:3 1 on: 21105/2007 
Refresh Time: 5 
HR Sa02 Sv02 Press vSQ aSQ Tc Tp IrLED RLED Gain 
99.9 96.6 9 1.7 12.7 95.2 98.6 0 0 255 255 9 
104.8 96.5 93 12.8 95.7 98.7 0 0 255 255 9 
94.8 96.4 91. 1 12.7 95.6 98.5 0 0 255 255 9 
94.5 96.7 92.6 12.7 97 98.5 0 0 255 255 9 
99.2 96.5 92 12.9 95 .8 98.3 0 0 255 255 9 
102 .3 96.5 90.9 12.9 95.5 98.5 0 0 255 255 9 
Figure 4.19 - Processed data file layout 
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4.3 THIRD GENERATION PROTOTYPE- CURRENT VERSION 
The third generation prototype was built as an embedded system without depending 
on external systems or computers. Apart from adopting the approach of designing a 
self-contained device, other significant improvements were implemented within the 
prototype device: An automatic pressure modulation algoritIun was implemented, 
the PPG board was replaced by a miniature-sized board providing digital data 
without requiring a DAQ, and a mini-ITX computer system with a touch screen was 
installed within the custom designed enclosure. The result is a small-sized system 
powered from an external medically approved switch-mode power supply, virtually 
ready to go into the clinical setting for further eva luation of the non-invas ive venous 
oxygen saturation measurement method. 
4.3.1 Miniature PPG System 
The PPG board previously employed in the second prototype was replaced by a 
miniature PPG board (Venox PPG, Shanghai Berry Medical), which supports up to 
four different wavelengths and provides all raw data in a digital format via a RS232 
serial port. The communications protocol was designed in a similar way to the 
control board, while the implemented raw data packet syntax provides simple 
collection and storage and packet integrity check. 
The PPG board is based on a PSoC Mixed Signal Array (CY8C27443-24PVXI, 
Cypress MicroSystems), which performs analogue-to-digital conversion (14-bit), 
digital signal filtering, LED driver control with ambient compensation and serial 
communication via the RS232 protoco l. Its small size factor (80mm x SOmm) 
compared to the previous ly used PPG board (2S0mm x 21 Omm), as well as the low 
power consumption (O.SW) and its ability to operate from a single voltage supply 
rail (+SV), have permitted the design of a small-sized prototype. Additionall y, the 
built-in analogue-to-digital converter has replaced the previously required DAQ 
resulting in a more straightforward system design. Figure 4.20 illustrates the 
miniature PPG board's basic operation principles and fi gure 4.2 1 shows the circuit 
board. 
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Figure 4.20 - Miniature PPG board operation block diagram (LPF is 3 rd order 
f CIlI.ol/= O.lHz; HPF is 3rd order f CIlI.ol/= O.5Hz) 
Figure 4.21 - Miniature PPG circuit board in real size (front side) 
4.3.2 Automatic Digital Pressure Modulation Control 
One of the targets of the third generation prototype design was automation therefore 
an improved pressure modulation system was designed which allows for automatic 
frequency selection of the artificial pulsations. The aim of the algorithm is to 
prevent the artificial modulation frequency from overlapping with the heart's 
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harmonics, as shown in figures 3.8 and 3.9. The software algorithm based upon the 
average heart rate calculated every Ss, checks the condition of equation 4.61661. 
fnlod IIlation :t n x /',carf' n E N 14.6) 
Therefore by measuring the heart rate every Ss, the system calculates the harmonics 
and chooses the best modulation frequency possible, in terms of distance from the 
adjacent harmonics. For exanlple, if the heart rate is 60 bpm, then.li"a,F l Hz and its 
harmonics will be at 2Hz, 3Hz, 4Hz, 5Hz, 7Hz, 8Hz etc. Table 4.3 shows how the 
modulation frequency is selected. 
Table 4.3 - Selection of best modulation frequency for heart rate = 60 bpm 
Frequency Left Harmonic Right Harmonic min(fmO(rJilUrmoll;c) 
Selection (Hz) (Hz) (Hz) (Hz) 
6.45 6.00 7.00 0.45 (max) 
6.67 6.00 7.00 0.33 
6.90 6.00 7.00 0.10 
7.14 7.00 8.00 0.1 4 
7.41 7.00 8.00 0.41 
7.69 7.00 8.00 0.31 
8.00 7.00 8.00 0.00 
Hence, the best modulation frequency when the heart rate is 60bpm would be 6.45, 
since it will be as di stant as possible from the nearby harmonics. A software 
algori thm calculates the heart's harmonics in the range between 6-8Hz and 
compares them with the available modulation frequencies (6.45, 6.67, 6.90, 7. 14, 
7.41 , 7.69 and 8.00Hz), thus selecting the modulation frequency with the maximum 
value of the function min(f.nad- .Ii,.,monIJ, as shown in table 4.3. 
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4.3.3 Embedded Acquisition System 
The second generation prototypes required the use of data acquisition board in order 
to convert PPG analogue signals into digital data. The third generation prototype 
employs a miniature PPG board which features on-board fi ltering and ana logue-to-
digital conversion. The PPG board transmits data packets via a RS232 serial port to 
the computer, which is embedded with the rest of the system. 
The data protocol was designed in such a way to provide data integri ty check by 
means of checksum, while packets are clearly separated from each other with square 
brackets. 
The PPG board outputs packets in HEX fo rmat, containing a single 12 bit va lue (3 
HEX characters) for each of 8 output channels fo llowed by an 8 bit check sum value 
(2 HEX characters) . Each packet starts and ends with square brackets: 
[AAABBBCCCDDDEEEFFFGGGHHHXX][AAABBB ... ] 
where the signals are in the fo llowing order: 
xx is the data integri ty segment (CHECKSUM), which will be calculated in the 
PPG board and then sent within the packet (XX). For a data packet, fo r example 
[I 352F74E43 B65FFAB 1 DA384B--] the checksum would be calculated as follows 
by the PPG board : 
• Step 1: 13+52+F7+4E+43+B6+5f+F A+B I +DA+ 38+4B = 60Ah. 
• Step 2: Drop carry nibble: OAh. 
• Step 3: Get the two's complement ofOAh = F6h. This is the checksum. 
Therefore the packet will look like: 
[1352F74E43B65FFAB 1 DA384BF6] 
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Data integrity can be checked in software in the following steps: 
• Step I: 13+S2+F7+4E+43+B6+Sf+FA+B I+DA+ 38+4B = 60Ah. 
• Step 2: Add the Checksum byte (F6) to the sum (60A) to yield 700h. 
• Step 3: Drop the carry nibble to get OOh. 
Since the result is OOh, the packet has reached the computer without errors. 
Regarding the control of LEDs and photodiode gain, the board accepts commands 
in the following format: 
*Xnnn<CR> «CR>=carriage return) 
where X is the parameter to be changed and nnn is a number between 000 and 063 
for the LEDs, and between 000 and 03 1 for the gains. The board confirms that it has 
received and executed the command by replying: 
XnnnOK 
Table 4.4 shows the registers for each parameter: 
Table 4.4 - Control registers of the miniature PPG board 
Register Parameter Register Parameter 
A LEDI B Gain l 
C LED2 D Gain2 
E LED3 F Gain3 
G LED4 H Gain4 
For example, to set Gainl = IO (decimal), the command would be: 
*BOIO<CR> 
C HAPTER 4 92 
ENGINEER ING D EVELOPMENT 
The board acknowledges receipt of the command by replying between packets: 
[ . .. ]B0 100K[ . .. ] 
Therefore the board is fu lly controllable via a serial connection wi th the computer, 
set at 115,200 bps. 
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4.4 OVERVIEW 
Over the course of investigating thi s non-InvaSive venous oximetry method, a 
number of changes have been made to both, software and hardware. The first 
generation design was a large and very heavy prototype (fi gure 4.1), lack ing real 
time control, di splay and signal process ing, all of which had to be done off- line. 
Additionally, the complexity of the system required the assistance of someone 
familiar with the technology in order to operate the system. One of the most 
important issues when recording is the signal quality and the strength of the 
modulation depth, both very important in the degree of accuracy of the method. 
Figure 4.22 - Third generation prototype 
After several stages of development, the third generation prototype is easy to be 
operated by clinicians, fac ilitating the fast data acquisition on a large scale clinical 
trial. Moreover, by providing real-time processed data such as oxygen saturation, 
heart rate, temperature and signal quality index, it is extremely fast to produce 
stati sti cal numbers from the automatically generated log fil es using standard 
statisti cs software packages. Hence, cl inicians and medical stati sticians can produce 
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results from a clinical trial without the need for post-processing of the raw data. 
While a large-scale trial would previously take long periods to complete, it can now 
be completed in a fraction of the time by providing more prototypes to be operated 
by clinicians. 
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5 EXPERIMENTAL I NVESTIGATION 
The non-invas ive method for measuring venous oxygen saturation has been 
evaluated in four different ways: 
• With an in-vitro experimental setup to perform a comparative 
calibration with a commercial pulse oximeter. 
• In the laboratory with a series of experiments in order to investigate 
the hypotheses of the theoretical model. 
• In the labo ratory setting with 13 volunteers participating in venous 
oxygen de-saturation study, with blood gas analys is facilit ies. 
• In the clinical setting, with 23 patients undergoing heart surgery and 
the heart-lung machine monitor employed as the gold standard . 
All data have been post-processed with functions written in Mallab, although 
real-time signals and values of processed parameters were avai lable during 
data recording. Results from the experiments are presented in separate 
sections further in this chapter. 
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5.1 IN-VITRO COMPARATIVE CALIBRATION 
A comparative cal ibration against a commercial pulse oximeter (Nonin 8600, Nonin 
Medical Inc) was performed by employing a simple finger phantom. A Nonin 
Finger Phantom diffuser shown in figure 3.9 was used as a scattering medium, and a 
set of light absorbers inside a custom-made cuvette shown in fi gure 3.10 simulated 
the changing absorbance of blood against different oxygen saturation values. 
5.1.1 Experimental Purpose, Protocol and Setup 
The finger model was constructed from a pai r of I mm thick glass slides cut 16mm x 
76mm x 3mm (width x height x depth). A chamber was formed between the two 
slides using double-sided high density sponge tape of I mm thickness, fo llowing the 
contour of the glass to form a watertight container of Imm thickness, figure 3.1 0. 
The entry to the container was kept open to administer the light absorb ing solutions 
and the glass container was then inserted in the Nonin light diffuse r shown in fi gure 
3.9 to form the optical phantom. The aqueous solutions were prepared wi th 
Methylene Blue (MB, or India Ink) and Cupric Sulphate Pentahydrate 
(CuS04.5H20) which have different light absorption properti es. Figure 5. 1 
illustrates the stock solutions' absorption curves. 
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Figure 5.1 - Absorption curves of Methylene Blue and Cupric Sulphate 
Pentahydrate in water 
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A total of II different solutions were prepared in order to simulate vary ing values of 
oxygen saturation. The high concentrations of the solutions (0.033x I 0-3M for MB, 
and O. IM for CuS04.5H20) as well as the significant scattering properties of MB 
have not permitted the agreement between calculated and measured absorptions. 
The non-negligible scattering ofMB can cause errors in optical phantom work if the 
ink is assumed to be a pure absorber, due to overestimation of the absorption if thi s 
is determined using spectrophotometry,81] This was also confirmed when measuring 
the calibration solutions with a spectrophotometer (UV- 1650PC Shimadzu, Japan). 
Hence, the calibration so lutions were made empirically by starting wi th a 0.1 M 
solution of CuS04.5 H20 and gradually adding MB unti l the required reading on the 
Nonin oximeter was reached. 
Since the method employs a 6.5-8 Hz artificial venous pulsation, it would be 
preferable to squeeze the phantom at thi s frequency range but the mechanically 
induced motion artefacts and the fact that the commercial oximeter is designed to 
operate within the human heart rate range, could raise questions about the accuracy 
of Sp02 readings . The method processes the high-frequency pulsations (6.5-8Hz) in 
the same way as heart pulsations to obtai n AC and DC levels with different filters 
(BPF 0.3-4Hz for arterial pulsations, BPF 6-8.5I--1z for venous pulsations), hence a 
" Iow-frequency" calibration (I I--1z phantom pulsations) was assumed to be suffi cient 
to investigate the level of agreement between the commercial oximeter and the 
proposed method when measuring oxygen saturation, in general. 
The phantom was mounted upright in a pulse oximetry finger probe, then the top 
part of the watertight container was lightly squeezed rhythmically once per second 
to mimic the pulsatile blood signal by creating small liquid displacements, 
emulating a typical pulse oximetry signal. The oximeter saturation values (Sp02) 
were recorded every 10 seconds for a period of 2 minutes, and this experiment was 
repeated fi ve times to investigate repeatability. The proposed method' s probe was 
then connected to the finger phantom and the above procedure was repeated; 
recorded R values were converted to Sp02 values by using the empirical calibration 
equation 5.1 with u= I000176] 
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5.1.2 Experimental Results 
15.11 
The comparative calibration results have shown exce llent repeatabi li ty with no 
significant deviation and a very close correlation between the prototype device and 
the Nonin oximeter. Figure 5.2 illustrates the calibration curves based on equation 
5.1 before (VENOX U) and after (VENOX C) comparative calibration. 
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Figure 5.2 - Nonin and Venox (the proposed method) calibration curves 
(VENOX U=before calibration, VE OX C = after calibration) 
All percentage Oz values are compared against the R values recorded by the 
prototype device for a given solution. For example, for the first solution the Nonin 
oximeter has shown an average of98. 10% while the prototype device has measured 
an average ratio of 0.48. By using equation 5.1, the corresponding SpOz was 
100.50%. After measuring all the samples it was clear that there was an almost 
constant average offset of 2% between Nonin and the prototype device (Nonin and 
Venox U respectively) . The calibration equation 5.1 was then adjusted so that the 
re-calculated values of the prototype device (Venox C) would fit the Nonin curve 
(Nonin), by adjusting a=1 000 to a=988. Table 5. 1 illustrates averages and range of 
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values from the Nonin oximeter and the prototype device, as well as the average 
ratios recorded by the latter. 
Table 5.1 Measurement results before comparative calibration. 
NONrN 
Average (%) 
98.1 
95.9 
94.8 
89.3 
86.2 
83 .0 
79.9 
76.2 
72.3 
70.7 
62.7 
Range (%) 
98.0-99.0 
95 .0-96.0 
94.0-95.0 
89.0-90.0 
86.0-87.0 
83.0-83.0 
79.0-80.0 
76.0-77.0 
72.0-73.0 
70.0-71.0 
62.0-63.0 
5.1.3 Discussion and Analysis 
VENOX U CUncalibrated) 
Average (%) Range (%) Average R 
100.5 99.8 - 101.6 0.48 1 
97.3 95.7 - 98.3 0.594 
94.8 93.4 - 95.3 0.674 
91.4 90.7 - 92.0 0.772 
88.1 87.2 - 89.4 0.856 
84.9 84.3 - 86.9 0.932 
81.7 81.1-83.1 1.003 
76.9 75.8 - 77.6 1.097 
74.5 71.9 - 76.0 1.140 
72.1 70.2 - 73.6 1.179 
69.4 68.4 - 71.6 1.222 
Recalling the fundamentals of PPG from chapter 2, arterial blood absorbs more 
infrared than red light and as oxygen saturation decreases, red light absorption 
becomes stronger than infrared light absorption. Hence, the arterial system had a 
mixture of MB and CS so lutions which provided a stronger infrared than red 
absorption and thi s was achieved by increasing the concentration of CS (the infrared 
absorber) in the solution. On the other hand, in order to simulate venous blood the 
red absorption must become stronger and as soon as it matches the infrared 
absorption, then accord ing to the standard calibration curve (equation 5.1) the 
saturation becomes 82% (for an absorption ratio R = 1). 
The purpose of the experiment was fundamentally to test whether the electronics of 
the prototype were providing the same ratio of red and infrared signals. For 
example, if a band-pass filter on the circuit board would fai l, there would be an 
imbalance of gain between red and infrared channels, which would lead to false 
readings. It was proven however that the prototype device was close to the 
commercial oximeter with only a quasi -constant 2% difference between them. This 
was attributed to the wavelength di fference between probes which varies between 
manufacturers . Figure 5.3 shows the light spectra of the Nonin probe and the 
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Viarned P861 RA probe in the 800nm-1 OOOnm region. The red light output peaks at 
664nm in both probes. Data were captured with a PCI spectrophotometer 
(ADC2000, Ocean Opti cs). The ji tter in fi gure 5.3 is due to electTi cal noise in the 
spectrophotometer. 
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Figure 5.3 - Infrared light output of Nonin and Viamed (J>861RA) probes 
Figure 5.4 shows the absorption curve of cupric sulphate pentahydrate in the region 
between 880nm and 930nm. 
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Figure 5.4 - Abso'·ption curve of CuS04.5H20 in the 880-920nm region 
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The reason for the 2% difference between the Nonin and the Viamed probes can be 
explained through figures 4.3 and 4.4. Referring to figure 5.3, the infrared emitter of 
the Nonin probe has a maximum peak at 920nm, while the Viamed probe's infrared 
light intensity peaks at 890nm. Moving to figure 5.4, it can be seen that the light 
absorption of CuS04.5I-hO is different between 890nm and 920nm. In fact there is a 
stronger absorption at 890nm than at 920nm. Recalling that the ratio of red/infrared 
signal essentially gives the oxygen saturation, the 920lml emitter will give a 
stronger in frared signal during a pulsation, than the 890nm emitter. This results in a 
smaller ratio which yields a higher saturation value when the 920nm is used; hence 
the average measured difference of 2%. 
Regarding the preparation of the absorbing solutions of MB and CS, the initial 
approach was the theoretical calculation of absorption based on the Beer-Lambert 
law. After preparation of concentrated solutions of MB and CS in water, the 
concentration-absorption curves (Beer's curves) were prepared by diluting the 
so lutions with di stilled water. For CS, the initial concentration of O.5M was reduced 
to O.2SM, O.12SM, O.062SM and 0.0312SM. For MB, the initial concentration of 
4.47x IO-4M reduced to half upon every dilution with water, until it was reduced to 
6.98 x I 0-6M. Figure 5.5 shows the Beer' s curves ofMB at 664nm and CS at 90Snm. 
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Figure 5.5 Beer's curves of CS at 905nm and MB at 6640m 
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It can be seen that CS has a linear concentration-absorption curve but MB does not 
follow Beer- Lambert 's law due to the significant scattering effects. The use of MB 
in opti cal phantoms is di scussed in a study(79] where it was concluded that the 
significant scattering effects of MB can lead to the overestimation of absorption 
when thi s is measured by spectrophotometry, which was also confirmed through the 
experiments as shown in figure 5.5. Further experiments were carried out by using a 
buffer so lution (phthalate) as a so lute instead of di stilled water, but similar results 
were obtained. To resolve thi s problem chemometrics[82] is often used, but further 
investigation was out of the scope of this experiment. The di sagreement between 
values obtained from the spectrophotometer and from the pulse oximeter has led to 
the empirical preparation of the absorbing so lutions and the scope of the experiment 
was successfull y fulfilled. 
Recalling that the aim of the comparati ve calibration experiment was to establish 
whether the PPG circuit board of the experimental prototype provided similar 
values to a standard pulse oximeter, it was concluded that the use of a standard 
pulse oximetry calibration curve was appropriate after modi fi cation of the parameter 
a in equation 5.1, from a= \ 000 to a=988. 
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5.2 EXPERIMENTAL INVESTIGATION OF THE THEORETICAL 
MODEL 
The theoretical model describing the non-invasive method for the measurement of 
venous oxygen saturation presented in chapter 3 investigated the fo llowing two 
aspects relating to anatomical and physiological effects: 
• The mechanical coupling between arteries and veins arising from the 
expansion of arteries when an arterial pulsation is present, and how this 
affects the venous optical path length. 
• The mechanical coupling between veins and arteries arising either from the 
expansion of veins when an artificial venous pulsation is present or from the 
direct modulation of the arteries when the modulation cuff pressure is high 
and sufficient to cause changes in the arterial optical path length. 
A series of laboratory experiments were carried out in order to investigate whether 
these effects exist and how they influence the arterial and venous oxygen saturation 
read ings. 
5.2.1 Experimental Purpose, Protocol and Setup 
The purpose of the experiments is to investigate the validity of the model. The 
investigation was separated into two sections; the first section investigates the 
arterial -to-venous effects described in the first part of the theoretical model, while 
the second section investigates the direct and indirect effects of the artificial venous 
modulation. Each section includes two sub-sections which describe the validation of 
the model through experiments and simulations with a clear interpretation of the 
model for each experiment. 
5.2.1a Arterial-to-Venous Coupling 
Recalling the first pmi of the theoretical model which focuses on the mechanical 
effects introduced to the venous system by the arterial contraction, the validation 
experiment can be carried out by creating two contrasting measurement conditions. 
In normal physiological conditions the arterial circulatory system has a pressure of 
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l20mmHg during systole and 80mmHg during the diastole phase, while the venous 
vascular system carrier a far lower pressure which varies between 20mmHg and 
OmmHg depend ing on the location and size of the venous vessel. Generally, the 
venous pressure is higher in veins which are away from the heart and becomes 
smaller in proximal areas of the heart; thi s pressure di ffe rence is one of the dri ving 
forces of venous circulation. 
Therefore the validation experiment was carri ed 111 the fo llowing two 
phys iologically di fferent conditions: 
Ca) When the arm is in hori zontal position rested on a fl at surface, arterial and 
venous pressures will have phys iological values. According to the 
hypothesis, veins will be vulnerable to external mechanical forces appl ied by 
the arterial expansion. Hence the venous optical path length, which in 
principle should remain steady over a short period of time, will be affected 
by arterial expansion. As a result the arteri al PPG signal will not only 
originate from the arterial path length change, but also from the venous path 
length change. 
Cb) Install an inflatable cuff around the arm and inflate to a pressure of 
80mmHg. This will cause no significant effect to the arteri al inflow but it 
will cause total venous occlusion during the first few seconds during which 
the venous pressure will keep on rising until it reaches approximately half 
the pressure of the cuffS31, hence 40mmHg. After this point, venous blood 
will start fl owing towards the heart but the pressure will be maintained. With 
a higher venous pressure, veins wi ll be less prone to compression originating 
from the arterial expansion. If the hypothesis is valid then there will be a 
di ffe rence in the PPG signals, since the venous path length will now be 
di ffe rent. 
Recall ing equation 3.45 from chapter 3, the arterial-to-venous coupling is described 
by the fo llowing equation: 
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where M(t)JI I(I,).) is the apparent arteri al normalised peak-to-peak s ignal which 
includes the real arteri al normalised peak-to-peak signal (A()') ) and the venous 
normalised peak-to-peak signal (V(?J) . 
During part (a) of the experiment it is assumed that there is some level of coupling 
between arteries and veins, therefore the enumerator and denominator of equation 
3.45 will be a mixture of arterial and venous blood. Given that the venous oxygen 
saturation is lower than the arterial oxygen saturation, the ratio-of-ratios R of 
venous blood is greater than the arterial R. Therefore, R. will be greater when there 
is coupling than when there is no coupling. Calling RI the ratio-of-ratios when there 
is coupling (part (a) of the experiment) and R2 the ratio-of-ratios when there is no 
coupling (no coupling is assumed in part (b) of the experiment). RI is given by 
equation 3.45 while R2 is given by: 
R = A(A,) 
, A(A, ) [5.2) 
because it is assumed that there is no coupling between arteries and veins, hence 
/:=0. For the purposes of demonstrating the numerical accuracy of the model , the 
maximum oxygen saturation during part (b) of the experiment is used as the 
"correct value" based upon the assumption that no arterio-venous coupling ex ists at 
that specific time. Hence the coupling coefficient /: will be calculated based upon 
this value. Recalling equation 3.47 fro m chapter 3, G is given by: 
A(A, )Ro - A(A,) 
c- = ----'--'-'----"-----'--'-'-
V(A, )Ro -V(A,) 
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Where R. will be the minimum value recorded during part (b) (max imum oxygen 
saturation), A(JJ the normalised arterial AC peak-to-peak values and V(A) the 
normalised venous AC peak-to-peak values. 
The experimental protocol di vided in parts (a) and (b) was carri ed out continuously 
without interrupting the data recording in order to show clearly the effect of 
occluding the venous outflow and it was repeated one more time during the same 
recording. The subject was a healthy male, age 29 wi th no hi story of cardiovascular 
related di seases. The prototype device recorded data at a sample rate of 128Hz using 
a standard pulse oximetry probe (P86 1 RA, Viamed UK), whi le the modulation di git 
cuff was installed on the same finger with the pulse oximetry probe in order to 
create venous pul sations. Recorded data were processed off-line in Matlab. 
5.2.1 b Venous-to-Arterial Coupling 
Recalling the second part of the theoretical model focusing on the mechanical 
effects introduced to the arteri al system by the artific ial venous pul sations, the 
validation experiment can be carried out in a s imilar way to the arterio-venous 
experiment, by creating the fo llowing two contrasting measurement conditions: 
(a) When the arm is in horizontal position rested on a fl at surface, arteria l and 
venous pressures will have physio logical values. The venous modulation 
system operates at a low pressure of 15mmHg hence the modulating cuff 
will be unable to cause high frequency modu lation of the arteri al fl ow, since 
the arteri al blood pressure is normally above 80mmHg. In this case the high 
frequency signal will only be due to venous optical path length changes . 
(b) Increasing of the modulation cuff pressure to a value higher than the arteri al 
systolic pressure, acco rding to the hypothes is, will cause the introduction of 
venous pulsations into the arterial blood. If the hypothesis is true, then the 
venous oxygen saturation value during this part of the experiment will be 
higher that in part (a) . This is due to the high frequency signal originating 
not onl y from the venous but a lso from the arterial optical path length 
change. The highly-pressuri sed cuff operating at a pressure higher than the 
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systo lic pressure will cause a local partial restriction of arterial flow during 
inflation, hence decreasing the arterial path length. During deflation, the 
arterial path length will be restored to its original state, therefore thi s 
di fference in the arterial path length between the inflation and deflation 
phases will introduce a high frequency signal component originating from 
arterial blood. As a result, the overall high frequency signal will be a 
combination of arterial and venous signals. 
Recalling equation 3.46 from chapter 3, the venous-to-arteri al coupling is described 
by the fo llowing equation: 
/ MCt, A,)/ I (t ,A,) ) = V(A,)-oA(A,) = R 
\ M (t, A, )/ I (t ,A, ) .,"ou, V(A,)-oA(A, ) , 
where M (t,JJI I(t,}J is the apparent venous normalised peak-to-peak s ignal which 
includes the real venous normalised peak-to-peak signal (V(A)) and the arterial 
normalised peak-to-peak signal (A (A) ). 
During part (b) of the experiment it is assumed that there is some level of coupling 
between veins and arteri es, therefore the enumerator and denominator of equation 
3.46 wi ll be a mixture of arterial and venous blood. Given that the arte ri al oxygen 
saturation is higher than the venous oxygen saturation, the ratio-of-ratios R of 
arteri al blood is lower than the venous R. Therefore, R, will be smaller when there is 
coupling than when there is no coupling. Let's call RI the ratio-of-ratios when there 
is no coupling (part (a) of the experiment) and R2 the ratio-of-ratios when there is 
coupling (part (b) of the experiment). R2 is given by equation 3.46 while RI is given 
by: 
R = V(A,) 
, V(A, ) [5.31 
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because it is assumed that there is no coupling between arteries and veins, hence 
15=0. Parts (a) and (b) of the experiment are consecutively repeated every 20s (lOs 
for each part). During part (a) of the experiment the venous ratio-of-ratios RI is 
calculated and subsequently used in equation 3.48 (as the "correct value") in order 
to calculate the coupling coefficient 15 during part (b). Recalling equation 3.48 from 
chapter 3, 15 is given by: 
8 = VeA, )R, - V(A,) 
A(A, )R, - A(A,) 
Where Rv will be the average value recorded during part (a) (correct venous oxygen 
saturation), A (A) the normalised arterial AC peak-to-peak values and V(}J the 
normalised venous AC peak-to-peak values. 
The experimental protocol divided in parts (a) and (b) was carried out continuously 
without interrupting the data recording and it was repeated 7 times during the same 
recording ( IOs low cuff pressure, 10s high cuff pressure, total recording duration 
140s). The subject was a healthy male, age 29 with no history in cardiovascular 
related diseases. The prototype device was recording data at a sample rate of 128Hz 
using a standard pulse oximetry probe (P86IRA, Viamed UK), while the 
modulation digit cuff was installed on the same finger with the pulse oximetry 
probe in order to create venous pulsations. The peak cuff pressure in part (a) was 
4SmmHg and 260mmHg in part (b). Recorded data were processed off- line in 
Matlab. 
5.2.2 Experimental Results 
The hypotheses upon which the model was developed, divide the experiments in 
two sections; the first section describes the coupling between arteries and veins and 
how the arterial expansion during the systole phase may affect the venous flow, 
while the second section describes the effect of the artificial venous modulation on 
the arterial flow. The model was demonstrated through experimental tests which are 
presented further on. 
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S.2.2a Arterial-to-Venous Coupling Results 
The coupling coeffi cient e gives the indication that there is a venous component in 
the arteri al signal when it is not equal to zero . This part of the model is based upon 
the hypothesis that in part (b) of the fi rst experiment (highl ighted areas in figure 
5.7) arterio-venous coupling is not significant. For the purposes of demonstrating 
the model, the maximum value of oxygen saturation obtained during thi s part was 
assumed to be the correct arteri al value. This assumption was based upon the 
hypothesis that the prolonged venous occlusion would cause an increase of the 
venous blood pressure in the lower arm, therefore the expansion of the arteri es will 
have a smaller or no effect on the high-pressure veins. Hence, the ' low-frequency' 
signal (natural arteri al pulsations) will originate from arteri al blood only when the 
veins are minimally disturbed, resulting in a higher saturation value compared to the 
baseline measurement, where the venous pressure was normal and was assumed that 
arterial pulsations affected the venous flow. The results of thi s experiment are 
shown in figure 5.6. 
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Figure 5,6 - Results of experiment 1: arterial-to-venous coupling 
The experiment started with the measurement of arteri al blood pressure which was 
found to be 132/85mmHg. The occlusion cuff was placed around the upper arm 
while the artificial venous modulation operated throughout the duration of the 
experiment. Parts (a) and (b) were carried out twice as it can be seen in figure 5.6 
and more specifically the following protocol was implemented : 
I ) The pulse oximetry probe and the modulating digit cuff were at1ached to the 
I SI digit of the left hand. The left arm was positioned on a fl at surface and 
PPG signals were observed in order to establish steady-state PPG signals. 
2) Recording was initiali sed with the arm cuff deflated and continued until 
1=60s. 
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3) At 1=61 s the occluding cuff was inflated to 90mmHg and continued 
recording for 420s until 1=480s, when the occlusion cuff pressure was 
deflated. 
4) The occluding cuff remained deflated fo r 120s unti l 1=600s. At 1=60 l s the 
occluding cuff was inflated to 80mmHg and continued recording for 420s 
untill= 1020s, when the cuff was deflated. Recording stopped at 1= 1140s. 
The different phases of the protocol were selected after multiple experiments were 
carried out, in order to establish the average time required for the DC va lues to be 
stabilised. A constant DC value indicates a state of equilibrium between blood 
inflow and outflow. Hence with the arm cuff inflated at 80mmHg the venous 
pressure is closer to the arterial pressure and as a result the veins will be less 
susceptible to compression during the arterial expansion. The level of pressure at 
the arm cuff was set just below the arterial diastolic pressure in order to avoid 
interfering directl y with the arterial inflow. 
Data were processed in 30s long windows, sliding by 15s each time. The model was 
interpreted in Matlab through the following algori thm : 
I) Read the recorded file, place AC and DC values in vector variables. 
2) Fi lter AC signals and separate arterial from venous frequency components. 
3) Resample from 128Hz by applying a 30s sl iding window (4 values per 
minute) and calculate signal quality SQ (red trace on top graph) by 
correlating the arterial red and infrared AC signals . 
4) Normalise the AC values by dividing them by the DC values and calculate 
the ratio-of-ratios RI hence the oxygen saturation Sa02 (b lue trace on top 
graph) using equation 5.1 (with a=988). These are the "un-corrected" values 
of Sa02. 
5) Calculate the arterial ratio-of-ratios (R2) using equation 5.2 for the occlusion 
periods and find the minimum values (max imum Sa02). These are assumed 
to be the correct arterial values since they occur after venous pressure was 
built-up and denoted by the two asterisks in figure 5.8. 
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6) Calculate e USing equation 3,47 separately for periods 0<t<480s and 
481<t<1140s (red trace on bottom graph). 
7) Calculate RI using equation 3,45, hence the corrected oxygen saturation 
cSaOl (green trace on top graph) from equation 5.1 (with a=988) . 
Although it cannot be concluded whether the occlusion has raised the venous 
pressure high enough in order to prevent the compression of veins whenever arteries 
expanded (which was assumed for the purposes of the experiment), there was a 
di fference of 2.5-2.8% between SaOl and cSaOl (the latter being greater) which is 
in agreement with the initial hypothes is. It is worth noting the variation of the DC 
values during occlusion which confirms that the total blood volume in the measured 
area was increased vastly, since the light intensity had decreased from 4.5 V to less 
than 2V. The value of e depends on the level of venous oxygen saturation as well as 
the relati ve amplitude of arterial and venous red and infrared signals, hence the 
absolute value of e does not offer any information unless it approaches zero (e<O.I), 
which means that the arterio-venous coupling is minimal. 
S.2.2b Venous-to-Arterial Coupling Results 
The coupl ing coeffi cient <5 gives the indication that there is an arteri al component in 
the venous signal when it is not equal to zero. This part of the model is based upon 
the hypothesis that in part (a) of thi s experiment, venous-arteri al coupling is not 
signifi cant. For the purposes of demonstrating the model, the average venous 
oxygen saturation during part (a) was assumed to be the correct venous value. 
Figure 5.7 illustrates the results from the experiment. 
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Figure 5_7 - Results of experiment 2: venous-to-arterial coupling 
The experiment started with the measurement of arterial blood pressure which was 
found to be I 25/78mmHg. The artificia l venous modulation operated throughout the 
duration of the experiment, while the modulation depth was changed from 45mmHg 
to 260nunHg and back to 45mml-lg, a llowing 10s of data recording for each 
pressure leve l. Parts (a) and (b) were carri ed out seven times as it can be seen in 
fi gure 5.7 and highlighted areas are the high modulation depth pe riod . The 
fo llowing procedure was implemented: 
I) The pulse oximetry probe and the mod ulating digit cuff were attached to the 
I st digit of the left hand . The le ft arm was positioned on a fl at surface and 
PPG signals were observed in order to establish steady-state PPG s ignals. 
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2) Recording was initia li sed with the modulation cuff operating at P=4SmmHg 
between 0<1< IOs. 
3) At t= I Os the modulation depth was increased to 260mmHg and continued 
recording fo r 10s until t=20s, when the modulation depth was set back to 
4SmmHg. 
4) Steps 1-3 repeated seven times. 
The pressure level of the modulation cuff was set between two different values, in 
order to achieve two contrasting conditions: in the low pressure level (4SmmHg) the 
cuff pressure is sufficient to only modulate venous blood flow without affecting the 
highly-pressurised arterial system (>80mmHg), while the high pressure level 
(260mmHg) was selected in order to intentionally introduce maximal disturbance to 
both the arterial and venous blood fl ow. Therefore, in the low pressure condition the 
modulated signal originated from veins only, while in the high pressure condition 
there was a combination of arterial and venous components. The purpose of this 
protocol is to determine the level of coupling between the modulated signal and the 
arteries, when the pressure exceeds the arterial diastolic pressure. This allows for 
the application of high pressure modulation in poor peripheral blood perfusion 
conditions, where a stronger mechanical stimulation of the area is required to 
produce a suffic ient venous signal. 
Data were processed in I s long windows and values were averaged every 10s in 
order to provide a single value for each part or the experiment. The model was 
interpreted in Matlab through the following algorithm : 
I) Read the recorded fil e, place AC and DC values in vector variables. 
2) Filter AC signals and separate arterial from venous frequency components. 
3) Resample from 128Hz to 1Hz by applying a Is moving window with no 
overlapping. 
4) Normalise the AC values by dividing them by the DC values and calculate 
the ratio-of-ratios R hence the venous oxygen saturation SV02 (blue trace on 
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top graph) using equation 5.1 (with u=988). These are the "un-corrected" 
SV02 values. 
5) Calculate the venous ratio-of-ratios (R,) using equation 5.3 fo r the low 
modulation depth periods (part (a)) and calculate the average values. These 
are asswned to be the correct venous values because of the low modulation 
depth. 
6) Calcul ate 0 using equation 3.44 for the hi gh modulation depth periods of the 
experiment, shown in the bottom graph of figure 5.7. 
7) Calculate the average maximwn pressure (modulation depth) fo r each 10s 
data segment, shown in the middle graph of fi gure 5.7. 
8) Calculate R2 using equation 3.42, hence the corrected venous oxygen 
saturation CSV02 (red trace on top graph) from equation 5. 1 (wi th u=988). 
It is evident from experiment 2 that when the modulation depth is high, venous 
oxygen saturation values are greatly affected because of the resuliing arteri al 
modulation. The results have confirmed the initial hypothesis of the model' s second 
part, where hi gh venous oxygen saturation was expected in high modulation depth 
conditions. 
5.2.3 Discussion and Analysis 
The aims of experiments I and 2 were to confirm the hypothesis that there is 
mechanical arterio-venous coupli ng, which were both confi rmed. The first 
experi ment investigated the mechanical coupling of the arterial pulses when the 
venous pressure has physiological values which are significantl y lower than the 
arterial blood pressure. According to the model thi s coupling effect would be 
minimised upon increment of the venous pressure, which was confirmed by 
inflating an arm cu ff at a pressure of 80-90mmHg, creating venous occlusion. The 
arterial now was assumed to be unaffected since the cuff pressure was lower than 
the diastolic pressure. In the second experiment, the modulation depth was changed 
between low and high va lues in order to investigate the presence of arteri al signal in 
high modulation depth conditions, due to arterial optical path length variations. 
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S.2.3a Arterial-to-Venous Coupling 
Referring to fi gure 5.6, during the first 60s the arm cuff was deflated and according 
to the model hypothesis the arterial PPG signal comes from both the changes of 
arterial and venous path lengths /'"Za and /'"Zva respecti vely, as shown in fi gure 3.6, 
chapter 3. The average arteri al oxygen saturation during thi s period was Sa02(0-
60')=97.2%. During the next 420s the arm cuff was inflated to 90mmHg in order to 
cause venous blood pooling, which in turn would increase the venous pressure. 
Referring to the bottom graph of figure 5.6, the DC signals show how the received 
light intensity was gradually decreased over a peri od of several minutes . This 
proves essentiall y that there was blood pooling afte r inflation of the arm cuff, since 
the light absorption was increased. Moreover, it is worth noting that not only the IR 
DC and the R DC values had changed dran1atically but their diffe rence had also 
changed significantly. While ini ti ally (0<t<60s) the R DC was greater than the IR 
DC, after inflation of the arm cuff and upon gradual venous blood pooling the R DC 
became smaller than the IR DC, hence /',,(I R DC) < /',,(R DC). Recalling that 
reduced-haemoglobin (venous blood) absorbs stronger than oxygenated-
haemoglobin (arteri al blood) in the red range, it can safely be concluded that venous 
blood poo li ng had caused the change in the difference between the R DC and the IR 
DC signals. In simple terms, more venous blood had caused more red absorption 
which in turn caused less red light intensity. 
At t=420s the maximum arterial oxygen saturation was measured, which also 
happened to be towards the end of the occlusion period and after the DC values had 
settl ed. During thi s time, it was assumed that /'"Zva was zero or insignificant, 
therefore the measured value of 98.9% was considered to be the real arteri al oxygen 
saturation value because no venous component was involved in the arterial signal. 
Hence, G was calculated from equation 3.47 and had a max imum value at the 
max imum diffe rence between Sa02 and cSa02. It is important to note that the 
experi ment was based upon the assumption that the real arterial oxygen saturation 
had remained the same throughout the length of the recording. At t=421 s the same 
procedure was repeated and the same effects were observed, with the particularly 
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interesting observation that the di fference between Sa0 2 and CSV0 2 has remained 
quasi constant between 2.5% and 2.8% which shows the consistency of the 
experimental protocol. 
S.2.3b Venous-to-Arterial Coupling 
Referring to fi gure 5.7, during the first 10s the low modulation depth does not cause 
any mechanical effects to arterial fl ow hence according to the model hypothesis the 
venous PPG signal comes purely from the changes of venous path length. On the 
other hand, when the modulation deplh was set high, according to the hypothesis the 
venous PPG signal originated from both venous and arterial optical path length 
changes t.Zv and t.Zav respectively, as shown in figure 3.7. The average venous 
oxygen saturation during thi s period was SV02(O. IOS)=86.9%. During the next 10s the 
modulation depth was increased to 260mmHg (peak pressure) in order to introduce 
pulsations in arteri al blood and according to the model hypothesis, the venous 
oxygen saturation value would be greater than when the modulation depth is low, 
because the venous PPG signal would be a "mixture" of arterial and venous signals. 
The same experiment was repeated seven consecutive times and the hypothesis was 
confirmed in all cases, as it can be seen in figure 5.9. The continuous blue line is the 
continuously measured SV0 2 both at low and high modulation depth conditions. In 
low modulation depth conditions (0-1 Os, 21-30s, 41-50s, 61-70s, 81 -90s, 101-11 Os, 
12 1-1 30s), SV02 was lower than in high modulation depth conditions (1 1-20s, 31-
40s, 51-60s, 7 I -80s, 91-1 OOs, 111-120s, 13 1- I 40s) as predicted by the model. 
At thi s point the coupling coeffi cient (j was calculated from equation 3.48 and 
subsequently the "corrected" venous oxygen saturation values CSV0 2 (red lines in 
figure 5.9) were calculated from equations 3.46 and 4.1. It is important to note that 
the experiment was based upon the assumption that the venous oxygen saturation 
had remained the same throughout the length of each 20s-long section, however it 
appears that the venous oxygen saturation had changed quite signifi cantly over the 
experiment. Nevertheless, CSV0 2 values during high modulation depth, match with 
the SV02 values from the low modulation depth periods hence the model can 
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accurately detect and correct the presence of arterial components in the venous 
signal. 
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5.3 VENOUS OXYGEN DE-SATURATION INVESTIGATION 
Venous oxygen saturation (SV02) is a function of oxygen supply and demand, in 
other words it depends on a number of parameters, such as: 
• Arterial blood supply from the heart (Card iac Output). 
• Arterial Oxygen Saturation (Sa02). 
• Regional blood fl ow depending on the nervous system. 
• Local tissue oxygen extraction according to demand fo r oxygen. 
• Other physiological effects triggered by secondary parameters, such as 
environmental changes or pathological conditions which may affect any of 
the above. 
This series of experiments were carried out with healthy volunteers in normal 
temperature conditions (2 l -23°C) in order to minimise environmental effects to 
blood supply and oxygen consumption. 
5.3.1 Experimental Purpose, Protocol and Setup 
The aim of the experiment is to investigate two aspects of the method: 
• The validation of a standard pulse oximetry calibration curve III venous 
oximetry. 
• The accuracy of the method when compared to blood gas analysis. 
In order to obtain a series of di fferent values of venous oxygen saturation a de-
saturation experiment was set up after consultation with collaborating clinicians. 
Subsequently ethics approval was obtained from the Loughborough University 
Ethical Advisory Committee (Ref 0 R07-P I2) and tests were carri ed out in 
Glenfie ld Hospital, UHL. 13 volunteers were recruited in the study, all of whom 
completed a health questiOImaire, and were informed both verbally and in writing 
through an information sheet about the purpose and the protoco l of the study. 
Participants were asked to sign a written informed consent fo rm. 
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The protocol was designed around the hypothesis that total occlusion of arteria l 
blood supply would cause gradual venous oxygen de-saturation, because even 
though there would be no blood flow, stationary blood would continue to release 
oxygen to the tissues in order to satisfy the needs for oxygen, hence venous oxygen 
saturation would gradually decrease. The following procedure describes the 
experimental protocol: 
• Allow the subject to relax for 2 min, seated wi th the right arm resting on a 
desk. 
• Arterial blood pressure measurement by a qualified clinician. 
• Installation of finger probe and modulation cuff on the 1st digit, and 
occlusion arm cuff on the upper arm. 
• Initiali se recording with modulation depth set at 12mmHg, without blood 
occlusion for I min. 
• Inflate the arm cuff until a pressure of approximately 200mmHg is reached. 
• Continue recording whi le monitoring the venous oxygen saturat ion. 
• Draw a venous blood sample from a proximal metacarpal dorsal vein, as 
soon as venous saturation drops below 80% approximately. 
• Release the arm cuff air slowly to restore circulation and stop recording 
data. 
The experimental setup included a mercury pressure meter with an arm cuff, the 
prototype system fo r pressure modulation and signal acquisition, a pulse oximetry 
probe (P861 RA, Viamed UK) and a digit cuff (DC- 1.6, Hokanson USA) and 
consumables for blood collect ion and analysis. Blood sampling and gas analysis 
were performed by qualified clinicians by following hygienic practices . 
5.3.2 Experimental Results 
The initial hypothesis was that occlusion of the upper arm would infer gradual drop 
of venous oxygen saturation due to continuing release of oxygen to the ti ssues, 
despite the fact blood flow was stopped. This was confirmed in all cases but with 
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different time delays between subjects due to the different physiological response of 
each individual. From a total of 13 data sets collected, one had to be excluded from 
the study due to insufficient blood sample volume. Although the blood gas analyser 
only required 200-300!!1 of blood volume, it can often fail to report results due to 
insufficient volume therefore it is usually preferred to introduce larger vo lumes of 
blood. Although the blood sample vo lume for this particular case was nearl y I ml , 
the analyser did not produce any results. 
Each case is presented separately, in order to demonstrate clearly the oxygen de-
saturation of venous blood as well as to display how quickly the venous blood 
sample was drawn (within the indicated window), as prolonged blood drawing 
might have introduced errors. For example, if it took 90s to draw the sample, it is 
unknown whether most volume came from the initial period (0-30s) or from the last 
period (60-90s), which makes it difficult to make a di rect comparison witll the non-
invasively obtained venous oxygen values. Moreover, in cases where the oxygen 
rate of change was fast, the error can be large, as there was a case where the rate of 
change was as high as -60%/min. 
Non-invasively measured values are average values extracted from a data window 
corresponding to the blood sampling time period. Venous oxygen de-saturation 
occurs almost immediately after the arteria-venous occlusion (at 60s), initially at a 
small negative slope and as time progresses, the negative rate of change increases in 
most cases. In the fo llowing figures , the following parameters are presented in 
different colours and formats: 
• SV02 (blue line) - Venous oxygen saturation (%). 
• IR x P (green line) - Correlation coefficient (%) of the infrared raw signal 
with the pressure sensor signal, which is high when the ' high frequency' 
component (6.S-8Hz) is strong (high SNR) and in phase with the pressure 
sensor. Low values indicate the possible presence of a heart harmonic 
overlapping with the artificial venous pulsation, or small SNR. 
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• R X P (red line) - Correlation coeffi cient (%) of the red raw signal with the 
pressure signal, similar to LR x P. 
• R x lR (cyan) - Correlation coeffi c ient (%) o f the red and infrared signals. 
Low values indicate low SNR. 
• Blood sample (red asteri sk) - Venous oxygen saturation (%) measured by 
blood gas analysis, invasiveiy. 
• Calculated (blue asteri sk) - Venous oxygen saturation (%) measured by the 
non-invasive method, averaged over the blood sampling time period. 
Because the arteri al flow was completely occluded there was no arterial pulse 
therefore no harmonic components, hence the modulation frequency was fi xed to 
8Hz. 
Case 1: male, age 46, height I 72cm, weight 90kg, arteria l blood pressure 
I 35/85mmHg. Blood sample data: 13/03/2007 16:02, Sample No. 14451, Gas 
analyser ID. 348-3353 
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Figure 5.8 - Case study no. l 
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Case 2: male, age 47, height 170cm, weight 78kg, arterial blood pressure 
110/75mmHg. Blood sample data: 13/04/2007 12:23, Sample No. 14604, Gas 
ana lyser ID. 348-3353 
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Figure 5.9 - Case study 00.2 
Case 3: male, age 32, height 175cm, weight 84kg, arterial blood pressure 
130/85mmHg. Blood sample data: 13104/2007 14:00, Gas analyser ID. 
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Figure S.IO - Case study 00.3 
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Case 4: male, age 29, height 183cm, weight 100kg, arterial blood pressure 
I 35/85mmHg. Blood sample data: 13104/2007 14:48, Gas analyser ID. 
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Figure S.1l - Case study no.4 
Case 5: male, age 54, height 181 cm, weight 83kg, arterial blood pressure 
120/75rrunH g. Blood sample data: 13/04/2007 15:3 1, Gas analyser ID. 
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Figure 5.12 - Case study no.S 
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Case 6: female, age 65, height 178cm, weight 79kg, arteri al blood pressure 
I 28178mmHg. Blood sample data: 16/04/2007 13:50, Gas analyser ID. 
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Figure 5.13 - Case study no.6 
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Case 7: female, age 30, height 165cm, weight 90kg, arterial blood pressure 
144/94mmHg. Blood sample data: 16/04/2007 14:36, Gas analyser ID . 
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Figure 5.14 - Case study no.7 
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Case 8: female, age 52, height I 72cm, weight 60kg, arterial blood pressure 
II S/70mmHg. Blood sample data: 16/04/2007 15:11 , Gas analyser ID. 
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Figure 5.15 - Case study no.8 
Case 9: male, age 32, height I 79cm, weight S9kg, arterial blood pressure 
I 32/SSmmHg. 
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Figure 5.16 - Case study no.9 
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Case 10: male, age 30, height 17Scm, weight 70kg, arterial blood pressure 
110170mmHg. Blood sample data: 16104/2007 16:41 , Gas analyser ID. 
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Figure 5.17 - Case study no.10 
Case 11: male, age 27, height 17Scm, weight 85kg, arterial blood pressure 
I 25175mmHg. Blood sample data: 17104/2007 12:54, Sample No. 14625, Gas 
analyser ID. 348-3353 
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Figure 5.18 - Case study 00.11 
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Case 12: female, age 45, height 173cm, weight 70kg, arteria l blood pressure 
120175mmHg. Blood sample data: 17104/2007 13:34, Sample No. 14627, Gas 
analyser ID. 348-3353 
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5.3.3 Discussion and Analysis 
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Although some values are closely related with a di fference smaller than 4%, there 
are large di ffe rences in some paired values and the source of errors is discussed in 
each case separate ly, with a particular attention on signal quali ty indices (lR x P, R 
x P, IR x R) which provide the Following ind ications in the presence of arteri al and 
venous pulsations: 
I) Good quality venous signal - no overlapping with heart harmonics: IR x R 
high (high SNR) and IR x P, R x P high (high frequency PPG signal well 
correlated with the pressure sensor signal). 
2) Good quality venous signal - overlapping wi th heart harmonics: IR x R high 
(high SNR) and IR x P, R x P low (venous signal not very well correlated 
with the pressure sensor signal because of potential phase difference 
between high freq uency PPG signal and pressure sensor signal). This does 
CHAPTER 5 129 
EXPERIMENTAL INVESTIGATION 
not apply to this experiment, as arterial pulses and therefore arterial 
harmonics are not present. 
3) Low quality venous signal : IR x R low (Iow SNR) and IR x P, R x P low 
(either because of the low SNR or overlapping with heart harmonics). It can 
be distinguished whether low IR x P , R x P are due to overlapping with heart 
harmonics, but the heart rate must be known. In this experiment, the heart 
rate is unknown due to arterio-venous occlusion, therefore poor signal 
quality indices can only be attributed to noisy signals. 
Each case is separately discussed in the following section, where the time stamps 
represent the time interval after commencement of the study. 
• Case I : blood sample was drawn over a period of 30s, between 490s and 
520s. During this period, all three signal quality indicators were high, 
therefore the source of the error cannot be attributed to poor signal (high 
IRxR). During the fi st few seconds of sampling (490s < 1 < 500s) the non-
invasive measurement was showing values around 80% (compared to 
8l.2% obtained from the blood sample) therefore if most of the sample 
volume was drawn during the first few seconds, then there is a close match 
between invasive and non-invasive methods. 
• Case 2: blood sample was drawn over a period of 50s, between 540s and 
590s. During most time in this period, all three signal quality indicators 
were high, therefore the source of the error cannot be attributed to poor 
signal (high IRxR). Furthermore, the non-invasive values seem to vary 
mainly between 70% and 80%, apart from short periods of dropping to 
lower values which are most likely contributed to low signal quality, as 
indicated by low va lues of IR x R, IR x P and R x P. Therefore no 
conclusion can be made about the difference between the two methods. 
• Case 3: blood sample was drawn over a period of 35s, between 605s and 
640s. During the first half of the blood sampling period, signal quality was 
low and non-invasive va lues went unexpectedly high, however, during the 
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second half of the sampling period signal quality indicators returned to 
high values and non-invasive values went down to 55%, fo llowing the 
interpolated slope shown in figure 5. 10. Therefore it can be concluded that 
there was a close match between the two methods. 
• Case 4: blood sample was drawn over a period of 40s, between 340s and 
380s. During the blood sampling period, the venous oxygen saturation was 
dropping rapid ly from 90% to 50% therefore since the blood sample 
volume was drawn over this period, the source of the error cannot be 
described. If it was known that most blood volume was drawn during the 
middle 15s of the sampling period, there would be a close match between 
the invasive and non-invasive methods. 
• Case 5: blood sanlple was drawn over a period of 40s, between 380s and 
420s. During the blood sampling period, the venous oxygen saturation has 
only changed by a few percentage units, while the signal quality indices 
were high, especially the lR x R which defines the SNR. The invasive and 
non-invasive methods have given closely matched values in thi s case. 
• Case 6: blood sample was drawn over a period of 40s, between 380s and 
420s. During the blood sampling period, the venous oxygen saturation has 
only changed by a few percentage units, whi le the signal quality indices 
were high. In thi s case it was difficult to obtain enough blood hence the 
surrounding ti ssues where rubbed in order to cause di splacement of venous 
blood towards the punctured vein. The 9% difference between the two 
methods could be attributed to the fact that drawn venous blood originated 
from a different area, which although was proximal, it may have consumed 
less oxygen than the measured area, hence the higher venous oxygen value 
obtained from the blood sample. 
• Case 7: blood sample was drawn over a period of 20s, between 370s and 
390s. During the blood sampling period, the venous oxygen saturation has 
changed rapidly from 54% to 35%, while the signal quality indices were 
high. The blood sample was quickly and easi ly drawn and the invasive and 
non-invasive methods have given closely matched values. 
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• Case 8: blood sample was drawn over a period of 60s, between 365s and 
425s. During the blood sampling period, the venous oxygen saturation 
seems to have changed by approximately 10% if non-invasive values were 
interpolated. It was difficult to obtain a blood sample and rubbing of 
surrounding vessels was required in order to obtain enough blood volume. 
The large di fference between invasive and non-invasive methods could be 
attributed to the blood sanlple ori gi nating from a different area where more 
oxygen was extracted. 
• Case 9: blood sample was drawn over a period of 20s, between 560s and 
580s. The blood sample was quickly and eas ily drawn but there was a large 
difference between the two methods, hence due to the good signal quality 
indices no conclusions can be made. 
• Case 10: blood sample was drawn over a period of 20s, between 325s and 
345s. The blood sample was quickly and easily drawn and the small value 
difference shows that there is a close match between the two methods. 
• Case 11: blood sample was drawn over a period of 120s, between 240s and 
360s. It was extremely difficult to obtain a blood sample and repeated 
rubbing of surrounding vessels was required in order to obtain enough 
blood volume. The large di fference between invasive and non-invasive 
methods could be attributed to the blood sample ori ginating from a 
different area where more oxygen was extracted, but it can also be due to 
poor signal quality. 
• Case 12: blood sanlple was drawn over a period of 20s, between 255s and 
275s. The blood sample was quickly and eas il y drawn and the small value 
difference shows that there is a close match between the two methods 
however it is questionable whether the low signal quality contributed to the 
increase of measured venous oxygen saturation. If the non-invasive values 
were interpolated during the low signal quali ty period, then the average 
non-invasive value would rather be at the high 70's to low 80' s region. 
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A ll data have been processed in Matlab and a reasonable agreement was observed 
between the invasive and the non-invasive methods, although is has to be said that 
the major source of error is likely to be the diffi culty of obtaining blood samples. 
Periphe ral perfusion can be poor at times therefore it is not always possible to easily 
draw a blood sample, especially from veins which are essentiall y thin collapsible 
tubes. Figure 5.20 shows paired values of invasively and non-invasively obtained 
values o f veno us oxygen saturation . Cases 8 and II denoted with' ... ' in figure 5.20 
were not taken into account when calculating the trend line, the mean error and the 
standard deviation because of the long blood sampling periods (60s and ISOs 
respecti vely). The mean error was 0.4%, the standard deviation between the two 
measurement methods was ± 7.8% and the 95% confidence interval was ± 4.87%. If 
case 9 denoted with '. ' was also di scarded because of the substanti all y larger error 
among paired values, then the mean error, the standard deviation and 95% 
confidence interval would be -1 .4%, ± 5.5% and ± 3.63% respectively, wh ile the 
correlation coefficient wo uld change from 0.7 to 0.86. 
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An important conclusion from this study was that the method of obtaining blood 
samples with fine-needled syringes, although it is the less painful solution, it could 
be less efficient than the method of cannulisation, where a cannula-operated needle 
wou ld be inserted before the start of the experiment to provide blood samples 
without having to puncture a vein during measurement. However, collaborating 
clinicians have advised against it due to increased pain invo lved, as well as because 
it was anticipated that the blood filling the needle upon insertion of the cannula 
would affect the accuracy of the results. More specifically, the blood which would 
occupy the cannula would not lose any oxygen, therefore the drawn blood sample 
would contain a mixture of blood before and during the experiment. 
It is still questionable thought if the use of a cannula would actuall y decrease the 
degree of diffi culty to obtain enough blood vo lume from proxi mal veins, due to 
collapsing of the vessel. Depending on the particular vascular structure of each 
subject, in some cases it was reasonably easy and quick «30s) to draw a venous 
blood sample but in other cases there was not enough venous blood, which required 
the rubbing of the surro unding area in order to move some more venous blood 
towards the punctured vein resulting in prolonged periods of sampling. 
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5.4 FEASIBILITY STUDY IN HEART SURGERY PA TlENTS 
The technique underwent various stages of laboratory tests in order to identify a 
reliable protocol which would infer venous oxygen saturation changes. One method 
which has shown consistent results during preliminary tests was the total occlusion 
of the arm (arm cuff pressure higher than systolic pressure), where gradual decrease 
of venous oxygen saturation was observed. It was not feasib le to reli ably obtain 
venous blood samples from the 1st digit (the measurement site of the proposed 
method) and hence direct comparison of blood gas analysis and readings from the 
proposed technique was not tenable. However, the study presented in section 5.3 
where blood samples from large proximal veins were obtained has shown good 
agreement in some cases but there have been other cases where there was a large 
difference when comparing the oxygen values obtained invasively and non-
invasively. A study carried out wi th patients undergoing various heart operations is 
presented in thi s section. 
5.4.1 Experimental Purpose, Protocol and Setup 
The pilot study presented in this section was designed under the hypothesis that in 
patients undergo ing heart surgery where blood volume and temperature are both 
being contro lled in the bypass machine during CPB, it would be possible to observe 
synchronised changes of peripheral (SXV02) and mixed (SV02) oxygen saturations. 
The bypass machine employs an optical fluorescence and reflectance-based in-line 
system to perform blood measurements and is been as the go ld standard for this 
study. Ethical approval was given by the Leicestershire NHS Health Authority 
Research Ethics Committee (Appendix Ill). Each case is presented separately in 
Appendix I. 
After patient anaesthetic induction and before final preparation for surgery, the 
pulse oximetry probe and pressure cuff were applied to the 1 st digit of the left hand. 
The system then logged raw PPG data for the full length of the procedure. The cuff 
pressure was set to inflate/deflate at a maximum pressure of 40mmHg (baseline 
value OmmHg) and the modulation frequency was initially set at 7.85 Hz which was 
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re-adjusted when necessary in order to avo id overlapping with the heart 's 
harmonics. At the end of each inflation/deflation cycle, the cuff completely deflates 
to avoid unwanted effects, such as venous stasis. 
As part of the standard surgical procedure and anaesthetic process, arteri al blood 
samples fo r blood gas and acid-base status were taken besides venous blood 
samples which were taken from a peripheral cannula inserted in a vein in the 
dorsum of the left hand. Venous blood sampling was not included in thi s study, as 
poor peripheral perfusion precluded the collection of suffic ient blood quantity fo r 
analysis. Also the heart-lung bypass machine monitoring system was used to 
continuously monitor critical blood parameters, i. e. flow, pH, PC02 (Partial 
Pressure of CO2), P02 (Partial Pressure of O2), K+, temperature, S02 (0 2 saturation), 
haematocrit and haemoglobin, while HCO)- (bicarbonate), BE (Base Excess) and 
V0 2 (02 consumption) were calculated values. Flow, blood temperature, S02 
(venous) and V02 were considered in thi s study. Arteria l oxygen saturation was not 
included in results and di scussion, as no variations were observed in all patients 
(98% - 99%). 
The heart-lung machine monitor logged all available blood parameters every 5 
minutes and a ll data recorded by the prototype device were sampled at the same 
rate. SV02 and SXV02 were expressed in a "self-normalized" format as a percentage 
of the variation fo r a given patient, in order to compensate for diffe rent variations. 
For example, if max(SvOz)=90 and min(Sv0 2)=50 respectively, then SvOz=70 
expressed as a percentage of the variation, would be nSv02=50%. 
During the course of the operation all important events and cri tical changes in the 
haemodynamic status of the patient were logged for post-operative data analysis. As 
part of the surgical protocol in certain operation procedures, the blood temperature 
was dropped to extreme hypothermic levels (24°C) resulting in poor perfusion of the 
periphery, hence a trained operator was monitoring the venous signal quality index 
to improve signal quality when necessary; i.e. increase the photodiode 's amplifier 
gain, should AC was too small due to hypoperfusion. In a typical CPB procedure, 
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body temperature is gradually decreased to reduce the metabo lic rate and to avoid 
ti ssue damage; the heart is arrested after aortic cross-clamping with a cardioplegic 
solution. During the cooling phase, V0 2 drops dramatically resul ting in increased 
SV02 due to low metabol ism. When the surgery is completed, the aortic cross-clamp 
is released and the patient is warmed up to a body temperature of approx imately 
37°C; dur ing the rewarming phase, rapid changes of V0 2 cause dramati c variations 
of SV02. The body's increas ing demands fo r oxygen dur ing thi s phase are 
compensated for, by increasing the blood flow, which in turn increments SV02. The 
main focus of thi s study is to observe the response of the proposed method under 
similar conditions of supply/demand balance changes. 
The values and signals di splayed on the prototype device were not used during 
surgery and no changes were made to the patient treatment plan as a result of 
participating in this study. The study setup included the bypass machine monitor 
(CDI-SOO, Terumo USA) which measured the parameters described above, a 
prototype device to measure peripheral venous oxygen saturation from the I st digi t 
of the left hand, including a pulse oximetry probe (p86 1 RA, Viamed UK) and a 
digit cuff (DC-I .6, Hokanson USA) which introduces artificial pulsations in the 
venous system. 
5.4.2 Experimental Results 
The primary aim was to observe the performance of the non-invasive technique 
during cardiopulmonary bypass where major physiological parameters are kept 
under control, such as temperature and flow. Data analysis has shown positive 
correlation between central and peripheral oxygen saturation in certain conditions, 
which implies that the proposed method applied in the periphery, can detect central 
venous oxygen saturation changes[84J These changes are more pronounced when 
there is an increasing or decreasing demand fo r oxygen. All patient data were 
grouped according to blood temperature, blood fl ow and V0 2 in order to show the 
overall responses of both the proposed method and the bypass machine in a compact 
format (Box-Whisker plots). 
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5.4.2a Veno us Oxygen Saturation and Blood Temperature as a Function 
of Overall Oxygen Consumption 
Box-Whisker figures 5.2 1, 5.22 and 5.23 show nSv0 2, nSxv02 and blood 
temperature for all patients plotted against total oxygen consumption measured by 
the bypass machine, normalized to body surface area (BSA) by using the Mosteller 
formula[851. Therefore the normali sed oxygen consumption units are ml 02 min- 1m-2 
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Figure 5.21 - Box and Whisker plot: negative correlation between nSv02 and 
nV02 
The values of nSv02, nSxv02 and blood temperature were grouped according to 
their corresponding V02 values. For example, the fi rst box in fi gure 5.2 1 shows all 
values of nSv02 when 30:SV02<40 ml min-I m-2• For each time instance, all three 
parameters were present; in order to achieve thi s, some data reduction has been 
perfo rmed. From 23 patients which took part in the study, 3 patient data sets were 
excluded due to insufficient data. From the remaining 20 data sets, there is a total 
number of n=466 S-mjnute measurements before data reduction; fo r each patient, 
mean=23.3 +/- SD=9.98. Regarding the data reduction, the total number of samples 
discarded fo r all patients was n=134 and for each patient, mean=6.70 +/- SD= II .86, 
mainly because in two long operations (8 1 samples in total) the bypass machine 
unexpectedly fa iled to record V02 along with some other parameters. 
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S.4.2b Venous Oxygen Saturation as a Function of Blood Temperature 
Figures 5.24 and 5.25 illustrate the variation of venous oxygen saturation centrall y 
and peripherally respectively, where each box corresponds to a range of 1°C. 
Simi larly to the previous section, some data reduction has been performed to ensure 
all three values (nSv02, nSvOz and blood temperature) were present for each time 
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instance. Before reduction, total number of samples n=466; for each patient, 
mean=23.3 +/- SD=9.98 samples. Data reduction: the total number of samples 
di scarded for all patients was n=44 and for each patient, mean=2.20 +/- SD= I.I S. 
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S.4.2c Venous Oxygen Saturation as a Function of Cardiac Index 
The card iac index (Cl in I min' l m'2) was calculated fTom the card iac output (CO in I 
min'l) by dividing it with the BSA of each subject. The CO value is essentiall y the 
blood flow of the heart, lung machine pump, Similarly to previous sections, data 
reduction has been performed to ensure values for all three parameters (nSv02, 
nSxv02 and Cl) were present fo r each time instance in fi gures 5,26 and 5.27. Before 
reduction, total number of samples n=466; for each pati ent, mean=23 .3 +/- SD=9.98 
samples. Data reduction: the total number of sanlples di scarded for all pati ents was 
n= 13 I and for each patient, mean=6.55 +/- SD= I 1.90. 
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5.4.3 Discuss ion a nd A na lysis 
The data recorded by the prototype device have been converted to oxygen saturation 
values by using a standard empirical calibration curve - equation 5.1 , and then each 
value was expressed as a percentage of variation for a g iven patient, as a means of 
' self-normalization'. Figure 5.2 1 shows the relation between normalized nSv02 and 
V02 normalized to BSA. nSv02 decreases when the total oxygen consumption 
increases which shows that when there is an increas ing demand for oxygen, nSv02 
drops because more oxygen was re leased to the ti ssues. 
Figure 5 .22 presents the relation between nSxv02 and normalized V02, where a 
trend similar to figure 5.2 1 is shown. Vasodilator and/or vasoconstrictor 
administration during CPB may affect the body oxygen metabo lism and worsen the 
complications induced by hypoperfus ion during CPB[861. Therefore, although these 
effects render di ffi cult the direct comparison between central and peripheral venous 
oxygen saturation, the significant trend s imi larity between fi gures 4.2 1 and 4.22 
may be an indication of relative agreement between the bypass machine and the 
proposed method. 
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Figure 5.23 shows that the main effect of low blood temperature is the decrease of 
the rate of metabolism and therefore the reduction of oxygen extraction compared to 
normothermic conditions. The primary purpose of reducing the blood temperature 
in ePB is to reduce the rate of oxygen metabolism in order to protect organs and 
tissues. However, a later studyl87I has concluded that an immediate decrease in V0 2 
caused by the initiation of deep hypothermic CPB could not be simpl y due to a 
decrease in the metabolic rate but also due to di sturbances in oxygen utili zation, one 
of which seemed to be caused by the impaired oxygen release from haemoglobin. 
Other studies[88J have investigated the relationship between SV02 and temperature 
and concluded that change of body temperature is the most important factor that 
affects SV0 2. 
The positive correlation between oxygen utili zation and blood temperature which 
can be concluded from figure 5.23 implies the negative correlation between 
normalized venous oxygen saturation and blood temperature (figure 5.24). Whether 
the oxygen ex traction is a function of meta bolism or impaired oxygen release there 
is negative correlation between oxygen consumption and normalized venous blood 
saturation. Figure 5.24 illustrates the reduction of nSv0 2 as the blood temperature 
approaches normal values while fi gure 5.25 shows the normalized oxygen 
saturation measured peripherally by the proposed method. In fi gure 5.24, nSv0 2 is 
negati vely correlated with blood temperature in accordance with a previous 
study[ 8S J. There is also a decreasing trend between nSxv02 and blood temperature in 
figu re 5.25, however the variations of nSxv02 for a given temperature range are 
larger than those of SV0 2, especially between 30°C and 31°C. In fact, most patients 
in thi s study were cooled down to 2SoC-30°C and therefore the rewarming phase fo r 
those patients was initiated in th is tempera ture region, hence metabolic acidosis or 
hypoperfusion during e PB may have caused thi s large variation of venous oxygen 
saturation. In the same study[8S] it was found that SV0 2 was markedl y decreased 
after rewanning, therefore high peripheral venous oxygen variations will occur after 
rewarming was initiated. It is important to emphasize that the maj ority of venous 
oxygen vari ations were observed during rapid changes in oxygen conswnption 
(V0 2) which closely followed blood temperature changes; hence the rewarming 
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temperature region has the largest venous oxygen variation observed. In the 
temperature region between 35°C and 38°C, nSxv02 clustered in higher values, 
which was almost certainly due to the recovery of peripheral perfusion which 
impl ies a higher supply/demand fraction. On the other hand, at low temperatures 
(24°C-26°C) both nSv0 2 and nSxv0 2 have unusuall y high values. In fact the 
study[85] concl uded that hypothermia reduces the oxygen consumption and increases 
the oxygen in physical solution; therefore, most of the metabolic need for oxygen 
can be met from the di sso lved oxygen without using the haemoglobin transport 
system, hence the high values of nSv02 and nSxv02. 
Figure 5.26 illustrates the relation between central venous oxygen and flow while 
peri pheral venous oxygen is shown in figure 5.27. The increasing trends of nSxv0 2 
(between 1.7 and 2.4 I min-! m-2) and nSv0 2 (between 1.7 and 2.0 I min-! m-2) are in 
agreement with the prev iously re ferenced study[85J, where it was observed that an 
adequate SV02 was found when the flow was greater than 2.4 I min-! m-2 No direct 
conclusions can be made, since the suppl y/demand balance is also a function of 
blood temperature affecting the venous oxygen saturation. More in particular, in the 
"high flow" region (between 2.3 and 2.7 I min-! m-2 for nSv0 2 and between 2.6 and 
2.8 I min-! 111-2 for nSxv0 2) both peripheral and central normalized venous oxygen 
values decrease. This could be attributed to the increased oxygen consumption at 
high flow rates (usually set towards the end of the operation) which are more often 
accompanied by blood temperature shi fts towards normothermic conditions, 
resulting in higher oxygen consumption. 
The present observation study indicates that continuous monitoring of peripheral 
venous oxygen saturation can be feasible with the proposed method in the clinical 
care. Direct correlation of centTal and peripheral venous oxygen saturation values is 
viable in certain cases where the supply or demand balance changes rapidl y, 
however it is not anticipated that it is presently poss ible to infer mixed venous 
oxygen saturation from the periphery. This study showed that the proposed method 
can detect V02 changes even under low perfus ion conditions which are common in 
CPB hypothermia. During hypothermia both nSxv0 2 and nSv0 2 values were found 
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to be elevated while during re-warmmg and upon rapid changes of V02, the 
proposed method was sensi ti ve to surges of oxygen extraction, indicating that the 
supply/demand balance had changed rapidly. There is also a similar sensitivity to 
changes of Cl under normal temperature conditions. This feature can be extremely 
useful in pathological conditions which can cause similar effects, such as 
sepsis[89,901. While this observation study describes the response of the proposed 
method to changes of oxygen consumption, blood temperature and blood flow, it 
cannot be concl uded whether the proposed method can accuratel y measure venous 
oxygen saturation. 
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5.5 O VERVIEW 
This chapter describes the evaluation of the non-invasive method for venous 
oximetry which was carried out from fo ur different perspectives: 
• The in-vitro experiment for the comparati ve calibration with a commercial 
pulse oximeter was aiming to the investigation of the PPG board 's signal 
quality and accuracy, which was found to be comparable to the commercial 
pulse oximeter. Without knowing the performance of the signal capturing 
device in controlled in-v itro conditions it would be impossible to evaluate its 
functional ity and performance in real-li fe experiments. 
• The model evaluation experiments a imed at the investigation of the 
hypotheses relating to anatomical and physio logical effects which can affect 
the accuracy of the method, when measuring arterial and venous oxygen 
saturation. Although the non-invasive method of measuring blood oxygen is 
an in-vivo method based on numerous assumptions, the modelling 
experiments have successfull y provided a certain level of understanding 
some basic anatomical and physiological effects of the vascular system. 
• The venous oxygen de-saturation study aimed at the confirmation of the 
method's capacity to measure venous oxygen saturation. Although the 
results when comparing the method with the gas-analysed blood samples are 
partly satisfactory, there are still questions about the method of blood 
sampling and whether adjacent veins actuall y have comparable oxygen 
saturation values. Nevertheless, the device was able to register the gradual 
decrement of venous oxygen saturation in every single case, which shows 
that the method is capable of measuring venous oxygen saturation. 
• The feas ibility study in the clinical setting aimed at the investigation of the 
method's performance and functionali ty in real -l ife cond itions. Not only 
from an environmental point of view (the operating theatre) but a lso from a 
feasib ility point of view (severe clinical conditions) in order to test the 
overa ll performance of the device in a variety of pathophys iological 
conditions arising in majo r operating procedures, such as heart surgery. 
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Moreover, this study has confirmed the robustness of the system in long 
recording conditions in an electricall y-noisy environment such as the 
operating theatre. 
Conclusively, the overall performance has proven that the method is worthy of 
further investigation and is di scussed in chapter 6. 
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6 CONCLUSIONS / FUTURE WORK 
Continuous monitoring of venous oxygen saturation currently requires the 
insta llation of a catheter, a complicated and time-consuming procedure which 
is highly invasive and involves severe risks for the patient. Although attempts 
have been made to address the lack of a non-invasive venous oximeter, no 
existing teclmology is suitable for the continuous, non-invasive measurement 
of simultaneous arteri al and venous oxygen saturation. The importance of 
having both these parameters available lies in the fact that oxygen 
consumption can be calculated, hence other physiological parameters may be 
extracted with the aid of a haemodynamic physiological model, or even by 
using known models such as the Fick principle, relating the cardiac output 
with oxygen consumption, arterial and venous oxygen saturations. These 
parameters can be for example, cardiac output currently requ iring the use of 
an invasive thermodilution technique, or oxygen consumption through the 
use of a spi rometer. 
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6.1 CONCLUSIONS 
a. Human physiology of oxygen supply and demand (aim J): The underpinning 
phys iological concepts were introduced in chapter 2. These concepts have provided 
the minimum content necessary to provide the context for the development of a 
device to measure venous oxygenation. 
b. Theoretical modelling and its validation (aim 2 and aim 4): The model 
developed to describe the arterial and venous PPG signals under certain 
physiological and anatomical conditions is consistent with the predominantly 
contemporary model of Beer-Lambert law, and has clarified the optimal operating 
conditions of the artificial venous modulation system as well as the possibility to 
introduce a method of correcting arterial oxygen saturation obtained from widely 
used pulse oximeters. Although the difference between uncorrected and corrected 
arterial oxygen saturation values (Sa02 and cSa02) was measured in the region of 
3% it is unknown whether such a difference might have a significant clinical 
meaning in the assessment of adequacy of oxygen supply. Nevertheless, keeping in 
mind that measurements were carried out on a healthy subject, it cannot be 
concluded whether similar differences would be observed in a clinical condition. On 
the other hand, the second part of the model has provided the means of 
understanding the mechanical coupling of the artificial pulsation into the arteries, 
which means the optimal modulation depth, is now known and can actually be 
measured. 
c. Development of venous oximetry (aim 3): Through the development of three 
different generations of prototypes it was shown that close collaboration between 
engineers and clinicians can lead to the successful design and realisation of 
innovative methods and devices which can contribute to better clinical monitoring 
facilities. Moreover, the easy-to-use fina l prototype device was designed and built 
in an embedded format , starting from a complicated, large and non-versatile design 
and through thi s prototyping experience, va luab le expertise on medical device 
design and construction was gained. 
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d. Comparativc calibration (aim 4): The calibration results have confirmed that 
the system performance in terms of measuring the absorbance of haemoglobin is 
closely matched with a commercial pulse oximeter, although it would be preferable 
to perform the calibration in a circulatory calibration system with real blood. The 
2% offset between the prototype device and the commercial ox imeter was 
successfully eliminated by adj usting equation 5.1 and the next step for calibration is 
to use real blood as the light absorber. 
c. Venous oxygen de-saturation study (aim 4): Through the venous oxygen de-
saturation study it was confirmed that the device detects the gradual decrease of 
venous oxygen saturation, although the comparability with blood gas analysis 
remains inconclusive because of the difficulty to obtain blood samples in certain 
cases. This problem may be el iminated by performing a study at a more central area 
where venous blood supply is higher, by employing a reflection mode probe and a 
patch-type cuff which are briefly presented in section 6.2. 
f. Feasibility study in cardiac surgery patients (aim 4): The method was 
evaluated in a number of different haemodynanlic conditions which may occur in 
the course of a heart surgery, such as low blood flow (cardiac index), 
vasoconstriction and low oxygen conswnption during hypothermia, or 
vasodilatation and increased oxygen consumption. The device was able to detect 
changes of blood flow and oxygen consumption, especially during the periods of 
patient rewarming which accompanied by increased oxygen consumption, therefore 
a further investigation in a larger scale study is worthwhile. 
The evaluation of the method and the device from four different points of view has 
demonstrated the capability to measure venous oxygen saturation, although further 
evaluation is necessary in a large number of subjects in order to establi sh the full 
potential of the technology. According to the collaborating clinicians, a continuous 
monitor capable of indicating cardiac output trends, even without absolute values, 
would be ex tremely useful post-operatively in heart surgery patients, as it would 
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provide another way of assessing the successfulness of the operation. Moreover, if 
absolute va lues of cardiac index would be possible then the device would make an 
excellent non-invasive tool for the long-term monitoring of patients suffering from 
cardiovascular diseases, in which case the doctor would be ab le to assess the 
efficacy of drugs administered. 
6.2 SUGGESTIONS FOR FUTURE WORK 
This section responds to aim 5 of the study and presents suggestions for future work 
in this area, highlighting both speculative applications empowered by the use of the 
artifi cial pulsations and possible studies that could be used to investigate further and 
develop more sophisticated models taking into account important phys iological 
parameters, such as local and central blood temperatures. 
6.2.1 Design of a Disposable Venous Oximetry Probe 
Although the current finger probe and modulation cuff configuration was sufficient 
to obtain reliably PPG signals, the use of a di sposable probe would provide multiple 
benefits, with the most obvious one being hygiene. The existence of highly 
contagious and li fe-threatening pathogens like the MRSA has been known for many 
years, disturbing the smooth operation of hospitals and clinics and subjecting 
patients to high ri sk. A re-usable pulse oximetry probe could be one of the 
contaminating sources if not properly sterili sed. Another benefit of single-use 
probes, especially when used with the non-invasive venous oximetry method, is the 
mechanical di fference with the re-usable probe. More specificall y, the re-usable 
probe has a spring in order to clip around the finger which is ti ght enough to keep 
the probe in place, without constricting arterial flow which can be caused by 
excessive pressure applied to Ihe clip. On the other hand, with the venous system 
operating at a very low pressure and given the co llapsibility of veins due to their 
particular structure, it was found that the venous PPG signal was a lot stronger when 
the probe's spring tension was reduced. This observation has lead to the conclusion 
that arterial pulse oximetry probes may not be fully compliant with the low venous 
pressure. In an attempt to reduce the spring tension by modi fy ing its steady-state 
dimensions it was noted that the probe became more susceptible to motion artefacts, 
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given that the spring tension was not enough to hold the probe ti ghtl y around the 
finger. Moreover, at high modulation depth conditions, the in:f1ation/deflation of the 
digit cuff can result in finger movement. Considering Ihe weight and inerti a of the 
probe, it is more than Ijkely that the coupling coefficient between the probe and the 
finger will change, leading to erroneous readings. If a disposable probe was used 
instead, neither problems would ex ist because the tightness can be adjusted and the 
small weight of the probe would solve the problem of motion artefacts. Figure 6.1 
shows a typical disposable pulse oximetry probe, while figures 5.2 and 5.3 illustrate 
an example of the proposed disposable venous oximetry probe. 
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Figure 6.1 - Typical disposable pulse oximetry probe design 
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Figure 6.2 - Disposable venous oximetry probe des ign (bottom view) 
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Figure 6.3 - Disposable venous oximetry probe application 
6.2.2 Design of a Reflection-Mode Probe 
It was demonstrated that it is possible to measure venous oxygen peripherally by 
applying a pulse oximetry probe and a digit cuff on a finger and it was also shown 
that there is some relation between cardiac output, oxygen consumption and 
peripheral venous oxygen saturation. But an important question that still remains is 
whether peripheral venous oxygen saturation will help in the overall assessment of a 
cl inical condition. One of the important targets for improving the method was to 
construct a reflection-mode oximetry probe in order to apply the venous oximetry 
technique as close as possible to the heart in an attempt to measure central venous 
oxygen saturation, a very important parameter in the assessment of overall oxygen 
utilisation. One of the problems associated with this approach was the small 
penetration depth of conventional leds which emit incoherent light, resulting to 
poor signal quality because of the low SNR. A new probe was designed using newer 
teclmology light emitters called RCLEDs, which stands for Resonant Cavity Light 
Emitting Diodes and provide laser-like performance with narrow light beams and 
more importantly, narrow output bandwidth. Although they are known for a few 
years, they have not been used yet in pulse oximetry; they are mainly used in 
telecommunications and more specifically in optical fibre networks. Their narrow 
beam means higher penetrations depth, while the narrower output bandwidth means 
that RCLEDs are likely to provide oxygen saturation values more accurately, since 
in practice they could almost be considered as monochromatic light sources. Figure 
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6.4 shows a single-wave (870nm) re flection-mode PPG probe, which was built to 
test the perfo rmance of RCLEDs in photoplethysmography, and it was fo und that it 
can pick up PPG signals from areas where it was previously impossible, li ke from 
the spine or the back of the head. Therefore it may now be possible to perfo rm 
measurements in areas which require a greater light penetration depth. Furthermore, 
the probe has been successfull y tested in non-contact experiments where it was 
shown that arterial photoplethysmographic signals can be captured from a di stance 
of several centimetres. Such a potential could in fact lead to non-contact pulse 
ox imetry which has not been previously achieved. 
Figure 6.4 - Single-wavelength RC LED reflection-mode PPG probe 
6.2.3 Application of Venous Oximetry to Other Areas 
Due to the lack of an appropriate probe the method was so far li mi ted to application 
on a finger. However, after the successful testing of the new reflection-mode probe, 
the method can now be applied to other areas with a particular interest in the neck. 
The internal (main return of venous blood from brain19 1,921) ex ternal jugular veins 
carry de-oxygenated blood from the head and descend on each side of the neck. 
Both veins present pulsations being close to the heart and provide extremely 
valuable haemodynamic in fo rmation about the function of the right atrium of the 
hear\. Although there are standard tests to assess jugular veins, the des ign of a 
protocol to continuously measure venous oxygen saturation non-invasively from the 
j ugular veins will provide a means of monitoring cerebral venous oxygen saturation. 
Furthermore, the j ugular venous oxygen saturation can provide other important 
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indications, such as the prediction of short-term postoperative neurologic 
dysfunction in elderly cardiopulmonary bypass patientsl931 
6.2.4 Assessment of Arterial Calcification 
Referring to the first part of the model developed in chapter 3 and evaluated in 
chapter 5, it was found that there was a difference of 2.5%-2.8% between low and 
high venous pressure, attribu ted to elasticity of the arteries. When the venous 
pressure was high (40-45mmHg) the arterial expansion did not affect the venous 
flow in the same degree as when the venous pressure was at physiological levels. 
This leads to the conclusion that the level of arterial expansion could be assessed by 
implementing the test protocol of the first part of the model in the sense that if there 
is no difference between the two phases of the protocol , then it could indicate the 
reduced arterial elasticity, a common symptom of the atheromatous plaque which 
causes arterial hardeningl941 . 
6.2.5 Calibration at a More Central Area 
Recalling the problems of obtaining peripheral blood samples in both the venous de· 
saturation study and the clinical evaluation, as well as the differences between the 
invasive and non-invasive values of the venous de-saturation study, it was 
concluded that it would be a better solution to perform measurements on a larger 
veins where blood sampling would be easier. The main problem was the acquisition 
of PPG signals from areas other than the finger, where the method is currently 
limited to. However, previous tests on the forearm and preliminary tests of the 
reflection-mode RCLED probe have shown that it can be possible to apply the 
technique to other parts of the body, hence perform a calibration study on well-
perfused areas. The investigation of applying the technique on the forearm has 
shown that it is possible to obtain PPG signals using a normal reflection-model PPG 
probe on the cephalic vein of the left forearm. The only limitation at thi s point is the 
generation of artificial venous pulsations in areas where a cuff cannot be installed. 
However, a custom-designed patch-cuff could be applied in areas where superficial 
veins exist. An example of such a cuff is shown in figure 6.5. 
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Figure 6.S - Patch cuff for use with a reflection-mode probe (bottom view) 
Therefore, with the use of a reflect ion mode probe similar to the one in figure 6.4 
and a patch-cuff shown in fi gure 6.5, a more accurate cali bration of the method 
could be implemented in a central area of the body. 
6.2.6 In-Vitro Ci rcula tory Calibration System 
The first approach for the comparative calibration involved the construction of a 
finger phantom model with silicone tubing of different sizes and characteri sti cs 
which was connected in a simple circulatory system, with a peristaltic pump (505S, 
Watson-Marlow Bredel Pumps Lnc) replicating the function of the heart. A set of 
light absorbing mixtures combined in several different vo lume ratios was prepared, 
in order to mimic the light absorption of arteri al blood. Figure 6.6 illustrates the 
arrangement of the circulatory model. 
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Figure 6.6 - Circulatory model for compara tive calibration 
The fi nger phantom was created around a silicone tube with inner diameter of 
12rnm and wa ll thickness of I mm, which contained two smaller latex tubes with 
3mm inner diameter and Imm wa ll thickness, representing an artery and a vein. The 
12mm tube representing the finger was fi lled with intralipid emulsion 10% di luted 
in di sti ll ed water, a popular di ffusion and scattering medium for biological 
phantoms, since its di ffus ion and scattering effects are closely matched with 
biological ti ssues[95.96[. The finger model is shown in fi gure 6.7. 
VEIN 
I 
ARTERY 
R INTRALlPID 
INSERTION 
/' 
Figure 6.7 - Finger phantom constructed from thin flexible tubing 
The ' arteria l' and 'venous' circulatory systems were separate systems dri ven by the 
same peristalti c pump but in opposite d irections, like the real human circulation. 
The venous system was also connected to two expandable reservoirs in order to 
minimise the pulsations of the pump by as much as possible; the two venous 
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reservoirs dissipate the pumping and suction effects by expanding and shrinking in 
size, respecti vely. 
Tests have shown that there were excessive motion artefacts in the finger model 
originating from the peristaltic pump's action , causing displacement of the artery 
and vein , therefore altering sign ifican tl y the light path, leading to erroneous 
readings. This was first noted when the pump was set to operate clockwise and 
a·fterwards anti -clockwise, where different readings were obtai ned from the pulse 
oximeter. 
Although the comparative calibration with the design and construction of a static 
finger phantom has produced very good results, the realisation of an in-vitro 
circulatory system using real blood would most li kely provide more infolmation, 
not only abo ut the accuracy of the method in tenns of oxygen saturation 
measurement, but with an accurately designed finger phantom, a novel flu id-
dynamic study could lead to a mathematical model for major haemodynamic 
effects, such as vasoconstriction and vasodi latation. By addressing the problem of 
lack of a physio logy model to describe these effects, it could be possible to infer 
peripheral venous oxygen saturation, to values of central venous oxygen. Such an 
achievement would introduce a medical device with an en0n110US number of 
app lications, from GP offices and ambulatory settings to operating theatres and 
intensive care units, to the same extent as conventional pulse oximetry. 
C HAPTER 6 158 
REFERE CES 
REFERENCES 
[ I] Shelley K. H, Tamai D, Jablonka D, Gesquiere M, Stout R. G, Silverman D. 
G. "The effect of venous pulsation 011 the forehead pulse oximeter wave 
foml as a possible source of error in Sp02 calculation", Anesth. Analg., 100, 
pp.743-747 (2005) 
[2] Shelley K, Dickstein M, Shul man S. "The detection of peripheral venous 
pulsation using the pulse oximeter as a plethysmograph", J. Clin. Monit. , 9, 
pp.283- 7 (1993) 
[3] Levy M.N, Pappano A.1. "Cardiovascular physiology" 9th edi tion, Mosby 
Elsevier, Phi ladelphia, pp. I-4 (2007) 
[4] Van De GraaffK.M, Fox S.l. "Concepts of human anatomy and physiology" 
3'd edi tion , WCB, Dubuque, pp.673-677 (1992) 
[5] Holden M, Makic M.B. "Clin ica lly induced hypothermia: why chill your 
pat ient?", AAC Adv. Cri!. Care, 17(2), pp.125- 132 (2006) 
[6] Stock M. C, Ryan M. E. "Oxygen consumption calculated from the Fick 
Equation has limited utility", Crit Care Med., 24(1), pp.86-90 (1996) 
[7] Gregory I. C. "The oxygen and carbon monoxide capacities of feta l and 
adu lt blood", 1. Physiol., 236(3) , pp .625-634, Feb. (1974) 
[8] Mark J. B, FitzGerald D, Fenton T, Fosberg A. M, CamatUl W, Maffeo N, 
Winkelman J. "Continuous al1eri al and venous blood gas monitoring during 
cardiopulmonary bypass", J. Thorac. Cardiovasc. Surg., 102(3), pp.431-439 
(1991 ) 
159 
REFERENCES 
[9) BelUlett D, Boldt J, Brochard L, Coriat P, Dhainaut J. F, Edwards D, Feihl F, 
Groeneveld J, Lamy M, Lemaire F, Payen D, Perret C, Rouby J. J, 
Scheidegger D, Singer M, Suter P, Thij s L, Vincent J. L. "Expert panel: Use 
of the pulmonary artery catheter" Intensive Care Med., 17, pp. J-VlII (1991) 
[10) Nelson L.D. "The new pulmonary artery catheters: Continuous venous 
ox imetry, ri ght ventricular ejection fTaction, and continuous cardiac output", 
New Hori z., 5, pp.25 1- 258 (1997) 
[ I I ] Weil M.H. "The assau lt on the Swan-Ganz catheter", Chest, 113, pp.1379-
1386 (1998) 
[12] Kelso L.A. "Complications associated wi th pulmonary artery 
catheteri zation", New Horiz., 5, pp.259- 263 ( 1997) 
[1 3] Roizen M. F, Berger D. L, Gabel R . A et al. "Practice Guidelines for 
pulmonary aliery catheteri zation. A report by the American Society of 
Anesthesiologists task force on pulmonary artery catheterization" 
Anesthesiology, 78, pp.380-394 (1993) 
[ 14] Cha lfin D. B. "The pu lmonary artery catheter: Economic aspects", New 
Horiz. , 5, pp.292- 296 ( 1997) 
[15) Leibowitz A. B, Oropello J. M. "The pulmonary artery catheter in anesthesia 
practice in 2007 : an historical overview wi th emphasis on the past 6 years", 
Semin. Cardiothorac. Vase. Anesth. , J J (3) , pp. J 62-1 76 (2007) 
[16) Scales K, Colli e E. "A practical guide to using pulmonary artery catheters", 
Nurs. Stand., 21(43), pp.42-48 (2007) 
160 
REFERENCES 
[17] McGee W. T, Mailloux P, Jodka P , Thomas 1. "The pulmonary rutery 
catheter in criti cal care", Semin. Dial. , 19(6), pp.480-491 (2006) 
[18] Pond C. G, Blessios G, Bowlin J, McCawley C, Lappas D . G. "Perioperative 
evaluation of a new mixed venous oxygen saturation catheter in cardiac 
surgical patients", J. Card iothorac. Vasc. Anesth ., 6(3), pp.280-282 (1992) 
[19] Harry M. H, Rackow E. C. "Cri tical care medicine", Arch. Intern . M ed., 
143, pp.139 1- 1392 ( 1983) 
[20] Reinhart K, Rudo lph T, Bred le D. L, Hannemann L, Cain S. M. 
"Comparison of central venous to m.ixed venous oxygen saturation during 
changes in oxygen supply/demand" Chest, 95, pp.12 16- 122 1 ( 1989) 
[2 1] Pinsky M. R. "Hemodynamic monitoring over the past I 0 years", Crit. 
Care., 10(1), pp. ll 7 (2006) 
[22] Goldman R. H, Brani ffB, Han·ison D . C, Spivac A. P . "The use of central 
venous oxygen saturation measurements in a coronary care uni t", Ann. 
Intern . Med., 68, pp.1280- 1287 (1 968) 
[23] Goldman R. H, Klughaupt M, Metcalf T, Spivack A. P, Harri son D . C. 
"Measurement of central venous oxygen saturation in patients with 
myocardial infa rction", Circul ation, 38, pp.94 1- 946 ( 1968) 
[24] Berridge J. C. "Influence of cardiac output on the correlation between mixed 
venous and central venous oxygen saturation", Br. J. Anaesth. , 69, pp.409-
41 0 (1 992) 
161 
REFERENCES 
[25] Ladakis C, Myri anthefs P, Karabinis A, Karatzas G, Dosios T, Fildissis G, 
Gogas J, Baltopoulos G. "Central venous and mixed venous oxygen 
saturation in critically ill patients", Respiration, 6S(3), pp.279-285 (2001) 
[26] Scheinman M. M, Brown M. A, Brown B. A, Rapaport E. "Critical 
assessment of use of centra l venous oxygen saturation as a mirror of mixed 
venous oxygen saturation in severe ly ill cardiac patients", Circulation, 40, 
pp.165- 172 (1969) 
[27] Martin C, Auffray J. P, Badetti C, PelTin G, Papazian L, Gouin F. 
"Monitoring of centra l venous oxygen saturat ion versus mixed venous 
oxygen saturation in criti ca ll y ill patients", Intensi ve Care Med. , IS, pp. I OI-
104 (1992) 
[28] Vincent 1. 1. "Does central venous oxygen saturation accurately refl ect 
mixed venous oxygen saturation? Nothing is simple, unfortunately", 
Intensive Care Med., IS , pp.386- 387 ( 1992) 
[29] Lee J, Wright F, Barber R, Stanley 1. "Centra l venous oxygen saturation in 
shock: A study in man", Anesthesiology, 36, pp.472-478 ( 1972) 
[30] Faber T. "Central venous versus mixed venous oxygen content", Acta. 
Anaesth . Scand. , 39~ pp.33- 36 (1995) 
[31] Yoxall C. W, Weindling A. M. "Measurement of venous oxyhaemoglobin 
saturation in the ad ult forearm by near infrared spectroscopy with venous 
occ lusion", Med. BioI. Eng. Comput. , 35(4), pp.331-336 (1997) 
[32] Casavola C, Paunescu 1. A, Fantini S, Franceschini M. A, Lugara P . M, 
Gratton E. "Application o f near-infrared tissue oximetry to the diagnos is of 
162 
REFERENCES 
peripheral vascular di sease", Clin , Hemorheo l. Microcirc" 21 (3-4), pp.389-
393 (1999) 
[33] Boushel R, Piantadosi C. A, "Near-InfTared spectroscopy for monitoring 
muscle oxygenation", Acta , Physiol. Scand" 168, pp,615-622 (2000) 
[34] Kama G, D, Starr] , M, Symreng T, "Continuous, in vivo pulmonary venous 
admixture from fiberopti ca lly measured hemoglobin saturations", Crit. Care 
Med" 18, pp , 141 9- 1422 (1990) 
[35] Armaganid is A, Dhainaut J, F, Billard J, L, Klouche K, Mira J, P, Brunet F, 
Dinh-Xuan A. T, Dall' Ava-Santucci ] , "Accuracy assessment for three 
fiberoptic pulmonary artery catheters [or SV02 monitoring", Intensive Care 
Med " 20, pp.484 - 488 (1994) 
[36] Miiller M, Lollr T, Scholz S, Thul J, AkintGrk H, HempelmarUl G, 
"Continuous Sv02 measurement in infants undergo ing congenita l heart 
surgery--first clinical experi ences with a new fi beroptic probe", Paediatr. 
Allaesth., 17(1), pp.5 1-55 (2007) 
[37] Goodri ch C. "Continuous central venous oximetly monitoring", Crit Care 
Nurs Cl in North Am" 18(2), pp.203-209 (2006) 
[38] Reinhart K, Bloos F, "The value of venous oximetry", Curr. Opin, Crit. 
Care" 11(3), pp,259-263 (2005) 
[39] Eichler J, Knof J, Lenz H. "Measurements on the depth of penetration of 
light (0.35-10J-lm) in tissue", Rad, And Ellvironm. Biophys" 14, pp,239-242 
(1977) 
163 
REFERENCES 
[40] Barton F. E "Theory and principles of near infrared spectroscopy", 
Spectroscopy Europe, 14(1), pp.12-1 8.(2002) 
[41] Jobsis F . F. "Nonin vasive, infrared monitoring of cerebra l and myocardi al 
oxygen su ffic iency and circulatory parameters", Science, 198, pp. 1264-
1267 (1977) 
[42] Wyatt 1. S, Cope M, Delpy D. T, Richardson C. E, Edwards A. 0 , Wray S, 
Reynolds E. O. R. "Quantitation of cerebral blood vo lume in human infants 
by near infrared spectroscopy", J . Appl. Phys iol. , 68(3) , pp. 1 086-1 091 
( 1990) 
[43] Yoxall C. W, Weindling A. M, Dawani N , Pearl I. "Measurement of cerebral 
venous ox yhemoglobin saturation in children with near infra red 
spectroscopy and partial jugular venous occlusion", Pediatr. Res., 38, 
pp.3 19-323 (1995) 
[44] Miccormick P. W, Stewart M, Goetting M . G, Balakrishnan G. "Regional 
cerebral oxygen saturatio n measured by optica l spectroscopy in humans", 
Stroke, 22, pp.596-602 ( 199 1) 
[45] Longini R. L, Zdrojkowski R. HA note on the theory of back scattering of 
li ght by li vi ng tissue", IEEE Trans. Biomed. Eng. , 15, pp.4-IO (1968) 
[46] Feng W, Haishu D , Fenghua T, Jun Z., Qing X, Xianwu T. "Influence of 
overlying tissues and probe geometry on the sensi tivity of a near- infrared 
tissue oximeter", Physio l. Meas. , 22 , pp.20 1-208 (200 I) 
[47] Wray S, Cope M, Delpy D. T , Wyatt J . S, Reynolds E. O. R. 
"Characterization of the near in frared absorption spectra of cytochrome aa3 
164 
REFERE CES 
and haemoglobin for the non-invasive monitoring of cerebral oxygenation", 
Biochim. Biophys. Acta., 933(1), pp.1 84-1 92 (1988) 
[48] Hertzman A. B. "The blood supply of various skin areas as estimated by 
photo-electric plethysmograph", Am. J. Physiol., 124, pp.328-340 (1938) 
[49] Gu Y. Y, Zhang Y. T. "Reducing the influence of contacting force applied 
on photoplethysmographic sensor on heart rate variabi lity estimation", Proc. 
Conf. IEEE. EMBS., 3, pp.27 18-2620 (2003) 
[50] Alien J. "Photoplethysmography and its appli cations in clinical 
phys iological measurement", Physiol. Meas., 28(3), pp. RI-39 (2007) 
[51] Hertzman A. B. "Photoelectric plethysmograph of the fingers and toes in 
man", Proc. Soc. Exp. BioI. Med., 37, pp.529-534 (1937) 
[52] Yeldemlan M, New W. "Evaluation of pulse oximetry", Anesthesiology, 59, 
pp.349-352 (I 983) 
[53] Yoshiya I, Shimada Y, Tanaka K. "Spectrophotometric monitoring of 
arteri al oxygen saturation in the finger tip", Med. BioI. Eng. Comput. , 18, 
pp.27-32 (1980) 
[54] Teng X. F, Zhang Y. 1., "The effect of contacting force on 
photoplethysmograph ic signals", Physiol. Meas. , 25, pp.1323-1335 (2004) 
[55] Hurch A, Hurch R, Ko urg V. "Limi tations of pu lse oximetry [letter]", 
Lancet, I , pp.357-359 (1988) 
165 
REFERE 'CES 
[56] De Trafford J, Lafferty K. " What does photopleth ysmography measure? 
[letter]", Med. BioI. Eng. Comput. , 22, pp.479-480 (1984) 
[57] Abramowitz H. B, Queral L. A, Flilm W. R, Nora P. F. "The use of 
photoplethysmography in the assessment of venous insuffi c iency: a 
compari son to venous pressure measurement" , Surgery, 86, pp.434-441 
(1979) 
[58] Barns R . W. "Noninvas ive diagnostic techniques in peripheral vascular 
di sease", Am . Heart l. , 97, pp .2-9 (1979) 
[59] Fronek A, Blaiek V. "Automatic calibration of the D-PPG: its meaning and 
effectiveness", Report by Third Almual of Congress ofNASP, Phoenix 
USA, (1990) 
[60] Williams D. T, Harding K. G, Price P. E. "The influence of exercise on foot 
perfusion in diabetes", Diabet. Med. , Online Early Articles (2007) 
[6 1] Alien J, Oates C. P, Lees T. A, Murray A. "Photoplethysmography detection 
of lower limb peripheral arteri al occlusive di sease: a comparison of pulse 
timing, aplitude and shape characteristi cs", Physiol. Meas., 26, pp.8 11-82 1 
(2005) 
[62] O'Rourke M. F. "Principles of arteri al hemodynamics" in Mechanics of the 
Circulat ion, H. E. D. J. Ter Keurs and J.V. Tyberg, Martinus N ijhoff, 
Dordrecht, pp.240 (1987) 
[63] Sherebrin M. H, Sherebrin R. Z. "Frequency analysis of the peripheral pulse 
wave detected in the finger with a photoplethysmograph", IEEE Trans. 
Biomed. Eng. , 37, pp.313-317 ( 1990) 
166 
REFERENCES 
[64] Wukitsch M W, Petterson M. T, Tobler D. R, Pologe J. A. "Pulse oximetry: 
Analys is o f theory, technology and practice", J. Clin . Monit. Compllt ., 4(4), 
pp.290-30 I (1988) 
[65] Reynolds K. J, Moyle J. T . B, Sykes M. K, Halm C. E. W. "Responses of 10 
pulse oximeters to an in vitro test system", Brit. J. Anaesthesio!. , 68, pp.265-
269 (1993) 
[66] Reynolds K. J, Palayiwa E, Moyle J. T. B, Sykes M. K, Hahn C. E. W. "The 
effects of dyshaemoglobi ns on pulse oximetry", J. Clin. Monit., 9, pp.8 1-90 
( 1993) 
[67] Chan F. C. D. "Non-invasive venous ox imetry through venous blood vo lume 
modulation", Doctoral Thesis, Loughborough University (2002) 
[68] Chan F. C. D, Hayes M. J, Smith P. R. "Venous pulse oximetry", 
International Patent W012003/063697 (2003) 
[69] Steinke J. M, Shepherd A. P. "Role of light scattering in whole blood 
oximetry", IEEE Trans. Biomed. Eng., 33(3), pp.294-30 1 (1986) 
[70] Webster J. G. "Design of pulse oxi meters", ToP Publi shing, London (1997) 
[71] DlIl ' nev G. N, Korotkevich M. M, Pilipenko N. V, Sigalov A. V. 
"Mathematical modelling of heat-echange processes in the human body", J. 
Eng. Phys. Thermophys., 46(1), pp.117-125 (1983) 
[72] Liapis C. D, Balzer K, Benedetti-Valentini F, Fernandes e Fernandes J. 
"Vascular Surgery (European manual of medicine)", Springer-VerJ ag, 
Berlin, Heidelberg, pp.539 (2007) 
167 
REFERE CES 
[73) Yorkey T. l. "Two 'rat rat' derivation", Personal communication, Hayward, 
Nellcor Inc. 
[74) Moyle l . T. B. "Pulse ox imetry", BMG, London (1994) 
[75) Volgyesi G. A. "Method of testing the accu racy of pulse oxi meters and 
device therefor", US patent 5, 166,5 17 (1992) 
[76) l ing L, XU L. X. "Estimation of blood perfusion using phase shift in 
temperature response to sinusoidal heating at the skin surface", Trans. [EEE. 
Biomed. Eng., 46(9), pp. I 037-1 043 (1999) 
[77) McDonald D. A. "Blood flow in arteries", Edward Arnold , London (1974) 
[78) Flewell ing R. "The Biomedical Engineering Handbook I st Edi tion, vo l I", 
CRC Press, Boca Raton, pp.86-6 (2000) 
[79) Barros A. K, Wisbeck l , Ohnishi N. "Extracting the heart rate variabi lity 
from an electrocardiogram sampled at a very low frequency", Comput. 
Cardio \. , 26, pp.335-338 (1999) 
[80) McKenzie-Smith I, Hughes E. "Hughes Electri cal Techno logy". Longman 
Group Ltd (7lh ed), Essex (1995) 
[8 1) Madsen S. l , Patterson M. S, Wilson B. C. "The use ofIndia ink as an 
optical absorber in ti ssue simulating phantoms", Phys. Med. Bio \. , 37(4), 
pp.985-993 (1992) 
[82) Kramer R. "Chemometric Techniques for Quantitati ve Analysis" , Dekker, 
New York (1998) 
168 
R EFERENCES 
[83] Seagar A. D, Gibbs J. M, Dav is F. M. " In terpretation of venous occlusion 
plethysmographi c measurements using a simple model", Med. Bi oI. Eng. 
Comput., 22(1) , pp. 12- 18 (1984) 
[84] Echiadis A S, Crabtree V P, Bence J, Hadj iniko laou L, Alex iou C, Spy! T J 
and Hu S. "Non-invasive measurement of peripheral venous oxygen 
saturation using a new venous ox imetry method: evaluation during bypass in 
heart surgery", Physiol. Meas., 28(8), pp.897-9 11 (2007) 
[85] Mosteller R. D. "S implified calculation of body-sur face area", N. Engl. J . 
Med., 317(17), pp.1 098 ( 1987) 
[86] Sato K, Sogawa M, Namura 0 , Hayashi J. "Deterioration of body oxygen 
metaboli sm by vasodilator and/or vasoconstrictor administration during 
cardiopu lmonary bypass", Asaio J. , 52(1), pp.96-99 (2006) 
[87] Irita K, Kai Y, Takahashi S. " Impaired oxygen utili sation during rapid 
cooling on cardiopulmonary bypass", Fukuoka Acta Medica, 90(1) , pp.14-
22 ( 1999) 
[88] Baraka A, Baroody M, Haroun S, Naw fa l M, Dabbous A, Sibai A, Jamal S, 
Shamli S. "Continuous venous ox imetry during cardiopulmonary bypass: 
influence of temperature changes, perfusion fl ow, and hematocrit levels", 1. 
Card iothorac. Anesth ., 4(1), pp.3 5-38 (1 990) 
[89] Boushel R, Piantadosi C. A. "Near-Infrared spech'oscopy fo r monitoring 
muscle oxygenation", Acta. Physiol. Scand., 168, pp.6 15-622 (2000) 
169 
R EFERE CES 
[90] Quaresima V, Colier W N, van der Sluijs M, Ferrari M. "Nonuniform 
Quadriceps 02 Consumption Revealed by Near Ln [Tared Multipoint 
Measurements", Biochem. Biophys. Res. Commun., 285(4), pp.l034-1039 
(200 I ) 
[9 1] Huber P . "Cerebral angiograp hy", Thieme, Stuttgat1 ( 1982) 
[92] Mueller H.R, HilUl G, Buser M.W. "Intemal jugular venous flow 
measurement by means of a Duplex scarmer", J. Ultrasound . Med. , 9, 
pp.261 - 265 (1990) 
[93] Kadoi Y, Saito S, Goto F, Fujita . "Decrease in jugular venous oxygen 
saturation du ri ng nonnothermic cardiopulmonary bypass predicts short-term 
postoperati ve neurologic dysfunction in elderly patients", J . Am. Col!. 
Cardio !. , 38, pp.1450-1 455 (2001) 
[94] icita-Mauro V, Maltese G, Nicita-Mauro C, Basi le G. "Vascular aging and 
geriatri c patient", Minerva Cardioangio!. , 55(4), pp.497-502 (2007) 
[95] van Staveren H. J, Moes C. J. M, van Mar1e J, Pral S. A, van Gemert M. J . 
C. "Light scattering in intTalipid-1 0% in the wavelength range of 400- 1100 
lUll", App!. Opt. , 30, pp.4507-4514 (199 1) 
[96] Flock S. T, Jacques S. L,Wi lson B. C, StarW. M, van Gemert M.J. C. 
"Optical properties of intralipid: a phantom medium for light propagation 
studies", Lasers Surg. Med., 12, pp.5 10- 5 19 (1992) 
170 
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ApPENDIX 
I. CLINICAL FEASIBILITY STUDY PLOTS 
This appendix presents the results from the feas ibility stud y which was 
carried out in heart surgery, and was presented in chapter 5. Each case in 
presented on a separate fi gure which shows the studied variables (mixed 
venous oxygen saturat ion SV0 2, peripheral venous oxygen saturation SXV0 2, 
blood fl ow, blood temperature and oxygen consumpti on V02, plotted against 
time. These individual plots aim at the better understanding of the device 's 
response to changes of blood flow, blood temperature and oxygen 
consumption. In certa in cases, the bypass machine failed to record certain 
paramelers, therefore in some plots blood flow and oxygen consumpt ion are 
not present. 
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During Bypass triaI07102004/ lutllriaI07102004.dat 5)(°2,5..02", 0.35 (n:20) 
5)(02,8T::: -0.70 (n:::20), 5IC02-O: -0.08 ("",20.00). Sx02N02", .a,3t (n:20) 
S>'o2,8T • .0.62 (ns20). S>'o2'O= 0.49 (n=20),S>'o2'V02", .0,4' (n=20) 
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During Bypass triaI211 02004/fulltriaI21102004.dat $)(°2.5>.02- 0.75 (n:20) 
$IC02-8T: ·0.32 (n:20). SICO~ta lll -0.18 (n=2O.00), Sx02-V02- ·0.75 (n: 20) 
5>'o2·8T= -0.56 (0:21). S..ofQ = ..().31 (n=21).S..o2"V02: -0.99 (n:21) 
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During Bypass IriaI28102004/ full lriaI2Bl02004 .dat Sx02,S\,()2= -0.03 (n::dS) 
Sx02,BT: -o.oa (n::15). 5x02-O:: -0.0 1 (n"" 5.00), SxOZ.v02'" 0.08 (n=lS) 
S..o2·BT: -0.21 (n::IS), S\lQ2-Q:: 0.49 (n:1S),Sv02·VOi" -0.74 (n=ls) 
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During Bypass Irial02112004lfuIUriaI02112004.dat 5x02,5..o2= -0.32 (n= 18) 
SxOz,BT= -0.56 (n=18), 5x02,O= -0.58 (n: 17.00). Sx02N02", -0.23 (n= 17) 
S..o2,BT= -0.52 (n= 18). S>'oz..Q= -0.42 (n=17).S..oz,vOz= -0.79 (n: 17) 
............ :. .. ..... , .......................... , .... · ...... , .............. , .............. , ........ ·•• .. -<-- .... · .. ••• .. 1 .. · ............ l ............ · .. : .... · .. ··· 
............ ~ ........ · .. T.. .. ............ 1 ...... · .. ·'1' .. · .......... :--··· ...... 1' ............ '1" .. · .... ·" ............... · .. · ...... r ...... .. 
......... u .i'h __ ..... __ n.~ __________ • ___ ~. H .._ ..... H';" ~~ ______ ~. ____ j _._ ~ ___ . _____ ~_ ..... __ h -- : -__ .h --nu' '1--......... H __j_ ._u_'''' _._ .. : - U· ... .. 
r-t-. , . . ,: ~ ... ~: ....... 
I[llirl~!Tt-
:::: :::::J:, ... _._--~ .. ~. :~::~:~::~:~:.:~:~.:~:~:~:~::~:~:~: :~:l~:~:~::~:~: :~:~::~:~::~:fl~:~::~:~: :~:~: :~:~::~:~I:~:~::~:~: :~:~::~:~, :~:fl:~:~' :7'"'''''' ............. -~... . ...... ~... ........ T .......... T" .... .. 
........ ; .............. ; ....... -- ..... ; ....... --------:--_ .......... : ......... . 
, , , . , . : --r-: : .-r 
..... ---.... :-. _ ............ ~ .. ----- -- -----~--. -------.. --; --- ----- ------: ------ --- -- --- : -------------- ~-- - ----- -----~- --- --- --------:- ---------- ----:- -- ---- --------:- ------- --
;-: ' , ~, : l : 1 1 
~~f;~, rirIIlrLI 
10:26:24 10:33:36 10:40:48 10:48:00 10:55:12 11 :02 :24 
Time 
11 :09 :36 11 16:48 11 :24:00 11:31:12 11 :38:24 
() 
t'" 
Z 
n 
:>-
t'" 
"T1 
m 
:>-
Ul 
CD 
t'" 
=i 
-< 
Ul 
-l 
C 
o 
-< 
." § 
Ul 
» 
." 
." 
rn 
Z 
2 
x 
00 
IV 
""l 
iQ' 
= ... 
'" 
..... 
..... 
I 
("J 
S· ;;. 
'" 
..., 
'" '" 
'" 
'" ... 
= c.. 
'< 
..... 
..... 
:. 
E 
~ 
} 
> 
" .S E 
~ 
0 ;; 
0 
u 
~ 
oN 
!!. 
• ~ 
~ 
.. 
During Bypass Irlal04 11 2004lfulltriaI0411 2004.dat Sx02-5..o2", -0.96 tn: 17) 
SxOZ-BT= .(1.49 (0: 14), 5)(°2-0: -0.62 (0: 14.00). Sx02-V02= .0,79 (n=1 4) 
S..o~fBT.= 0.26 (n", '4), 5\002.0: 0.22 (n: 14),S..oZ'V02= -0.37 (n=1 4) 
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During Bypass IriaI1811 2004/1uIllriaI18112004.dal SI(02-S..o2'" 0.29 (n::33) 
51(02-8T", -0.12 (n.:33), SI(02-O,: -0.18 (n.:33.oo). 5K02,V02", -0.24 (n.:33) 
5..o2,8T: 0.02 (n:33), S..o2-o: -0.54 (n=33),5\Q2,VOi'" -0.86 (n=33) 
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DurIng Bypass IrtaI2S1120041~lIlriaI25' 12004 .dal $x02,8..o2= 0.39 (n:14) 
Sx02,BT: .(l.2 t (n_ 14), Sx02.Q:z -0.12 (n,. 14,OO), S,,02-V02'" -0.36 (n=14) 
S..o2,BT: -0,23 (n lE 14), S..o2-o: -0.24 (n". 14),S..o2.v02'" -0.58 (n: 14) 
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During Bypass triaJ02122004/ iull lriaI02 122004.dal 5IC02,5..o2", 0.64 (n .. 23) 
Sx02,BT: -0.22 (n::23), $x02-O:: -0.11 (n:23.00). Sx02·V02''' -0.75 (n:23) 
S..o2·BT: -0.65 (n:23). 51002-0: 0.27 (n=23),SIo02,V02", -0.90 (n:23) 
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During Bypass Irial09122004Jfulllrial09122004.dal Sx02,Sv02= 0.07 (n:15) 
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110 r--------r---------,----------r---------,----------r---------,----------r---------,----------r-------, 
:: : !: 
100 ----------- ••• }. ...... ----,.-. ••••••••• • ------- -- -
. , . , . , , . . 
90 ............•.•.•......•..... : ..........•...... : ..••.. ············,···············T···············,················T······································-
80 -····-·····,-·~··-····-····-···-f-·······---·-·---i---··-----··-,------!--------·----·,-··~-··----·--·------l .• -------- ... -- ... : ..... ----- .. ---- .. }.--- .. -- ........ -~.-- ......... -
! __ -+0-- ! .~ ! ! ! ! : 
.e- ~ -- : ----~ ;" - ' ; : : : 70;. ............ [ ................. 1. ................................................................ B ..... i ................. ~ ......... ~; .. t .. : ...... ~.~ .,,~ ..... _ 
60 ••••.••••••. ""[" ....••••.••••.• [ ••..•••.••••.••.. 1""" ...... ·········r···············T································r············r·············T··········-
~ V···················································· .....•............................ ......................... ~ .................•............................ -
40 ··············r·················;··············X ··············""["···············r ··············"j"··············r···············;-············T:········-
30 ......••..•••. , ••.••...•.••.•..•.•••••••........••..•••••••.•..•••••..••..••••.••••..•••..•..•......•• •••••.....••.•... ~ ..•....••..•..•..•..............•............ -
20 ·:=·~:::::s:~; ·········;················· · ············ ........................................................... ~ ............................................... -
10 ==~:~~:~:::'::~2 ..................................................  "["" ............... ................. ~ .................................. , ......... _ 
o 
10.40.48 10.48.00 10.55.12 , 1.02 .24 11 .09.36 
TIme 
11.16.48 11 .24.00 11.31 :12 11 .38.24 
""l 
riQ. 
c 
.< 
... E 
'" E 
-
N 
-
"N 
"" 
0 
> 
I :. ;> Q 
" 
." ~ 
." 
en = 
0 
Z ;;. .. 0 Cl ., 0 
X .., § ., 
'" 0'" 
'" 
'" 
t. 
-C • Q. 
* '< ~ 
-
"" 
Q. 
00 
..., 
During Bypass IriaI20012005lfulllrial2001200S.dal 5x02,5\o2''' 0.20 (n:21) 
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During Bypass IriaI27012005JfuUtriaI2701200S.dat Sx02-SI02- 0.81 (n:9) 
Sx02·BT: .0.27 (n_9). Sx02-O= 0.00 (0_7.00), Sx02,V02''' .(1,69 (";7) 
S..o2,BT= ·0.48 (na9), S..o2-O= -0.00 (nz7).SIo02,V02''' -0,97 (n=7) 
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During Bypass IriaI03022005l1u1lIriaI03022005.dal SXOZ-S\02'" 0.44 (n=3O) 
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ELECTRONIC CIRCUITRY 
ApPENDIX 
11. ELECTRONIC CIRCUITRY 
This appendix presents the schematic diagrams of the pressure modulation 
contro ller, as well as the microcontroller code which provides all the 
functionality described in Chapter 4. 
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:VENOX. 90ARD. MICROCONTROLLER CODE fO R Tile PRESSURE MODULATION 
CONTROL BOARD, RUNNING ON MICkOClllP' 16fS76A ~ lOMIt.. FEATURING 
,.RS211 BI·DJI~fCTtONAL COM.'.Il/NICATION wmt PC 
,·AID CONVERSION OPTlIE PRESSURE SENSOR SIGNAL 
,.MASTER CONTROL OfTltE SLAVE MtCItOCONTROLLER ( 161'621) WIUCU OI'EkATES 
THE PINCl-i VALVE 
,.DI RECT PUMP SPEED CONTROL 
.,Le D SCREEN CONTROl 
..IIOOTlOAOER fOR QN.Q()ARD PROGRAMMING VIA use 
UST P- 16Fl76A. R- DEC 
• ..c lud~·PI6F176A tNe 
,CON fiGURE TilE FUSES 
... ...................................................... 
_co"r.. _HS_OSC A _lV"OFl'.t _ WOT, DI'I'.t . PWRTE. ON. , 00001, 101" 
......................................................... 
.DEfiNE RESEll VECTOR AND OOI!UUPT SERVICE ROUTINE ,lOCATlONS 
... ...................................................... 
RES~::t_V I:QU Cb.000 
1~~:-.~ .. •. . . ..... . . 1:9~ ... ~x.~ . . .... . ... .. ............... . 
:ASSIGN NAMES TO SOMe. PORTS AND PINS 
LeD_DATA EQU PORTB 
LeD_DATA_TRlS EQU TRlSD 
LeD_CTRl EQU PORTA 
LCD_RW EQU I 
LCD_I! EQU 1 
~:? .~ ........... ~~ ....... ~ ........................... . 
.,usIGS MEMORV ADDRESSES TO VARIAUI.ES 
............................................................. 
LeD UNED EOO 1I'0000' 
LeD: TBtP EQV IrooM' 
DELAV EOO 1fOO21' 
X_DELAV EQV 1fOO21' 
TEMP EOO IroG2J' 
TEMP~ EOO IroG24' 
TEMI'CHAR EQU IfOOU 
TEMPREG EQU IroG26' 
1'-'11 EQU If002? 
I' _LO EQU If 0021' 
FLAG IOQU If 0029' 
......................................................... 
.PROGRAM START 
ORG RESET V 
CUP rcuTit 
GOTO START 
......................................................... 
.PERIPHERAL INTERIIUPT RO UTIN E 
ORG ISR_V 
RfTflE 
.................... ..................................... 
.ISITIAlISE PROCESSOR REGISTERS 
START CL" mrus 
CL" INTCON 
CU P PORTA .CLEAR ALL PORTS 
CUP PORTB C,,, PORTC 
MOVLW 
"'" 
. IOOOOOOL AID MODULE POW!R lll' 
MOVWF AOCOSO 
'" 
Sf A Tl.IS.IU'O 'sELECT BM'); I 
BCf STATl.IS.R.I'L 
MO"'-W "OCI! .CONFIGURE AID 1l00L 110 
MQVWF ADCON, ,RM ANALOGUE, RES RLGIrT JUST 
.TAD-FOSCl64 (110) 
MOVlW 
"000 .ALL INTERRUPTS OFF. PI!LE. GEm ON 
MOVWF INTCON 
MOVLW 
"'''' 
.RAOINI'VT 
MOVW' ""SA ,!tA7 I OUTPUTS 
MOVLW 
""" 
.RB70 0lJTPUTS 
MOVWF TRISU 
MOVLW 0.010 .I!NABLE RX. AlL OTHER OllTPIITS 
MOVWF TRISC 
............................................................. 
.SET BAUD RATE TO COM MIJI'IICA TE WITH TIlE PC 
.BAUD RATE " 9600. "'0 PARITY. L STOP DlT 
.MAIN PROGRAM 
MOVLW 
MOVWF 
MOVLW 
MOVWF 
oa 
MO"'-W 
MOVWF 
CL" 
CALL 
0010 
CAO.' C"'-, 
CAO.' 
MOVlW 
CAll 
MOVlW 
MOVWF 
. SP 
frOOI I' 
SPORG 
1f00U 
TXSTA 
ST A TlJS.RPO 
....". 
,cm 
PORTB 
HEXMAP 
MAIN 
leDrNIT 
ISIT ..... ·M 
,coco. ..... 
leD_UNED 
l CI)SDOA 
(I'OO L 10001' 
nOON 
PO RTC.O 
:DECLMAL 1 29(21)MI~ XTAL) 
.BAUDRATE" 96OCIbp6 
.BROII .. L. TX ENABLED 
.sELECT BA.'';!: 0 
.ENABLE SERIAl PORT 
.SETCO"'TI~WUS REalVE 
.CONSTRUCT HEX·ASClL MAP 
.INITlAUZETIIE LCO 
.INITIALlZE THE PWM GENERATOR 
.ClEAR TIlE lCO 
.MOVE CURSOR TO UNEO 
.SWITOi l EO ON 
E LECTRON IC CIRCU ITRY 
~WN2 .CAlL PRESS URE .R.£AD PRESSURE 
MOVLW 
'" MOVWF 
'" MOVF INDP,W 
CALL CONVERT 
p" PORTC.O 
CAll REC£IVE .WAIT FOR CHARACTER INPUT pe, PORTC.O 
OOTO OII(R .0070 CIIECt: CHARACTER 
EXITJR pe, "-AG,' .CLEAR ERROR PLAG 
OOTO MAIN} 
............................................................. 
• AID CONVERSIOS OF Till:! PRESSURE SENSOR 
............................................................. 
PRESSURE CALL DELAV I 
CALL DELAV I 
BSP AOCONo.2 
DTFSC AIlCONO.1 
GOTD S· L 
MOVLW H'OQo&l' 
MOVWF f$1I. 
.STARTCONVERSrON 
.IS IT OONE YEn 
.11' YES St:IP "'£XT UN"E 
.POI,,"TO AODRESSOXGO 
MOVF ADR£$H.W .STORE tuGH SIDBLE 
MQVWF INDP 
MOV\\,'P P)II 
LNCF FSR.I' 
OSP STATUS.Rf'O 
MOVF AORI'.5L,W 
BCF STATUS,RPO 
MOVWP ISOI' 
MOVWF P_LO 
CAlL D£LAY I 
CAll DELAY I 
OOETUON 
.POI,," TO ADORESS OXI).I4 
.SELECT DANI( \ 
.STORE LOWER NIlIULE 
.SElECT BANt: 0 
,RETURN 
. ............................................................ . 
,DECIDE IFTIIE 1:>O'COMJNG MCt:ET IS 
,A COMMAND (-) OR AN ENQUIRV (1) 
............................................................. 
O IKR MO VF RCREG.W 
MQw,'1' TEMPOtAR .STORE INCOMLNG CHAR 
SUBLW 'T 
BTFSC STATUS,Z .IS IT A 'T 
0070 READ .VESOOTO READ VALUE 
MOVF TEMPOIAR.,W 
SUBlW .LS IT A .... 
BTFS(' 5T A TUS,Z 
OOTO WRITE .YESOOTO WRITE NEW VALUf 
.................. ~:.~ ••••• ~~~';I.~ •••••• :~:".~~~:!!;!'! . ~ BACK 
.INQUlRV ~ACt:ET DECODING. PO INTS TO TI ll:! 
.AI'PRO~RIATE REG ISTER TO SEND BACK TO I'C 
............................................................. 
READ CAll RECEIVE .WAlTFOR NEXTOIARAFTER 7 
MOVWP T£MI'CHAII. ,STOR.£ 
SUBlW '2' 
BTFS$: STATUS,Z .ISIT ·l'7VENOXID 
GOTO EXITJR .NO. PACKET LNVAlJOEXIT 
CALL RECEIVE .VES. WAIT FOR NEXT CltAR 
MOVWF TEMPCIIAR .STORE O IAIlACTER 
SUBlW 0.000 .15 ITCAAAIAGE RfTURN1 
BTI'SC STATUS.2 ,1P"ESEXITWITIJERXOR 
OOTO EiUtMSO .SEND ERROR MESSAGE TO PC 
MOW TUIPCHAR. W .NOT CR. MOVE TO W 
MOW,'P PSR .POINTfSRTOCIlARVALIJE 
SUDLW 'r .IS TlIECIlAR ·>"(ASCTI)7 
BTFSS STATUS.C ,LP "ES. REGLSTER OIlTOF RA~'GE 
GOTO ERRMSG ,EX IT WLTlJ ERROR 
MOVLW 'A' ,IS THE CHAR· OR AFTER 'A' (ASCII ) 
SUBWP FSR,W 
BTFU ST A TUS.C 
GOTO EII.RMSG 
CALL RECEIVE 
SUBL W H'OOOD' 
BTFSS ST A TUS,Z 
OOTO s·) 
MOVLW '2' 
CAll SEND 
MOVl' FSR,W 
CAll SEND 
MOVLW 
CALL SEND 
MOVl' INOF.W 
CAl l CONVERT 
MOVLW IroooD' 
.LF VES. RfOISTER IN kANGE 
.IF NO. EXIT WITIt ERROR 
• W AIT fOR NEXT CHAR 
.IS IT CARRIAGE RET\JRN'P 
.NO. WAIT FOR NEXT CHAR 
."£S. REPLVWITH REG VALUE 
.SfNDID-2 
,COPY VALUE OF POINTER TO W 
.SEND VAlUE OF POI,,"ER 
.SEND· ' 
.CONTe.'TS 01' POI,,"ER TO W 
.CONVERT VALUE TO ASCIIISENO 
CALL SEND .SEND CAkRl AG!! R£T\/1UoI 
.................. ~:.~ ••••• ~I.:-:I.~ •••• • • :~. .~.~~~~.ROUTINE 
.ERRM SO · SEND ERROR MI'.5SAGE TO PC 
............................................................. 
ERRMSG CAl l RECEI VE .WAIT FOR CA RRIAGE RETURN 
ERRMSGL 
SUUlW IroeJOD' .BEFORE SENDING ERROR 
BTFU ST A TUS.2 
OOTO ElAAlSG 
MOVLW '2' 
CALL SEND 
MOVlW 
CALL 
MOVl W 
CAll 
MQVlW 
CAU 
MOVLW 
CAO.' 
MOVlW 
CALL 
OOTO 
SEND 
'" SEND 
'" 'ENO 
'" SEND 
''''''''' ,,,"0 
EX IT_Ill 
.SENDOtAR7 
.SEND CIIAR " 
,SEND CHAR 'E' 
.SEND OIAR 'R' 
.SEND CHAR 'It' 
.SENOCARRlAGE R£T\/1UoI 
.RerURN TO MAIN ROUTINE 
Figure I 1.3 a - Master JlController code part (a) 
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...... RlTE PACKET DECODING POllIo'TS TO THE 
,APPROPRIATE REGISTER AND EXECUTES COMMAND 
............................................................. 
WRITE CALL RECEIVE .REAO CHARACTER 
MOVWf TEMl'CtlAR 
SUBLW 'r 
UTFSS Sf A TUS.z 
GOTD EXIT_IR 
CALL RECEIVE 
MOVWF TEMl'CllAR 
SUBL W If'OOOO' 
BTfSC STArus.z 
.IS IT 1~17 
.NO, IGNORE AND RETURN TO MAIN 
• YES, GET NEXT CIIAR 
.srn", 
,IS IT CAIWAGE RET\1RN"I 
GOTO EIUl.MSG • YES, PACKET INCOMI'LETl:. ERROR 
MO"" TeMPCtlAltW.NO.MOV!CttARTOW 
MOVWF FSR ,POINT FSRTQ VALUE OP CHA R 
MOVWF TEMP REG 
SUUL\\, 'A' .IS IT'A'7 
DTPSC ST" rus,z 
COTO PUMP · "£S. ADJUST ruMP SPEED 
MOVP FSltw 
SUOLW '0' , IS IT 'In 
OTfSC STATUU 
ooTO V ......... E • YES. ADJUST \' A1. VE FR.£QUENCY 
MOVF FSltW 
SUBLW 1:' ,IS IT n 
8TfSC 51 ... TUS,Z 
OOTO lCOC ;YES. SI!NO LCD COMMAND 
MOV' FSltW 
SUBL"'" 'F' . IS IT'M 
8TfSC Sf ... TUS,Z 
ooTO LeeD • \·ES. SEND LCD DATA 
MOVP F'SltW 
SUOLW 'CO' .IS IT 'G'1 
BTPSC ST A TUS-Z 
OOYO USERCHAR • YES. SEND CtJSTOM USUCUAI 
MOVP FSltW 
SURlW 'Ir ,ISIT 'I" 
IlTFSC Sf A TUS.Z 
GOTO p_e TltL ,\·ES. SET MAX PRESSURE (NOT uStm) 
GOTO MAlSZ 
GOTO EIUlMSCi .NONE 01' TtIEM, IU!11JRN ERROA 
............................................................. 
• PUMp - EXECUTES TIlE COMMAND TO UPDATE mE PUM P SPEED 
............................................................. 
PUMP CALL OIK I .READ NUMERICAL VALUE OF p ... CKET 
10RWl' TEMP,' .STOR£ 90TII OIARS IN SINGLE REO 
MOVI' TEMp,W .COI'Y TIlE TOTAL VALUE TO ..... 
MOVWI' INDI' ; ..... "DTlIEN TO TIlE MEJ.1ORY 
C ... LL 
SU DLW 
OTPSS 
00>0 
""SC 
OOTO 
MOVI' 
MOVWI' 
MOVLW 
CALL 
.l.1OYf' 
CALL 
MOVLW 
RECEIVI! 
IfOOOD' 
STArus,Z 
,., 
fLAO,O 
ERAAISG 
INOI',W 
CCpRl 1. 
·r 
SEND 
PSR.W 
'ENO 
CALL SEND 
MQVL ..... '0' 
CALL SEND 
"lOVP CCPRIl .. "'" 
CALL CONVERT 
MOVLW '0' 
CA LL SEND 
MOVLW 'K' 
CALL SENO 
MOVLW 11'OOOD' 
.LOCATION FOR THE PUMP 
,WAIT FOR t:NDOI'I'ACKET (CR) 
.11' NO ERAORS.I'lI;W !'Wo" SPEED IN W 
,CllANGE TIlE pWM DltfY CYClE 
,SEND CON~'RMATlON OF EXECUTION 
,COPY NEW PUMP VALUE fROM I'WM 
; CONVERT TO ASCII CtIARACTERS 
CALL SEND .ENDOI'PACKElSENT 
•••••••••••••••••• ~:.~ ••••• :~~~ .'.~ •••••• :~~~~~~.~ ~~~~~ElED, EXIT 
• VALVE · EXECUTES TIlE COMMAND 10 UPDATE TIE VALVE filEQUENCY 
............................................................. 
VALVE CALL 
10RWI' 
MOVI' 
MOVW I' 
CALL 
SUBL ..... 
.ms 
OOTO 
""SC 
OOTO 
RL' 
RL' 
RL' 
MOVI' 
ANDLW 
IORWI' 
MOVW, 
MOVLW 
CALL 
,\.1OVI' 
CALL 
MOVLW 
CALL 
MOVLW 
CALL 
MOV, 
ANOLW 
MOVW, 
.." 
OlK1 
TEMP.' 
TEMr.w 
INDI' 
REC£IVE 
'''''''' STATUS,Z 
,., 
FlAO.O 
ERAAISO 
TEMP.' 
TEMP.' 
TEMP.' 
PORTC.W 
0' 11 Il00111 ' 
TEMp.W 
PORTC 
·r 
SEND 
PS,W 
SE.'liD 
SEND 
.. 
''". I'ORTC.W 
8'00111000' 
TEM' 
TEMp.1' 
,READ I<o'llMERlCAL VALUE Of PACk El 
,STOR£ DOTII OIARS IN A SINGLE REO 
,CO~YTIIE TOTAL V ... LUETO W 
;"'NOTII!!N TO TIlE MI!MORY 
.LOCATlON ~"ORT IIEVALVE 
.WAIT FOR ENOOI' PACKET (eR) 
,M ... KE SUR£ TIIER£ WERE:-.'O ERRORS 
;ROTATELEFT 
;ROTATE LEFT 
;ROTATE LEFT 
;COPY f'ORTC VALUI! 
.OISC"'RDOLD VALVE VALUES 
.ADD NEW V AL VI! VALUE TO I'ORTC 
.copy UPD ... TED POJtTC 10 TlfE PORT 
,5ENDCONfIRM ... Tl0NTO re 
.READ VALVE VALUE FROM PORT 
.IT WAS PROPERLY UPDATED 
.ROT ... TE IUOlfT 
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RAP TEMp.1' 
RAP TEMp.1' 
MO"'f' TEMP."'" 
C ... LI. CONVERT 
MO"'I.W '0' 
C ... LL SEND 
MO ... L..... 'K' 
CALL SEND 
MO ... L..... II'OOOD' 
.ROT A TE JUGKT 
.ROT A TE JUGKT 
.COI'Y RESULT TO ..... 
.CONVERT IIEX TO ASCII CHARS 
C"'LL SEND .ENOOI' MCKET SENT 
.................. ~:.~ ..... :::~~.I.~ ........................ . 
.LCDC - EXEOJTES nIE COMMAND TO SENO COM~IAND TO nIE LCD SCREEN 
............................................................. 
LCDC C"'LL CIII(I .NUMERIC ... L "''''LUEOI' p ... CKIIT 
10 RWI' TEMp,1' .STORE DOTlI CHARS IN ... REO 
MOVI' Tlltolp,W .copy TIlE TOTAL VALUE TO ..... 
MOVWI' INOI' .... NO TIIEN TO THE MeMORY 
CALL RECEIVE 
SUOLW IrOOOO' 
IITPSS ST ... TUS,Z 
ooTO s·) 
DTFSC fl.AG.O 
ooTO EAAMSG 
MOVP mol',"'" 
C ... LL LCDPUTCMD 
MOVLW '1' 
C"' I.L SEND 
MOVI' PSR.W 
C"'LL SEND 
MOVLW ,. 
C"'LL SEND 
MOVLW '0' 
CALL SENO 
MOVI' INDI'.W 
CALL CONVERT 
MOVLW '0' 
C"' I.L SI!ND 
MOV LW 'K' 
C ... LL SEND 
MOVL W H'OOOD' 
.LOC ... T10N fOR TIlE LCO o.ID 
.w ... 1T FOR DlDO' I''''CKET (Clt) 
.M ... KE SURE nlEkE WER£ 1<0'0 EH 
.MOVECOM!>IANDTOW 
.SEND COMMAND TO LCD SCREEN 
.SEND CONFIRMATION TO PC 
,Il£AO LCO eMD fROM MEM LOC 
,CONVEltT 0.10 TO ASCII CHARS 
CALL SEND ,ENDOI'I'AClCETSENT 
. ..•....•.......••. c:<!~ ....•............... ~!;.~~ .......... . 
.LCOO. EXEClJTES Tlte OO MMANO TO SEND O ... TA TO TIlE Leo SCREEN 
LCUD C"'LL 
IORWI' 
MOVI' 
MOVWF 
O IKI 
T6Ip." 
TEMP."'" 
11'101' 
CALL RECEIVE 
SUBLW If'OOOO' 
BTPSS ST A 1lJS,Z 
ooTO So) 
.~'UMEJUCAL V AI.U1! 01' PACIUIT 
.STORE 90TII OIARS IN A REG 
,COPY TilE TOTAL V ... LUETO W 
.AND TIIEN TO TilE MEMORY 
.LOCATION FOR TilE LCD O ... T ... 
OTl'SC FlAO.O .MAKE SURE TIIERE WERE t«) ElU. 
GOTO EltRMSG 
MOVI' INDI'.W .MOVECO,\{~IANDTOW 
CALL LCOI'UTOIAIt .SEND DATA TO TIlE LCO SOl£EN 
MOVLW .,. .SENOCONI'IRMATIONTOI'C 
CALL SEND 
MOVI' FSR.W 
CALL SENO 
MQVLW •• 
CALL SENO 
MOVLW V 
CALL SEND 
MOV' INDF,W ,LCO OATA FROM MEMORY LOC 
CALL CONVERT ,CONVERT O ... TA TO ASCUCIIARS 
MOVLW '0' 
CALL SEND 
MOVLW 'K' 
CALL SEND 
"lOVL W IfOOOD' 
CALL SEND ,ENDOI"ACKET SENT 
ooTO EXIT_IR 
. ........................................................... . 
.USERClIAR - EXECUTES TIlE CO!>IMAND TO SEND<:unOM CltAR 
.TO TIlE LCO SCREEN 
............................................................. 
USI! RCIIA R 
CALL 
10RW' 
MOVF 
"lOVWF 
CALL 
SUOLW 
OTFSS 
00>0 
MPSC 
COTO 
MaVI' 
CALL 
MOVLW 
CALL 
MOv, 
CALL 
MOVLW 
CAU. 
MOVLW 
CAU. 
MOVI' 
c ... LL 
MOVLW 
CALL 
"IQVLW 
CtuU 
TEM',I' 
TEMI'.W 
ISOI' 
RECEIVE 
' '''''~ STATUS.Z 
,., 
FlAG,O 
I!ltRM SO 
IND!',W 
LCDSC(jA 
7 
SEND 
,,.w 
SEND 
''''. .. 
SEND 
INOI'.W 
CO NVERT 
'0" 
SEND 
~. 
,NUMEJU CAL VALlre 0 1' PACKET 
.STOR£ aoTII OIARS IN If. R£O 
.copy TIlE TOTAL VALUETOW 
.ANOTHENTO nIE MEMORY 
.LOCATION FOR TIlE Leo DATA 
,MAKE SURE THERE WERE NO I!RR 
.MOVE CO MM AND TO W 
.SEND CUSTOM OIAR TO Leo sat 
.sEND CONFIRMATION TO PC 
.CUSTOM CIAR FROM MEM LOC 
,CONVERT DATA TO ASCII CIIARS 
Figure 11.3b - Master flController code part (b) 
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CAll SENt) 
MOIIL W ImooD' 
CAll SEND ,ENDOI'PACKETSENT 
................. ~:.~ ..... ............... ~!::;-!~ .......... . 
.011( I • READ TilE NUMERICAL VALUE WIIlCtt COMf..s AFTER 
.TIIE PARAMETER LETTER . E.O _ lAlR. R£AD'SIr 
CIIKI 
CIlIU 
CIIARI 
",-w.1I 
<HA" 
NU'" 
cm 
MO~' 
MOVWF 
SllBLW 
""'SC 
GOTO 
MOVLW 
SUBWP 
IITfSS 
GOTO 
GOTO 
S~'APP 
CALe 
MOYWp 
""VW, 
SUBLW 
.mc 
GOTO 
MOVLW 
SUBWP 
STfSS 
GOTO 
OOTO 
MOVLW 
SUBWf 
,m, 
GOTO 
GOTO 
MOVLW 
","W, 
GOTO 
MOVLW 
SUBWF 
BTPSS 
GOTO 
GOTO 
MQV l W 
SU DWp 
BTFSS 
GOTO 
GOTO 
MOYLW 
SUOWP 
UTFSS 
GOTO 
GOTO 
MOVLW 
SUOWF 
RETURN 
/oIOVl W 
SUOWF 
OTFSS 
GOTO 
GOTO 
MQVLW 
sunwp 
BTFSS 
'" 
""'" RETURN 
RECEIVE 
TEMP 
TEMPOIAR 
""'" STArus.z 
EIUt,\.lSOI 
1f00.61 ' 
TEMP,W 
STATtJS.C 
NUMI 
CHARt 
TEMP. ' 
'-.ECElVI! 
TEMPl 
TEMPO"'1t 
''''''' STATUS.l 
ERRMSG I 
IfOOH' 
TEMI'1.0 
STATUS.C 
NI»-U 
cnA" 
,rn"" 
TEMI'.W 
STATVS.C ,., 
ERR.MSO 
IfOOl7' 
TEMI'.f 
0"" 
IfOO1A' 
TEMI'.W 
STATU5.C 
,., 
ERRMSO 
11'00)0' 
TEMp,p 
STATUS,C 
'''''''' 0"" 
,n." 
TEMI'1.W 
STAT\JS.C ,., 
I!IUtMSO 
1t'00}7 
TEMI'l.W 
Iroo)A' 
TEMI'1.W 
STATUS,C 
,., 
I!RRMSCi 
Iroo}O' 
T £MP1.p 
STATUS.C 
FLACi,O 
TEMl'l.W 
.RECElVE fiRST e ll"R OF l>'UM VALUE 
.MOVE VALUE 01' 1ST CHAR TOTEM!' 
.MOVE SAME V AtUE TO TEMI'OWI. 
,IS ITCAlllAGE RJ!T\J1tN1 
.11' YES. I' ACKET INCOMI'LETE. ERROR 
.MOVE HEX'~ I ' (STAAT 0" ALPHABETIC 
.CIIAllS) TO W 
,SUBTRACT W PROM TEMP 
.CIIECK CARRY O1T STATUS. TO 
.CHECK W>fOR WO I' 
.11' TEMP</lEX'41', IT'S NOT A LETTER 
.11' TEMP~IIEX'41 ', IT'S NOT A NUMBER 
.SWAPLOW ANOIIlGII NIBBLES 
,RECEiVE t-'£XT CIIARACTER 
STORE CHAR TO rEM!"! 
STORE CHAR TO TEMl'CtlAlt 
.IS IT CAJUUAGE RET\IRN'I 
• YES. INCOMI'LfTE rACKET · ERROR 
.MOVE IIE)('~I ' (START 01' ALPHABETIC 
;CIlARS) TOW 
.SUBTRACT W f ROM T EMPl 
.OlECK CARRY BlTSTATtJS. TO 
.OlEO:: W>P OR W<I' 
:11' TEM Pl<11EX" I',1l"S NOT A LETTER 
.11' TEMP2->II£X"I '. Irs NOT ,,"'UMBER 
,MOVE IIEX'41IN W 
:SUBTRACT Il£X'47' FROM TEMP 
.IS TEM P -> OR < THAN W7 
,TEMP<W, CHARACTER bEFORE 
,ASOI( Ir47') 
.TEM .... :>W. CHARACTER EQUAL TO OR 
;AFTEIt ASCII(Ir41') 
~\lOVE HEX"7' TO W 
.TEMI' NOT A L£TrU,IS rr",'UMBER' 
,SUBTRACT HEX'JA' FROM TEMP 
.IF TEMJ>::> IIEX'JA,' NOT A "'UMBER 
,TEMP<IIEX')A', pROUAULYA NUMBER 
;TEMI'> IIEX'lA' NOT A NUMIIER.ERROR 
,MOVE II EX')O'TO W 
,SUBTRACT IlEX'JO' 1' 1I.0M TEMP 
,IF TEMP-::>11EX')0' Q£1'1f'JITEL Y NMBER 
. IF TEM P<HEX'lO'. NOT "''UMBER . ERR 
,GOTO CHttX SECONO CHAAACTER 
~\fOVE HEX'41' IN W 
.SUBTRACT 1 1£X'~ 1' FROM TEMI'l 
,IS TEMPl e OR < TItAN W7 
;TEMP2<W. CHARACTER BEFORE 
,ASCtI{lU7) 
,TEMP2->W. O ..... AACTER EOUAL TO 
,OR AFTER ASOI (lr'T) 
,MOVE 11£X')7 TO W 
,T EMP2 NOT A LETTER. IS rT NUMBER? 
,SUBTRACT IlEX')A' FROM TEMP2 
.lFTEMP2>IIEX'lA· NOT A NUMIIER 
,T EMP2<IQ!X')A' I'ROUABlY NUMBER 
,T EMP2>II£X'lA' NOT A NUMBER . ERR 
,MOVE IIEX')O' TOW 
,SUBTRACT IIEX')O' PROM Tl!J>lPl 
,IF TEMPl:>I(£'x')O' PEflNITEL Y NMBEM. 
.sET BlTaOf fl.ACiTO MARK ERROR 
.omuR.' 
............................................................. 
.IIEXMAI' • ROlTTlNE TlIA T CONSTRUCTS A TABLE wmt AlL 
• I'O$1IBI.£ a ..... RACTERS IN HEX FORMAT (0.9 M'D A. F) 
............................................................. 
ItEX MAp MOVLW 
MOVWF 
MOVLW 
MovwF 
INCF 
MOVLW 
MOVWf 
INO' 
MOVLW 
MOVWf 
INCF 
MOVLW 
MOVWp 
INO' 
MOVLW 
MOW' F 
'Na 
MQVLW 
MOVWF 
'NCl' 
MOVLW 
MOVWF 
INCI' 
MOVLW 
MO~' 
INO' 
l rOO'4' 
FSR 
11'00]0' 
INOI' 
FSR.I 
IfOOll ' 
INOf 
I' SR.I 
ItoOl r 
I'SR. I 
IfOO))' 
INOp 
PSR.1 
l rool~' 
INOF 
l'SR.1 
11'00,," 
lNDP 
,S<, 
Iroo36' 
INOF 
FS" 
IfOOl7' 
INOP 
"" 
.POINT TO MEMORY ADl)RESS IIEX'S4' 
.IIEX')O' IS ASCII CI1AII '(1 
.COPY TO MEMOIIY I.OCATlOS HEX'So!' 
.INCREASE TIlE MEMOIIY POI"'"!ER TO 
.IIEX'S' ··I 
.IIEX·)t · IS ASCII a ..... 1I. ' I ' 
.INCltEASE TltE MEMORY I'OISTER • I 
.1Q!X'lr IS ASCII CHAR 'r 
INDf 
.INCR.EASE TilE MEMORY I'OINTER • I 
.IIEX'))· IS ASCII Cl lAR ')' 
.INC'R£ASE TI lE M!!MORY I'OISTU' I 
. II£X').I· IS ASCII CIIAR ',' 
.INCREASE Tli£ MEMORY I'OINTER • I 
.1100n))' IS ASCII ClIA R 'S' 
.INCREASE TIlE MeMORY POINTER' I 
.~· IS ASCII CHA R '6' 
,INCR£ASE THE MEMORY POI"'"!ER. I 
,HE:n7IS ASCII alAR '1' 
. INCREASE THE MEMORY I'OI"'"TER' I 
ELECTRONIC CIRCUITRY 
MQVLW 1r0031' ,l lEX'JI' IS ASCII CIlA R T 
MO~' !NDF 
INO' fSR. 1 ,lNCkl!.ASe TilE ",EM POINTER. I 
MOVLW tfoo)9' ,HEX'3,. IS ASOI CIIAR '9' 
MOVWp INOF 
INCf ,,,, ,INCREASE TilE MEM I'OINTER • I 
MOVLW 1I'OCI41' ,III!X'~I 'IS ASCII C IIAR 'A' 
MOVWf INOF 
JNCP FSR. I .INCIlEASE TIlE MEM POI"'"!ER' I 
MOVlW It'OOH' .IIEX ', }, IS ASCII C IIAR '8' 
MOVWf INOF 
INCP ,,~, .INCREASE TIlE MI!J>I I'OTNTER • I 
MO"'-W """0' .ltEX'~l· IS ASCII CHAR 'C' MO~' INOF 
'NI> FS~' .INCREASE TI lE MEM I'OINTER • 1 
MOVlW IJ'OOoI4' .IIEX'~4' IS ASCII OIAR 'D' 
MOVWF INOF 
INCF FSR. I .JNCRi!A$E Tltil M ilM PO INTER . I 
MOV LIV 11'0045' . l lI!X'~ S' I S ASCi i CllAlI '",' 
MOVW," INDp 
'Na FS~ ' . INCREASE TIlE M EM POINTER· I 
MOVLW 
''''''''. 
.IIEX'~6' IS ASCII alAR 'f' 
MO~' INOF 
OU!TURN 
............................................................. 
.CONVEIlT • ROUTINE TIIA T INPUTS A V Al.UE ANP OlTTI'UTS T I lE 
,LOw "' .. 0 IIlGH NIBBLES SEQUENTIAlL Y FOR CONVERSION TO ASOI 
............................................................. 
CONVERT MOVWF TEMPOIAR .COPY VALUE TO TEMI'CI IAR 
SWAP~ TEMl'CHAR.W ,SWAPHlCi Il AND l OW NlIlBlES 
ANDLW IroooF' .I~EEF ONLY T ilE MOST SIGN!!' BITS 
MOVWI' TEMP2 ,COPY RESULT TOTEMP2 
MQVLW 11'005)' ,SET THE MEMO RY POINTER 
MOYWF PS R ,IIEFORE TIli! STARTOFTAfllE 
MOVLW Ir ooFF' ,COPY VALUE 11EX1'F'TOW 
MOVWF T[.\olp ,COPY TO TEMP 
CALL OUIIEX ,CONVERT l OW N18 BlE INTO ASCII 
MOVf TEMPOIAR.W ,M.EI'I';AT TilE AOOVE FOR TlI£LS8 
ANOLW 11'0001" 
MQYW P TEMp2 
MOVlW 11'00$1' 
MOW' p PS R 
MOVl W trOOff' 
MOYWF TEMP 
CAll CU2ItEX 
RETURN 
............................................................. 
,ClI2I1EX· ROUTINE TlIAT CONVERTS A HEX VAlUE TO TIlE 
,COIIRESPONDlNG ASCIl CiIARACTER 
Cltl l lEX INCF 
INeF 
MOYP 
XQRWp 
BTPSS 
GOTO 
""'" CAlL 
RETURN 
FSR.I' 
TEMP.F 
TEM P.IV 
TEMPl.W 
STAru5Z 
ou"", 
INOF.W 
SEND 
,1f'JCRI'.ASE 'l 'lIl! M EM PO INTER BV I 
.SCAN ASCII TADLE 1'011 A "'ATCIl 
.OOT FOUND. ClIECK ,,"'£XT OIAR 
.FOUND, COI'Y ASCI I CIIAR IN W 
,SEND ASCI OWl. TO PC 
............................................................. 
.SEND· SEND A CllAkACTER VIA ItSl12 
............................................................. 
SEND MOVWp TX REG .MOVE CI IARACTER TO TX BUFt'ER 
NOP .WAITONECVCLE 
flTFSS PUtI.T"IF .CllfCK IpOIAR WAS READ BY PC 
GOl0 S· I .WAITUNTILDONE 
RETURN .RETURN 
.RECEIVE· RECl:IVE A CilAkACTER VlA ItSUl 
............................................................. 
RECEIVE OTfSS PI RI, ROF .CIIECK II' A CIIAR IS PRESENT 
GOTO S·I .K!!!!I' CIIECK ING UNTIL DONE 
MQVP RCREG,W .MOVERECEIVEOClIARTOW 
8CP I'ORTC.O 
RETURN .RETUR.~ 
.INTTI'Yo'/oI . INmALISE TI lE PICS I'WM MODIJL£ AT 19 S3k1lt. 
............................................................. 
INTTPWM DCF STAnJS.RPO .SElECTBANKO 
8CfI Sf A nJS.RP I 
MQVLW IfCiOOO' 
MOVWp CCi'2CON 
MOVP CCPI CON,W 
ANOL W I rooFa 
10Rl W IfOOOC' 
MQYWF CCI'ICON 
,OISAlII. ECCPl 
,Movf CC PI CONTO W 
,OISA OI. Il.CCFI MOOULE ANOT II EN 
,SETI'WM /oIOOE TOCCp l 
MOVLW lrooocr ,COpy IIEX'OO' TO W 
MOVWf TlCOS .sfTTMIU PRESCALER TO I 
MOVLW H'OOfF' .COI'Y 1IEX'fl" TO W 
MOW'f PIU ,SET t'WM ( . 19)Jlljllt. 
SSf TlCON.TMRlOS,STAII.TTI1E TIMER 
CUP CCPRIL ,PWMOlTTI'UTOF'F 
RETURN 
............................................................. 
,LCOIN!T · INITIALISE TI lE LeD SCItE£N 
............................................................. 
LCOINIT CLRF I'ORT A 
MOVLW 
CALL 
MOVlW 
CALL 
MOVLW 
CALL 
CALL 
MOVLW 
CAU. 
MOVlW 
CALL 
RETURN 
IfOOU' 
X_OELAYSOO 
IfOOlI' 
LCOPUTCMf) 
"""" LCOMQDE 
LCDCLfAR 
,.-' 
LCOMOOE 
''''''''' LCODtOOE 
Figure II.3c - Master flControl\er code part (c) 
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ELECTRONIC CIRCUITRY 
,LCDDU$V. C!lECK I'OR len SCREEN BUSY fU.(j 
............................................................. 
LCDOUS\' BSF sr ATUS.1U'O 
MOVL W H'OOfr 
MOVWF I'ORTO 
BCJ' STArus.RPO 
0Cf lCD_CTkLLCD_RS 
BSF LCD_cntLLCD_RW 
BSF LCD_CTRLLCO_E 
MOVf LCD DATA."'" 
DO' LCO=cnu..tCO_E 
ANOl w 11'0080" 
BTfSS Sf A TUS.Z 
GOTD LCDBUSY 
lCDNOmUSY DCf LCO CTRL Leo RW 
BSF STATvs.RPO -
MOVL W IrOOOO' 
MOYWf LCD_DATA_TRlS 
0Cf Sf A T\JS.RPO 
"""'" ....................................... ...................... 
• l.CDCLEAJt • CLEAR TIlE LCD SCREEN 
LCOCLEAR MQVLW trOOOl' 
CALL LCDPUTCMD 
"""'" ............................................................. 
.LCDHO~lE - 5E:'I/OTlI£ CUItSOR TO THE ItOME POSITION 
............................................................. 
LCOIIOME MOVl W Ifooor 
CALL LCOPVTCMD 
"""~, 
,LCDEMOOE· LCO D/TRY MODE 
,ENTRY MODE MUST BE STORED IN W BEFORE CALLING 
,bO 0 - NO DISPLAY SHIFT, ) .. DISPLAY SIfiFT 
,b) 0 - AlITO DECREMENT, I" AUTO·INCREMENT 
. bHl DON'T CARE 
LCOEMOOE ANOLW 
10lU.W 
eAU. 
"""'" 
",." 
"""'. 
LCOI'UTCMO 
.LCDOMOOE . LCO ENT1I.Y MODE 
.ENTRY MODE MUST ae STORED IN W BEfOfU: CALUNG 
,110 0 " ctJRSOR BUNK 0",. ) .. C\JJlSO R. aUNK ON (irbl • I) 
.bl 0 " ctJRSQR Off. l .. ctJlI.SORON 
.bl O" OISPI.AYOFF. t .. OISPLAYON 
.bl.bl DON'T CARE 
............................................................. 
LCODMDOE ANOLW IfOOOT 
10RLW IfOOOl' 
CALL LCOFUTCMD 
"""'" ............................................................. 
• LCOSCGA· SET CtlAltACTERGENEltATOR RAM ADDItESS 
.(;GRAM MUST BE STORED IN W OEFOfU: CALLING 
,b().5 fU:QUlRED <:GRAM ADDRESS 
,bl·b7 DON'T CARE 
............................................................. 
LCOSCGA ANDLW IfOOJP 
tORL W If 0040' 
CALL LCDPVTCMO 
RETURN 
.LCOSDOA. SET DISPLAY DATA RAM ADDRESS 
.DDRAM MUST DE STORED IN W BEFORE CAllING 
.110-6 REQUIRED DORAM ADDRESS 
.~1 DON'T CARE 
............................................................. 
LCDSDDA 10lU.W tl'OO8O' 
CALL LCOI'UTCMD 
"""'" 
.LCDGADDR. R.ETlJltNS ADDRESS cow..'TER COl'o'TEI'o'TS fOR DDRMI AND CGRAI>I 
.ADDRESS IS RETVR.'''ED IN W 
LCtX.iADDR ,se 
MOVLW 
MOVWF 
0Cf 
0Cf 
,se 
,se 
MOVl' 
"" ANDLW 
"" ,se 
""V>.W 
MOVWF 
"" 
"""'" 
STATIlS.Rl'O 
IrooF!" 
LCD_DATAJRlS 
STATIlS.Rl'O 
LCO_CT1U..LCD_RS 
LCD CTlU.,LCD RW 
lCO=CT1U..lCO=E 
lCO DATA,\\' 
lCO=CTRLLCD_E 
",,,p 
lCO_CTRLLCD_RW 
STAnIS.RI'O 
" ... lCO_DATA_TRlS 
STATlIS.RI'O 
............................................................. 
:LCDPlJTCItAR . SEND CHARACTER TO lCD SCREEN 
.OlARACTER MUST 8E STORED IN W IlEfORE CALL 
lCOPUTCltAR ""VW, 
CALL 
"" 
'" ,se 
""VI' 
""vw, 
"" 
"""'" 
lCOJEMP 
lCOBUSY 
lCD CT1U.. LCD ItW 
lCO=CT1U.. LCD=RS 
LCD_CT1U..lCD_E 
lCD_TEMP.W 
LCD_DATA 
.l CDPUTCMD . SEND COMMAND TO lCD SCReEN 
.COMMAND MUST IlE STORED IN W ll£fORE CALL 
..... ........................................................ 
lCDPUTCMD MOVWF lCDJEMP 
CAll lCOD USY 
DCI' lCD_CTRLlCD_RW 
DCI' lCO_CTRLlCD_RS 
OSP LeD_CTlU..LCO_E 
MOVP LeD_TEMP.W 
MOVWf LeD_DATA 
DCI' LCO_CTlU..lCD_E 
'"""'" 
.?~~.':~:.~.~  ....................................... . 
Deu.YSOO MDVlW ItoOAS' 
MOVWf DELAY 
OECFSZ [)£LA Y.f 
(iOTD S·I 
'ETU'" . .............................................. ............. . 
: ~.-.~~~~:.~~~~:rJ!'!:':~~~.~ .'?~.~ •. :.~ .. ~~ ............ . 
X_D£LAY500 MOVWf X DElAY 
CALL o£LAYSOO 
DECfSZ X_DElAY. I 
(;OTO S·2 
"""'" ............................................................. 
,DELAYI • snORT DELAY OF IOCYCLES' CALL' R~ 
DELAY! 
EN" 
NO' 
,~. 
>0' 
>0' 
>0' 
,~. 
"" . NO' 
"". NO' 
"'TU'" 
............................................................. 
• END OF lISTING 
Figure II.3d - Master /lController code part (d) 
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: v At VE • MICROCONTRQLLER COOl! fOR TIlE ~RESSUk£ MODULA nos_ 
.BOAltD. RUNNING ON' MICROCHIP 161621 @ lO~1Ik. WUICII EXQ.USIVCtV 
.DRlVES TIlE I'INCII V AL YE. Tins IS TIlE "SLA YE' M1O;OC()l'ITROtlER 
Sjf THE COSTltOl90ARO WIIIOII$ CONAGURED BY THE MASTER 
.MICROCO)<''TROLLER IN TERMS OF SWITCtIlSG SPEED. AS DESCRIBED IS 
.OIAPTEJ.l 
un P" 16F611 
.CONFIGURE Till! ~'USES 
_<011 (,8 _Cl' _OfF.t _WOT_O Ff &. _,"WRlE_ON &. _90I>EN_Off &; -'IS_DSC A 
_MC1.RE_ON &. _LVP_OFP 
........................................ 
.DEfINE RESET VECTOR AND lNTERRlIn' SUVla RO(f1'lNI! LOC .... TIONS 
'OU 
EQU 
..... 
..... 
,ASSIGN MEMORY ADDRESSES TO VARIAB LES 
TEMPO EQU 1h0ZO 
TEMPI EQU 1h0ZI 
TEM!'Z EO U 0..022 
del.ye,,'Z EOU 0.02) 
dd . yen1 EOU O. ON 
...................... , ....... , ........ . 
,PROGRAM STAAT 
ORG RESET V 
CUP PCl.A Til 
GOTO START 
..................... ' ........ , ..... , .. . 
,PERIPHERAL ImERR UPT ROUTINE 
........ , ......... , ................. , .. . 
• INITIALlSE PROCESSOR 
START cm PORTA • CLEAR ALL PORTS 
cm PORTa 
.," STATUS. RPI .SELECT BANKO 
ocr STATUS. RPO 
MOV1."" 0. .. 7 
MOvwf CMCOS .$WITCHOl'P ....... ALOOUf INPUTS 
.SF STATUS.RPO .SELECT BANK I 
MOVLW b'l00000' 
MOVWP TRlSA .!!.AS INPUT 
MOVLW b' lIl00000' .RB7 5 INPUTS 
MOVWP nu'" MOVLW ..... 
MOVWP OI'TION)l&i .CLEAR OPTION REGISTER 
MOVWF ImOON .DlSABLE INTERAUI'TS 
"" 
ST A T\J$.RPO .SELECT BANK 0 
,MA IN PROORAM 
MAIN cw 
cw 
cw 
cw 
cm 
GOTO 
TEMPO .CLEAR VARIABLES 
TEMPI 
TEMI'2 
dd~ycn'2 
dd.yenl 
REAOPORT , READ FRENQUENCY SELECTION lilTS 
............ , ........ , ................. . 
. 8ASEOELA y . VALVE OPERATes OI!TWI!EN 1.0 AND 6 d iU; 
.A BASIC DELAYOP O.06UOO2111. Bt.TWEEN ON ANDOPF 
.sr .... TESGIVE$ .... 1Ii1.. 11(2' 00621.)" IH( 
........................................ 
BASEDEl.A Y MOVL W D'T 
MOVWF TI!MPl 
MOVlw O'!.SI' 
MOVWF TEMPI 
MOVLW 0'111' 
MOVWI' TEMPO 
DECFSZ TEMPO, r 
GOTO $.1 
DECFSZ TEMPt. r 
GOTO $.) 
DECFSZ TEMPZ. ( 
GOTO s.s 
mu," 
........ , .............................. . 
. MOREDELAY . IN ORJ)l!R TO AQUEVE LOWER FllEQUE. ... OES 
~\IORE DEU "IS INTRODUCED APTU Tiff 8ASEDELAY DEPo.'OING 
.oN TIlE FREQUWCY COSFlGURA TION BITS (T ABLI! l .l • CHArTER ) ) 
.AN ADDITIONAL DEU Y Of 0 OO!SOO6oi FOR EAat ADDITIONAL BIT 
.INCREASES THE PERJODOF MODULATION BY ! ' OOO25OO6J _ OOO5Olh 
::! ~:~.~~~. ~.:~~.~!~~ !!!~.~~~~ OP MODULATION (r- IfT) 
MOREDELAY MOV1. ..... 
~IOVWF 
MO"1.W 
MOVWF 
D'cnz 
u<r 
TEMPI 
us. 
TEMPO 
TI!Ml'O.r 
ELECTRONIC CIRCUITRY 
GOTO 
0'<= 
GOTO 
OETU'" 
s·, 
TEMP I. r 
s·' 
........................................ 
,READPORT. READS PORTS RH1 RB) WIUCIt ARE TilE I'llEQuu.'CY 
.CONRGURAT10N' BITS. SI!T BV TIlE MASTER MrCROCOS'TROLLER 
.ASIN TABLE) 2.CHAI'TER 1. TIlE PORT VALUE IS ROTATED 
.FlVE TIMES TO BRING Till! BITS IN Till! LSD POSITIONS AND 
.sUBSEQt,lENTLY LOADED ON A COUNTER WIOCIl ADOS EXTRA DELAY 
,TO THE VALVE MODE (WIIETIIERON OR OFF) BY CALLING Ft)NCTION 
.MOREDELAY 
........................................ 
READP'ORT MOVF PORTB. W 
ANOL"" OxEO 
MOVWF dtl.yen1 
AAI' dd. y<""1. r 
R.RF dd'yea1. r 
AAI' dd.y<""1. r 
AAI' dd. ynll. r 
11.11.1' ""byenl. W 
ANOLW 0..07 
MOVWF dd.ycm 
MOVWF dd'yem! 
IIT FSC dd'yem.O 
G010 SWITCIION 
IITFSC dd.ye,,'. L 
GOTO SWITOION 
IITI'SC dd.YCRI. ! 
GOTO $WITCIION 
GOTO REAOPORT 
.COPY VALUP.OI' f'ORT 11 
,K!!EI' TIlE THREI! MSB 
,copy TOd.I . )(,,1 
,ROTATEAVI!TIMES TO 
,DIONG TilE THRE! MSII$ 
,TO nil! TIIRI!I! un. 
.DISCARD ANY CARRY BITS 
.COPY VALUE TO d.I . )(m 
.AND TOdd.)(",! 
.TEST U D 
.I!'SET MI!ANS SWITCIION VALVI! 
.11' NOT SET, CHECK 2ND LS D 
.11' SET. SWITOI ON VALVE 
.11'1 NOT SET. alECK JRD LSD 
.IF SET swrrCH ON 
.NONE IS SET. VALVE STAYS OFF 
.SW/TCHON· SWITQIES ON TIlE VALVE AND KEEPS IT OPEN 
.fOR I- DASEDELAY' ("",lipr .. ioa_biu l·MOREDELAV 
.11' canlip ..... _biu-oOO l TlIEN r - I liI. 
:~~~~~~.~~~.'!:'!!!.~I.I~~!:.~~~~ .... 
SwnatON BSI' PORTa, ~ 
BSI' PORTA. 0 
CALL IIASEOELAY 
DECfSZ ddqot" l. r 
MOREDELAY 
........................................ 
.OPEN VALVE 
.SWITCII ON LEO 
.WAIT I· BfUEDELAY 
.OECREASE TIlE COUNTER OP 
.MOREDELAY 
.AND CALL MOREDELA Y 
.SWITCIION. SWITCIIES OFI' nlE VALVE ANO KEEPS IT nOSED 
.FOR 1-BASEDELAY • ("",ropu"ioa_IMu) ' MOREOELAY 
.11'"", rop .. ioa_bilPOOl mEN ( -Ill< 
:~~~:~~.~;~.~!~!.~~!.:~~~~ .... 
SWITOtDfF ea f'OltTa, ~ 
END 
0C1' P'ORTA,O 
CALL BASEDELAY 
DECfSZ ebyeRI!. ( 
CALL 
GOm 
MOREDELAY 
IlEADPORT 
.ClOSE VALVE 
.S ..... ITCHOI'F LED 
.WAIT 1· 9 .... SEDELAV 
.DECREASE TilE COl/NiU OF 
.[)ELA ~· 
.CALLMCREOELAY 
.CVa.£ ANIS IIED. GO BACK ANO . 
.OIECX. CONAOURA TION alTS 
F igure 11.4 - Slave " Controller code 
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ETHICAL APPROVALS 
ApPENDIX 
Ill. ETHICAL ApPROVALS 
This appendi x presents the letters which confirm that ethical approval has 
been obtained from the relevant Ethics Committees. 
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ETHICAL APPROVA LS 
Leicestershire rl'l:k1 
MelanIeSUtaham 
Dl,ecfDiaJ 0" 6 258 ~6 ro 
10 September 2001 1 ~ S£P 2001 
Gw.ndolen Road 
Leicester 
LES 40F 
Mr T Spy! 
Te l: 0116 Z73 11 73 
Fax: 0116258S577 
OX 709470 Le icester 12 
Consultant Cardiothoracic Surgeon 
GJenfield Hospital 
Dear Mr Spy! 
19 SEP ZOO) 
Non Invasive Measurement of Change" In Peripheral Perfu .. lon during 
CardIac Surgery and Its Relation to Cardiac Functlon - ~r raf no 6416 
Further to your application dated 20 June, you w ill be pleased to know that the 
Leicestershire Research Ethics Committee at its meeting held on the 7 
September 2001 approved your application to undertake the above-mentioned 
research. 
The Committee wondered If patients would be randomlsed to either 
hypothermic or normothermic cardiopulmonary bypass. It was assumed that 
no randomisation was Involved as there is no mention of it in the application or 
protocol. 
The Committee felt that the patient information was too brief and should be 
revised to be more patient friendly and include more detail of the rationale, 
methods/design of the study. It was assumed that clinical management would 
be standard as for current practice. The collection of data was additional. 
'Essentially' In question 2 should be removed . Perhaps you would let me 
have a revised information sheet for further consideration. 
Your attention Is drawn to the attached paper which reminds the researcher of 
information that needs to be observed when Ethi~ Committee approval is 
given. 
Yours sincerely 
PG Rabey 
Chairman 
Leicestershire Research Ethics CommIttee 
(NB All communications relaUnlil to Lelcosbtfshire R .... rch Ethi~ .Committ:ae must tH 
s..,t to the Committee Socratar1at at LAIc:e.tNshlre Health Authority. If, however, your 
original ~plication ¥RS submitbtd through a Trust R4 ... rch & Development OffJee, 
then any response or further corr •• pondenC9 rnu.t be IIJJ.bmltted In the s.m. way.) 
Figure III.1 - Clinical feasibili ty study approval letter 
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ETHICAL APPROVALS 
LOUGHBOROUGH UNIVERSITY 
ETHICAL ADVISORY COMMITTEE 
RESEARCH PROPOSAL 
INVOLVING HUMAN PARTICIPANTS 
RefNo: R07-P1 2 
Title: Assessment of peripheral venous oxygen changes during arteria-venous 
occlusion using new non-invasive oximetry system (Venox) 
Appl icant: Dr S Hu, Mr A Echiadis 
Department: Electronic and Electrical Engineering 
Oat. 01 clearance: 13 February 2007 
Comments of tho Committee: 
The Committee agreed to issue clearance to proceed subject to the [ol lowing conditions: 
The Committee expressed concern that the high level o[ arm cuff pressure to be applied 
could cause Significant discomfort and bruising. The investigators were asked to provide 
additional information to justify the levels of pressure involved in the context of the 
research, and to establish that this was standard practice, The Committee noted also 
that partiCipants would be unlikely to understand what "twice your arterial systolic blood 
pressure~ actually meant in practice, and noted that the Participant Information sheet 
should be amended to explai n this more clearly in layman's terms. 
• That the investigators noted that the University's Code of Practice on Persons Having 
Contact with Human Body Fluids had been replaced with new Health and Safety Policies 
on Blood Borne Viruses and Pathogens (excluding Blood Borne Vi ruses). The new 
policies were available on the Committee's web-pages. 
• That full contact details, including telephone numbers, of the investigators be included 
on the Participant Inlomnation Sheet. 
• That question 4 of the Health Screen Questionnaire was removed, as it was intended for 
use in proposals which involved participants undertaking exercise and was not 
appropriate in this context. 
Figure 1I1.2 - Venous oxygen de-saturation study approvalleUer 
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